WorldWideScience

Sample records for 14c-urea breath test

  1. Patient risk of 14C-urea breath test

    Helicobacter Pylori bacteria infection is determined by activity measurement of the exhaled 14C-carbon dioxide formed from 14C-urea in stomach. About 37 kBq of capsulated 14C -urea is administered to the patient. Because 14C is a weak beta emitter, patients receive certain radiation dose. This could be the only drawback of this method. Because of that in this paper the effective dose has been determined. On that basis the patient risk has been estimated. The results show that the patient effective dose is at the level of the daily background radiation. So, from the radiation protection point of view this method is very safe. Including other excellent performances of the method like sensitivity, selectivity, noninvasivity, fastness and low costs, it could be recommended in diagnosis and eradication of Helicobacter Pylori infections. (author)

  2. Diagnostic value of 14C urea breath test for Hp-associated peptic ulcer

    Purpose: To develop a method of 14C urea breath test and to evaluate the accuracy of the method in clinical diagnosis. Methods: Helicobacter pylori(Hp)-positive patients were defined either by positive bacterial culture or by positive rapid urease test of endoscopic biopsy specimens. 1384 patients with suspected peptic disease were underwent 14C urea breath test. Of them, 44 patients underwent dynamic test at various intervals to determine the optimal time for expiratory air collection. Results: Dynamic breath test showed that the highest point of 14C counts was at 30 min after administration of 14C urea. When a cut-off value of 3.5 was selected, the sensitivity and specificity was of the test for detecting Hp infection 96.7% and 96.5% respectively. Hp positive rate detected by 14C urea breath test in 1092 adults and 292 children was 50.4% and 81.2%. Conclusions: This study suggests that 14C urea breath test is a simple and reliable method for detection of Hp infection and is of high sensitivity and specificity

  3. Validation of 14 C-urea breath test for diagnosis of Helicobacter pylori

    The aim of this study was to validate the 14 C-urea breath test for use in diagnosis of Helicobacter pylori infection. Thirty H. pylori positive patients, based on histologic test and thirty H. pylori negative patients by histology and anti-H pylori IgG entered the study. Fasting patients drank 5 uCi of 14 C-urea in 20 ml of water. Breath samples were collected at O, 5, 10, 15, 20 and 30 min. The difference of cpm values between the two groups was significant at all the time intervals, besides time 0 (p 14 C-urea breath test is highly accurate for Helicobacter pylori diagnosis. It is fast, simple and should be the non-invasive test used after treating Helicobacter pylori infection. (author)

  4. 14C-urea breath test for the detection of Helicobacter pylori

    The high urease activity of Helicobacter pylori can be used to detect this bacterium by noninvasive breath tests. We have developed a 14C-urea breath test which uses 5 microCi 14C with 50 mg nonradioactive urea. Breath samples are collected at baseline and every 30 min for 2 h. Our study compared the outcome of the breath test to the results of histology and culture of endoscopically obtained gastric biopsies in 84 patients. The breath test discriminated well between the 50 positive patients and the 34 patients negative for Helicobacter pylori: the calculated sensitivity was 100%, specificity 88%, positive predictive value 93%, and negative predictive value 100%. Treatment with bismuth subsalicylate and/or ampicillin resulted in lower counts of exhaled 14CO2 which correlated with histological improvement in gastritis. The 14C-urea breath test is a better gold standard for the detection of Helicobacter pylori than histology and/or culture

  5. [14C]urea breath test for diagnosis of Helicobacter pylori

    H. pylori is a potent urease producer, a characteristic that has been exploited in the development of the [14C]- and [13C]urea breath tests. The prevalence of H. pylori infection also is known to increase with advancing age; however, the individual patient's age has not routinely been considered when interpreting urea breath test results. The aim of this study was to validate a short, age-adjusted [14C]urea breath test for use in diagnosing H. pylori infections. Forty-one subjects (28 volunteers, 13 patients) underwent esophagogastroduodenoscopy with biopsies. Subjects were defined as being H. pylori-positive if histology or culture was positive. In addition, all subjects completed a 120-min [14C]urea breath test. A logistic regression analysis adjusting for age was used to estimate the probability of H. pylori positivity as a function of the 14C values generated. Sixteen subjects were H. pylori-positive, and 25 were H. pylori-negative. The 14C values generated between 15 and 80 min were found to be equally predictive in identifying H. pylori-positive subjects. Advancing age was associated with a higher probability of H. pylori-positivity. By taking advantage of the statistical probabilities, older patients could be accurately diagnosed with H. pylori at lower 14C values. We found that [14C]urea breath test to be both a sensitive and specific test that can be abbreviated to a 30-min examination (total test time). Moreover, our mathematical model indicates that a patient's age should be considered in order to optimize interpretation of the [14C]urea breath test, although further observations are needed to confirm this model

  6. The microdose rapid 14C urea breath test compares well with the original rapid 14 breath test

    Full text: The 14C urea breath test (CUBT) is a sensitive test used in the detection of H. pylori infection. The rapid 14CUBT using 185 KBq of 14C urea showed a sensitivity of 100% when tested in 36 patients. The aim of this study was to compare the results of the 14CUBT performed following the ingestion of 37KBq microdose 14C urea capsule (Bicapsule, Trimed) with the earlier method which uses 185 KBq 14C urea. 19 patients (nine female age 21-52 yrs) were studied. All subjects first underwent a 14CUBT with the microdose capsule and a single 15 minute post ingestion sample. An hour later the test was repeated but with a dose of 185 KBq 14C urea in liquid form. A normal result was taken as 2 = 0.92). This is shown above. The Rapid 14CUBT performed following the microdose capsule whilst reducing patient radiation exposure is an accurate test for the detection of H. pylori. Copyright (2000) The Australian and New Zealand Society of Nuclear Medicine Inc

  7. Influence of oral and esophageal commensal microflora on 14C-urea breath test

    Full text: Seventeen gastritis patients (12M: 5F; mean age: 40 y) were studied to evaluate the influence of oral and esophageal urease producing commensal microflora on the 14C-urea breath test(UBT). To determine the influence of oral bacterial on UBT, 111 kBq14C-urea in 10 ml water was given orally to 6 H.pylori negative subjects, with the instructions to expectorate the tracer after 30 sec. To evaluate the influence normal esophageal flora on UBT, the tracer was given to 11 patients (4 H.pylori-ve :7 H.pylori +ve) in the capsule and again after 6 h in water. One mmol C02 was collected before and up to 30 min. of tracer administration and 14C content measured. When given as mouth wash, 14C-urea liquid caused an immediate peak of 14C02 at 2 min (4263 ± 1024 dpm) and thereafter declined sharply reaching base line value after 10 min (208 ±62 dpm). When tracer was given in capsule, 14C02 level in H.pylori +ve patients increased significantly within 5 min and peaked at 10-15 min. (8644 ± 987 dpm at 15 min). However, when the tracer was given in liquid, 14CO2 levels were almost similar to those of 14C-urea mouth wash experiment in H.pylori -ve patients. It is therefore, concluded that normal commensal microflora present in the oropharynx and esophagus contribute significantly to 14C-UBT. For the accurate diagnosis of H.pylori infection, the tracer should therefore, be given in the capsule

  8. Confirmation of eradication of Helicobacter pylori infection by 14C-urea breath test

    Helicobacter pylori (H. pylori) is a potent urease producer, a characteristic that has been exploited in the development of the 14C-urea breath test (UBT). 14C-UBT is being used as a highly reliable test for the diagnosis of H. pylori infection. There is paucity of reports on the utility of this test to confirm the H. pylori eradication after its treatment. The study was conducted to determine the utility of 14C-UBT in confirming the eradication of H. pylori

  9. Analysis of 14C-Urea breath test in patients with halitosis

    Objective: To explore the relationship between halitosis and the infection of helicobacter pylori (HP). Methods: The results of 14C-urea breath test of 59 normal people, 50 patients with halitosis only and 56 patients infected by both halitosis and digestive diseases were analyzed. Results: It showed that the 14C content and HP positive rate in group infected by both halitosis and digestive diseases were much higher than that of halitosis only group and normal people group (P<0.05). Conclusion: The infection of Helicobacter pylori is an important factor but not only factor of halitosis. (authors)

  10. 14C-urea breath test in the detection of Helicobacter pylori infection

    Helicobacter pylori infection is supposed to be one of the major causes of digestive and other diseases. Among a lot of invasive and non-invasive methods for its detection, none is ideal. The aim is an assessment of the Helicobacter pylori infection in the stomach using breath test and comparison to other diagnostic methods, as well as following up the effects of therapy. In 17 patients with digestive discomfort, breath test, rapid urease test and histology were performed, while in 47 patients with proven HP infection the effect of therapy was followed up using breath test and clinical findings. Breath test was performed after per oral administration of the capsule of 14C urea (37 kBq). Findings of the breath and urease tests were in accordance in 14/17 patients (83%) while breath test and histology in 16/17 patients (94%). During follow-up of the therapeutic effects, breath test and clinical findings were in accordance in 43/47 patients (98%). Breath test can be useful in diagnosis but is a method of choice in following up the patients after therapy for H. pylori infection, because it is non-invasive, fast and precise. (author)

  11. Accuracy of the 14 C-urea breath test for the diagnosis of Helicobacter pylori

    The development of simple, accurate and low-expense techniques for detection of Helicobacter pylori infection has great relevance. The objective was to determine the accuracy of a rapid 14 C-urea breath test (UBT) employing a very simple device for breathed air collection. One hundred and thirty-seven adult patients who underwent upper gastrointestinal endoscopy in the Clinical Hospital. The main measurements were histology for Helicobacter pylori (HP); urease test; urea breath test (UBT). One hundred and fifteen patients were infected by HP (HP +) according to both histology and the urease test, and 22 patients were HP-negative (HP-), according to the same two tests. UBT was capable of discriminating between HP + and HP- in a way that was similar to the combination of urease test and histology. When this combination of results is taken as the 'gold standard' for HP infection, the sensitivity and specificity of UBT are both greater than 90% for a range of cut-off points and breathed air collection times. It was concluded that the rapid UBT employing a simple device for air collection has a high accuracy in determining HP infection. (author)

  12. The fate of ingested 14C-urea in the urea breath test for Helicobacter pylori infection

    The metabolic fate of the radioactive carbon in the 14C-urea breath test for Helicobacter pylori was investigated in 18 subjects. After ingestion of labelled urea, breath was sampled for 24 h, and urine was collected for 3 days. Subjects were designated high or low expirers on the basis of their breath counts, and this agreed well with H. pylori serologic analyses. When given 185 or 37 kBq of 14C-urea, 51% of the label was recovered from the breath of high expirers, and 7% from the breath of low expirers. The mean combined urinary and breath recovery for high expirers was 86%, and for low expirers it was 97%. It is concluded that the long-term retention of 14C from ingested 14C-urea is low. The results enable a more accurate estimation to be made of radiation exposure resulting from the 14C-urea breath test. 16 refs., 3 figs., 2 tabs

  13. Microdose 14C urea breath test for the diagnosis of Helicobacter pylori: a survey in Iranian population

    Reza Dowlatabadi Bazaz

    2005-01-01

    Full Text Available The carbon -14 urea breath test (UBTis a non-invasive and simple method for the diagnosis of Helicobacter pylori infection. Attempts have been made to use lower doses of 14C-urea in the UBT in order to reduce the radiation risk of the test. The aim of this study was to assess the accuracy of a microdose (1 µCi [37 KBq] 14C-UBT in Iranian population for validation of its diagnostic accuracy against gold standard methods. Eighty and two patients were subjected to upper gastrointestinal endoscopy as well as 14C-UBT in one week. Rapid urease test and histological examinations were used as gold standard. Breath samples were collected 10, 20 and 30 minute after ingestion of 1 µCi of 14C- urea solution and their activities were measured using a scintillation counter and expressed as counts per minute (cpm and disintegration per minute (dpm. Good agreement was observed between the 14C-UBT and gold standard for samples which were collected 20 minutes after 14C-urea administration. The 14CUBT showed 100% sensitivity, 95% specificity, 95.45% positive predictive value, 100% negative predictive value and 97.50% accuracy. The results of this study showed good concordance between the 14C-UBT and invasive methods.

  14. Intragastric acidification increases the sensitivity of 14C-urea breath test in patients taking a proton pump inhibitor

    Objective: To investigate if intragastric acidification at the ingestion of 14C-urea can decrease the likelihood of false-negative (FN) results of urea breath test (UBT) in patients taking a proton pump inhibitor (PPI). Methods: Twenty-three patients with positive 14C-UBT (UBT-1) results underwent an acid suppression treatment with omeprazole 40 mg/d for 14 d. On day 13, patients underwent second standard UBT (YBT-2). On day 14, patients underwent a modified UBT (UBT-3), which included consuming 200 mL of 0.1 mol/L citric acid solution 30 min before and at the administration of 14C-urea. Mean 14CO2 expiration and the number of FN results were compared for the three UBTs. Results: Omeprazole caused a significant decrease in mean 14CO2 excretion between UBT-1[(5.57 +- 3.90) Bq/mmol] and UBT-2[(1.98 +- 1.42) Bq/mmol, t=5.867, P=0.000]. Omeprazole caused 10(43.5%) FN UBT-2 results. Mean 14CO2 expiration in UBT-3 [(4.93 +- 3.77) Bq/mmol] was greater than that in UBT-2 (t=-4.538, P=0.000). UBT-3 caused only 2 FN results (8.7%, x2=6.66, P14C-urea increases 14Co2 expiration and decreases FN 14C-UBT results in patients taking PPI

  15. A study on Helicobacter pylori infection in different parts of Karnataka using 14C urea breath test

    A non-invasive 14C Urea Breath Test (14C UBT) technique was used for the diagnosis of Helicobacter pylori (H pylori) infection in symptomatic and asymptomatic individuals. The test utilises 14CO2 released due to the action of urease produced by H pylori. 14C UBT is found to be a simple alternative for endoscopic examinations for diagnosing H pylori infection. The test was performed on 664 subjects from various parts of Karnataka. Among them 34.9% of the subjects were found to be H pylori positive, and the infection rate varied from 16.9% to 38.6%. (author)

  16. A methodological aspect of the 14C-urea breath test used in Helicobacter pylori diagnosis

    The main purpose of those investigations was optimisation of the performing time of the breath test with 14C-labelled urea which reveals Helicobacter pylori infection. It was analysed 117 species, preselected according to endoscopy and histopathology results, 56 of them have suffered from chronic gastritis and 61 from gastric ulcer disease. Using microbiology diagnosis (culture + IFP test) it was found that 86 species were H. pylori infected. This group of patients were next subject to investigations with the breath test with 14C-labelled urea. Measurements of radioactivity of breathe air have been carried out for 30 minutes. The obtained results allow us to maintain that the optimal time of duration of the test described above is 30 minutes. (author)

  17. Investigation of the association between glaucoma and Helicobacter pylori infection using the {sup 14}C-urea breath test

    Tuzcu, Esra Ayhan; Aydogan, Fusun; Motor, Vicdan Koksaldi; Ilhan, Ozgur; Daglioglu, Mutlu Cihan; Coskun, Mesut; Parlakfikirer, Nihan; Keskin, Ugurcan, E-mail: drayhant@hotmail.com [Medical Faculty, Mustafa Kemal University, Hatay (Turkey)

    2015-07-01

    Purpose: to investigate the association between glaucoma and Helicobacter pylori infection by evaluating for the presence of H. pylori infection in patients with glaucoma using the 14C-urea breath test (14C-UBT). Methods: Using 14C-UBT, H. pylori infection positivity was compared between a group of patients with primary open-angle glaucoma and a control group with normal intraocular pressure and a normal optic disc or normal perimetry. Results: the 14C-UBT was positive in 18 (51.42%) out of 35 patients in the glaucoma group and in 15 (42.85%) out of 35 patients in the control group. H. pylori infection positivity rates were similar between the glaucoma and control groups (p>0.05). Conclusion: according to the 14C-UBT, there is no association between primary open-angle glaucoma and H. pylori infection. (author)

  18. Investigation of the association between glaucoma and Helicobacter pylori infection using the 14C-urea breath test

    Purpose: to investigate the association between glaucoma and Helicobacter pylori infection by evaluating for the presence of H. pylori infection in patients with glaucoma using the 14C-urea breath test (14C-UBT). Methods: Using 14C-UBT, H. pylori infection positivity was compared between a group of patients with primary open-angle glaucoma and a control group with normal intraocular pressure and a normal optic disc or normal perimetry. Results: the 14C-UBT was positive in 18 (51.42%) out of 35 patients in the glaucoma group and in 15 (42.85%) out of 35 patients in the control group. H. pylori infection positivity rates were similar between the glaucoma and control groups (p>0.05). Conclusion: according to the 14C-UBT, there is no association between primary open-angle glaucoma and H. pylori infection. (author)

  19. Prevalence of Helicobacter Pylori in gastric cancer in a south-east Asian population by 14C-urea breath test

    Helicobacter pylori is believed to play an important role in the aetiology of gastric cancer. There is a great variability in seropositivity and histological frequency of H. pylori in gastric cancer. The present prospective study investigates the prevalence of H. pylori infection in gastric cancer patients using 14C-urea breath testing. Patients with endoscopic biopsy-proven gastric cancer were fasted for 6 h prior to ingesting 18.5 x 104 Bq of 14C-urea cocktail orally. Breath samples were collected after 20 min by AS/King them to blow into a hyamine solution and measurements were read in a scintillation counter. Fifty out of 51 patients (98%) with gastric cancer were positive on the 14C-urea breath test compared to 29 patients (61%) who were positive on histology. There was no association between sex, age or tumour site, stage, differentiation, Lauren type and H. pylori status. The test was negative in one patient with cardiac tumour in which histology of the resected specimen was also negative for the bacteria. Active H. pylori infection is highly prevalent in gastric cancer in a South-East Asian population. The 14C-urea breath test is a highly sensitive method for detecting the presence of H. pylori even in gastric adenocarcinoma irrespective of the stage

  20. MIN 14C UBT: A combination of gastric basal transit and 14C-urea breath test for the detection of helicobacter pylori infection in human beings

    The purpose of this work is to demonstrate that the 14C-urea breath test (UBT) performed at different times combined with the study of the gastric basal transit, which evaluates the intragastric displacement of a labeled solution under fasting conditions, has the advantage of being representative of the whole stomach surface and constitutes a non-aggressive test for the detection of H. pylori. This test, which has been called MIN 14C UBT, is a modification of the conventional 14C UBT in which low volumes of a solution of 14C-urea together with 99mTc-sulfur colloid are administered. The 99mTc-sulfur colloid is not absorbed in the gastrointestinal tract and has the great advantage of allowing the 'visualization' of the transit of the 14C-urea within the gastrointestinal tract. This modification allows the simultaneous determination of the production of the 14CO2 and the place where this process occurs. The results show that there is a good correlation between the images obtained and the breath samples collected. We found that this test has a sensitivity of 98% and a specificity of 96% for H. pylori detection

  1. Influence of citric acid solution as a test drink in the 14C-urea breath test for diagnosis of helicobactor pylori infection

    Different test meals are used in the 14C-urea breath test (UBT) for the detection of H.pylori infection. The purpose of using test meals is to slow gastric emptying and to maximise the distribution of the urea substrate within the stomach so as to increase the area and time of contact between bacteria and substrate. Recently, citric acid has been suggested as an improved liquid test meal. The mechanism is not known and could act by delaying gastric emptying, decreasing the pH at the site of the bacteria, or both

  2. Comparative performance of capsulated Vs non-capsulated 14C-urea breath test for the detection of Helicobacter pylori infection

    Conventionally, 14C-urea breath test (14C-UBT) is employed as a 'gold standard' technique for the detection of active Helicobacter pylori (H pylori) infection, to follow up the patients after its eradication and for epidemiological evaluations. Due to high accuracy of this test and other benefits it is recommended as the best option for 'test-and-treat' strategy in primary health care centers. So far no appropriate study has been done to compare the performance of 14C-UBT using capsulated versus non-capsulated protocol. In this study, we employed a novel technique of performing capsulated 14C-UBT with simultaneous monitoring the dynamic movement of capsule and compared the results with non-capsulated protocol. (author)

  3. 14C urea breath test kit- an evaluation of a compact, cost-effective kit for the detection of H. pylori

    Full text: Helicobacter pylori infection of the gastric mucosa causes active chronic gastritis and peptic ulceration. Carbon-14 urea breath testing has been well documented in its ability to detect the presence of H. pylori. The aims of this study were to evaluate and refine the test to substantially reduce costs and improve its simplicity, availability and accuracy. We reviewed the results of 138 patients who underwent 14C urea breath testing for the detection of H. pylori utilising a kit developed at the Royal Adelaide Hospital. Modifications to the standard technique that were assessed included the relevance of buccal cleansing, single sample v multiple sampling, use of alternative CO2 absorbers and sampling techniques. In those patients with positive biopsy results, a test sensitivity of 100% was achieved. No buccal cleansing is necessary (45% oral contamination without brushing teeth v 41% with). A single breath sample only at 15 min resulted in 100% sensitivity. Alternative cheaper and safer) CO2 absorbers such as KOH can be used. Based on these results, modifications to this well documented test have enabled us to substantially reduce costs, improve simplicity and safety and increase accuracy and availability of the test for the detection of Helicobacter pylori

  4. {sup 14}C urea breath test kit- an evaluation of a compact, cost-effective kit for the detection of H. pylori

    Bellon, M.S. [Royal Adelaide Hospital, SA (Australia). Dept of Nuclear Medicine

    1998-03-01

    Full text: Helicobacter pylori infection of the gastric mucosa causes active chronic gastritis and peptic ulceration. Carbon-14 urea breath testing has been well documented in its ability to detect the presence of H. pylori. The aims of this study were to evaluate and refine the test to substantially reduce costs and improve its simplicity, availability and accuracy. We reviewed the results of 138 patients who underwent {sup 14}C urea breath testing for the detection of H. pylori utilising a kit developed at the Royal Adelaide Hospital. Modifications to the standard technique that were assessed included the relevance of buccal cleansing, single sample v multiple sampling, use of alternative CO{sub 2} absorbers and sampling techniques. In those patients with positive biopsy results, a test sensitivity of 100% was achieved. No buccal cleansing is necessary (45% oral contamination without brushing teeth v 41% with). A single breath sample only at 15 min resulted in 100% sensitivity. Alternative (cheaper and safer) CO{sub 2} absorbers such as KOH can be used. Based on these results, modifications to this well documented test have enabled us to substantially reduce costs, improve simplicity and safety and increase accuracy and availability of the test for the detection of Helicobacter pylori.

  5. Comparative diagnostic value of the breath test and the urine test with 14C-urea in the detection of the Helicobacter pylori infection

    Among 92 patients with chronic gastritis we conducted a synchronous diagnosis of the Helicobacter pylori (H. pylori) infection using a culture and a serological test (IFP), in conjunction with breath and urine tests involving 14C-urea (BTU-C14 and UTU-C14). The infection was confirmed by isolation in 71 persons (77.2%), the presence of specific IgG in the blood serum was found in 75 (81.5%). In comparison, the BTU-C14 indicated a group of 77 people (83.7%) as infected, and the UTU-C14 a group of 76 (82.6%). In order to determine the diagnostic value (sensitivity, specificity and efficiency) of the latter tests, the results were compared with those of the culture and of the serological tests. It was found that the BTU-C14 test used showed a 100% sensitivity, a 89.5% specificity and a 97.9% efficiency. The UTU-C14 test showed a 100.0% sensitivity, a 94.4% specificity and a 98.9% efficiency in the detection of the H. pylori infection. (author)

  6. A methodological aspect of the {sup 14}C-urea breath test used in Helicobacter pylori diagnosis; Wybrany aspekt metodologiczny testu oddechowego z mocznikiem znakowanym stosowanego w diagnostyce zakazenia Helicobacter pylori

    Kopanski, Z.; Niziol, J.; Micherdzinski, J.; Wasilewska-Radwanska, M.; Cienciala, A.; Lasa, J.; Witkowska, B. [Szpital Wojskowy, Cracow (Poland)]|[Institute of Physics and Nuclear Techniques, Academy of Mining and Metallurgy, Cracow (Poland)]|[Institute of Nuclear Physics, Cracow (Poland)

    1996-12-31

    The main purpose of those investigations was optimisation of the performing time of the breath test with {sup 14}C-labelled urea which reveals Helicobacter pylori infection. It was analysed 117 species, preselected according to endoscopy and histopathology results, 56 of them have suffered from chronic gastritis and 61 from gastric ulcer disease. Using microbiology diagnosis (culture + IFP test) it was found that 86 species were H. pylori infected. This group of patients were next subject to investigations with the breath test with {sup 14}C-labelled urea. Measurements of radioactivity of breathe air have been carried out for 30 minutes. The obtained results allow us to maintain that the optimal time of duration of the test described above is 30 minutes. (author) 38 refs, 2 tabs, 1 fig

  7. 口臭患者14C呼气试验检测的结果分析%Analysis of 14C-Urea Breath Test in Patients with Halitosis

    陈建中; 张旭峰; 张斌; 李黎; 童妙春; 陈驰

    2012-01-01

    Objective To explore the relationship between halitosis and the infection of helicobacter pylori (HP). Methods The results of l4C-urea breath test of 59 normal people, 50 patients with halitosis only and 56 patients infected by both halitosis and digestive diseases were analyzed. Results It showed that the 14C content and HP positive rate in group infected by both halitosis and digestive diseases were much higher than that of halitosis only group and normal people group (P <0.05). Conclusion The infection of Helicobacter pylori is an important factor but not only factor of halitosis.%目的 探讨口臭与幽门螺旋杆菌及其它因素的关系.方法 对59名正常组、50例单纯口臭组患者、56例口臭伴消化道疾病组患者14C 呼气试验的结果进行分析.结果 分析结果表明,口臭伴消化道疾病组14C呼气试验含量明显高于单纯口臭组和正常组(P<0.05),阳性率也明显高于单纯口臭组和正常组(P<0.05).结论 幽门螺旋杆菌感染是口臭的重要原因,但不是唯一原因.

  8. 14C-尿素呼吸试验检测消化专业医务人员HP感染及药物清除的观察%The Investigation of Prevalence of H. Pylori with 14 C-urea Breath Test and Therapeutic Effect in Digestive Staffs

    杨强; 方桢; 蔡丽; 艾津; 张克森

    2001-01-01

    目的:了解从事消化专业的医务人员HP感染情况及药物清除疗效。方法:14C-尿素呼吸试验检测天津 医大三所附属医院消化内镜工作者及相关人员25名的HP感染情况。应用法莫替丁,替硝唑,枸橼酸铋胺,三联2 周疗法对HP阳性者行根除治疗,同法检测根除疗效。结果:HP感染率为96%,高于文献报道普通人群的感染率。 14C-UBT放射活度测定值在医生组高于护技组,工作年限高于10年组高于短工作年限组。三联2周疗法HP根除 率为73.7%。结论:消化内镜工作人员对HP易感染,应注意对HP感染的预防。感染后药物根除治疗有效。%Objective:To investigate the prevalence of H. pylori (HP) and therapeutic effect in digestive staffs. Methods: The in fection of HP were detected in 25 digestive endoscopists and relative staffs using 14C-urea breath test (14 C-UBT). People with Hp positive infection were treated with famotidine, tinidazole, bismuth, and ammonium citrate for 2 weeks. Results: The rate of infection of Hp in endoseopists was 96% ,and was higher than that in regular people. The count ofdpm 14C- UBT was higher in doctor group than that in nurse and technician group,and it was higher in doctors with the experience more than 10 years than that with the experience less than 10 years. The rate of eradication against Hp with the treatment of famotidine, tinidazole,bismuth,and ammonium citrate for 2 weeks was 73.7 %. Conclusion: The endoseopists are sensitive to HP. Prevention from infection of-HP should be obtained for all endoscopists. Treatment of Hp infection with medicine is effective.

  9. An application discussion of 14C urea breathing test (UBT) examination H. pylori infection in senile disease diagnosis%14C尿素呼气试验检测幽门螺杆菌感染在老年人疾病诊断中的应用探讨

    关小红

    2005-01-01

    目的:探讨14C尿素呼气试验(urea breath test,UBT)检测幽门螺杆菌(H.pylori)感染在老年人消化道疾病、急性冠脉综合征(ACS)诊断中的意义.方法:用自身对照的方法比较30例消化道疾病患者内镜活检快速尿素酶试验H.pylori阳性与UBT阳性、血清学阳性情况,20例血清学H.pylori抗体阳性的ACS患者与UBT、内镜阳性情况.结果:消化道疾病组内镜活检H.pylori阳性者做UBT的阳性率为93%,血清学阳性95%,血清学H.pylori阳性的ACS者做UBT的阳性率为50%,不稳定心绞痛者症状消失10 d后查内镜H.pylori阳性率为42%.结论:用UBT诊断老年人与H.pylori感染有关的疾病安全可靠.

  10. Urea recycling from the renal pelvis in sheep: A study with [14C]urea

    To test the hypothesis that urea can be recycled from the renal pelvis, [14C]urea diluted in native urine (1 microCi/ml) was perfused (0.5 ml/min) into one of the pelvises of sheep fed either normal (NP) or low (LP)-protein diets. Blood samples were obtained from the ipsilateral renal vein and from the carotid artery throughout the perfusions. 14C activity determinations in urine and plasma demonstrated a flux of [14C]urea from the pelvis to renal vein blood (40,000 in NP and 130,000 disintegrations/min in LP sheep, P less than 0.01). The corresponding flux of native urea was only 1.5 times higher in NP than in LP sheep (6.8 +/- 1.1 vs. 4.7 +/- 2.9 mumol/min, not significant) despite their 8 times higher urinary concentration of urea. The fraction of filtered urea that was reabsorbed in the pelvis was larger in LP sheep (7.5 +/- 3.7 vs. 1.9 +/- 0.7% in NP sheep, P less than 0.05). A fraction of urea is thus actually recycled from the renal pelvis in sheep, and this pelvic retention is enhanced in LP animals. The importance of this phenomenon in the nitrogen economy is discussed

  11. A 20-minute breath test for helicobacter pylori

    In this study, we evaluated a simplified rapid 14C-urea breath test for the diagnosis of Helicobacter pylori. Fasting patients undergoing initial assessment for H. pylori drank 5 microCi of 14C-urea in 20 ml of water. Breath was collected at intervals for 30 min. Samples were counted in a beta-counter, and the results were expressed as counts per minute (cpm). In the same week, patients underwent endoscopy, and a blinded investigator examined biopsy samples of gastric mucosa by culture and histology for H. pylori. There were 49 H. pylori-negative (HP-) and 104 H. pylori-positive (HP+) patients in the study. HP+ patients expired a mean of 4398 cpm (SD 2468) per mmol CO2 in a sample taken 20 min after ingestion of the isotope. In contrast, HP--patients expired only 340 cpm (SD 196). If the mean +3 SD of HP- patients was used as a cutoff value, the 20-minute sample gave a sensitivity of 97% and a specificity of 100% for detecting H. pylori. The radiation exposure from this test is less than 1% of that received from an upper gastrointestinal series, and the short collection time makes it both convenient and cost effective

  12. Breath alcohol test

    Alcohol test - breath ... There are various brands of breath alcohol tests. Each one uses a different method to test the level of alcohol in the breath. The machine may be electronic or manual. One ...

  13. [Hydrogen Breath Tests].

    Häussler, Ulrich; Götz, Martin

    2016-02-01

    In the field of gastroenterology hydrogen breath test are used for the diagnosis of carbohydrate malabsorption and small intestine bacterial overgrowth. This paper provides information on performing a hydrogen breath test and shows potential sources of error. PMID:26886040

  14. Validation of a simplified carbon-14-urea breath test for routine use for detecting Helicobacter pylori noninvasively

    A carbon-14 (14C) urea breath test for detecting Helicobacter pylori with multiple breath sampling was developed. Carbon-14-urea (110 kBq) administered orally to 18 normal subjects and to 82 patients with Helicobacter infection. The exhaled 14C-labeled CO2 was trapped at 10-min intervals for 90 min. The total 14C activity exhaled over 90 min was integrated and expressed in %activity of the total dose given. In normals, a mean of 0.59% +/- 0.24% was measured, resulting in an upper limit of normal of 1.07%. In 82 patients, a sensitivity of 90.2%, a specificity of 83.8%, and a positive predictive value of 90.2% was found. The single probes at intervals of 40-60 min correlated best with the integrated result, with r ranging from 0.986 to 0.990. The test's diagnostic accuracy did not change at all when reevaluated with the 40-, 50-, or 60-min sample data alone. Thus, the 14C-urea breath test can be applied routinely as a noninvasive, low-cost and one-sample test with high diagnostic accuracy in detecting Helicobacter pylori colonization

  15. The isotope breathe test

    The foundations of the breath diagnostic test, based on application of the carbon compounds, labeled with the stable (13C) or radioactive isotope are presented. The methodology for conducting the breath isotope test and the apparatuses, making it possible to determine under clinical conditions the isotope composition of the carbon, contained in the expired air, depending on the introduced tracer type, is briefly described. The safety of the method and prospects of its application are discussed. The examples of the breath isotope test practical application are presented

  16. Effect of lung injuries on [14C]urea permeability-surface area product in dogs

    To determine whether [14C]urea permeability-surface area product (PS) is a reliable indicator of changes in permeability in various injuries and its relationship to indicator-dilution and gravimetric lung water contents, we studied six groups of anesthetized, paralyzed, and mechanically ventilated dogs (5 animals each). The groups consisted of control dogs, those injured by intravenous alloxan, oleic acid, or glass beads, and those exposed to acute hypoxia or increased left atrial pressure from volume loading (Pla). Interanimal variation of PS was large (3.0-15.0 ml/s), but successive hourly values in individual animals were stable for 2 h in experimental groups and for 4 h in controls. The PS increased after alloxan, elevated Pla, and 2 h of hypoxia; PS decreased after oleic acid and micremboli. The gravimetric lung water increased after alloxan, oleic acid, and microemboli, and indicator-dilution lung water increased only after alloxan. We conclude (1) that intersubject variability requires normalization to enable detection of significant deviation from base line, and (2) that decreased PS after oleic acid and microvascular injury occurred because vascular obstruction, which decreased surface area, masked probable coexisting increases in capillary permeability

  17. 13C-urea breath test analyzed with infrared isotope spectrometry for the diagnosis of Helicobacter pylori

    The authors have evaluated a 13C-urea breath test for the diagnosis of Helicobacter pylori infection. The 13C-test was analyzed with isotope-selective non-dispersive infrared spectrometry and compared with a 14C-urea breath test and the urease test in gastric mucosal biopsies. 46 patients were analyzed with breath tests, 23 patients were negative and 22 patients were positive with both methods. One patients was positive with 14C-method and negative with the 13C-urea breath test. 61 patients were analyzed with the 13C-urea breath test and the urease test. 30 patients were negative and 30 patients were positive with both methods, whereas one patient with a negative urease test had a positive breath test. 13C-urea breath test analyzed with isotope-selective non-dispersive infrared spectrometry is a fast, simple, non-radioactive, non-invasive, convenient and reliable method for the diagnosis of Helicobacter pylori infection. 12 refs., 2 figs., 1 tab

  18. Clinical applications of breath testing

    Paschke, Kelly M; Mashir, Alquam; Dweik, Raed A.

    2010-01-01

    Breath testing has the potential to benefit the medical field as a cost-effective, non-invasive diagnostic tool for diseases of the lung and beyond. With growing evidence of clinical worth, standardization of methods, and new sensor and detection technologies the stage is set for breath testing to gain considerable attention and wider application in upcoming years.

  19. Biokinetics and radiation dosimetry of 14C-labelled triolein, urea, glycocholic acid and xylose in man. Studies related to nuclear medicine 'breath tests' using accelerator mass spectrometry

    14C-labelled substances have been used in biomedical research and clinical medicine for over 50 years. Physicians and scientists however, often hesitate to use these substances in patients and volunteers because the radiation dosimetry is unclear. In this work detailed long-term biokinetic and dosimetric estimation have been carried out for four clinically used 14C-breath tests: 14C-triolein (examination of fat malabsorption), urea (detection of Helicobacter pylori infection in the stomach), glycocholic acid and xylose (examination of bacterial overgrowth in the small intestine) by using the highly sensitive accelerator mass-spectrometry (AMS) technique. The AMS technique has been used to measure low 14C concentrations in small samples of exhaled air, urine, faeces and tissue samples and has improved the base for the estimation of the absorbed dose to various organs and tissues and the effective dose to man. The high sensitivity of the AMS system has also made it possible to perform 14C breath tests on patient groups which were earlier subject for restriction (e.g. small children). In summary, our results show that for adult patients - and in the case of 14C-urea breath test also for children down to 3 years of age - the dose contributions are comparatively low, both described as organ doses and as effective doses. For adults, the latter is: 14C-glycocholic acid - 0.4 mSv/MBq, 14C-triolein - 0.3 mSv/MBq, 14C-xylose - 0.1 mSv/MBq and 14C-urea - 0.04 mSv/MBq. Thus, from a radiation protection point of view there is no reason for restrictions in using any of the 14C-labelled radiopharmaceutical included in this work in the activities normally used (0.07-0.2 MBq for a 70 kg patient)

  20. Radiation exposure of the patient in diagnostic nuclear medicine. Experimental studies of the biokinetics of {sup 111}In-DTPA-D-Phe{sup 1}-octreotide, {sup 99m}Tc-MIBI, {sup 14}C-triolein and {sup 14}C-urea, and development of dosimetric models

    Leide Svegborn, S

    1999-03-01

    Biokinetic and dosimetric models for a number of clinically used radiopharmaceuticals, for which information on the radiation dosimetry is scarce, have been produced. On patients undergoing investigations with {sup 111}In-DTPA-D-Phe{sup 1}-octreotide (for diagnosis of neuroendocrine tumours) and {sup 99m}Tc-MIBI (for myocardial perfusion imaging), whole body gamma camera scanning was performed several times after administration of the radiopharmaceutical. Total body and organ activity content was determined using the geometric mean of the number of counts in two 180 deg opposed planar images. A thorough investigation of sources influencing the accuracy of the quantification of activity was carried out, showing an overall uncertainty varying from 10% to 30% for organs with a significant uptake and 5% for the whole body. The activity in blood and urine was also measured. {sup 111}In-DTPA-D-Phe{sup 1}-octreotide was predominantly excreted via the kidney-bladder system and a typical investigation with 1200 MBq resulted in an effective dose of 8.4 mSv (0.076 mSv/MBq). {sup 99m}Tc-MIBI was to a great extent excreted via the gastrointestinal tract and an investigation with 1200 MBq resulted in an effective dose of 13 mSv (0.011 mSv/MBq). Accelerator mass spectrometry (AMS) was used to investigate the possibility to measure ultra-low activity concentrations of {sup 14}CO{sub 2}, in exhaled air from patients undergoing {sup 14}C-breath tests, with special application to {sup 14}C-triolein (for study of fat malabsorption). AMS was proven to be a useful technique for long-term retention studies of {sup 14}C, and was used together with liquid scintillation counting in an investigation of the biokinetics of {sup 14}C-urea in adult and paediatric patients (for diagnosis of Helicobacter pylori infection in the upper gastrointestinal tract). The effective dose for {sup 14}C-urea was 0.019 mSv/MBq for adults and from 0.041 to 0.019 mSv/MBq for seven- to fourteen -year-old children

  1. Radiation exposure of the patient in diagnostic nuclear medicine. Experimental studies of the biokinetics of 111In-DTPA-D-Phe1-octreotide, 99mTc-MIBI, 14C-triolein and 14C-urea, and development of dosimetric models

    Biokinetic and dosimetric models for a number of clinically used radiopharmaceuticals, for which information on the radiation dosimetry is scarce, have been produced. On patients undergoing investigations with 111In-DTPA-D-Phe1-octreotide (for diagnosis of neuroendocrine tumours) and 99mTc-MIBI (for myocardial perfusion imaging), whole body gamma camera scanning was performed several times after administration of the radiopharmaceutical. Total body and organ activity content was determined using the geometric mean of the number of counts in two 180 deg opposed planar images. A thorough investigation of sources influencing the accuracy of the quantification of activity was carried out, showing an overall uncertainty varying from 10% to 30% for organs with a significant uptake and 5% for the whole body. The activity in blood and urine was also measured. 111In-DTPA-D-Phe1-octreotide was predominantly excreted via the kidney-bladder system and a typical investigation with 1200 MBq resulted in an effective dose of 8.4 mSv (0.076 mSv/MBq). 99mTc-MIBI was to a great extent excreted via the gastrointestinal tract and an investigation with 1200 MBq resulted in an effective dose of 13 mSv (0.011 mSv/MBq). Accelerator mass spectrometry (AMS) was used to investigate the possibility to measure ultra-low activity concentrations of 14CO2, in exhaled air from patients undergoing 14C-breath tests, with special application to 14C-triolein (for study of fat malabsorption). AMS was proven to be a useful technique for long-term retention studies of 14C, and was used together with liquid scintillation counting in an investigation of the biokinetics of 14C-urea in adult and paediatric patients (for diagnosis of Helicobacter pylori infection in the upper gastrointestinal tract). The effective dose for 14C-urea was 0.019 mSv/MBq for adults and from 0.041 to 0.019 mSv/MBq for seven- to fourteen -year-old children, resulting in an effective dose of approximately 0.002 mSv per investigation

  2. Validity and cost comparison of "carbon urea breath test for diagnosis of H Pylori in dyspeptic patients

    Shahid Rasool; Shahab Abid; Wasim Jafri

    2007-01-01

    AIM: To validate and compare the cost of microdose 14C urea breath test (UBT) with histology and rapid urease test for the diagnosis of H Pylori.METHODS: Ninety-four consecutive patients with dyspeptic symptoms undergoing gastroscopy were enrolled. Gastric biopsies were taken for histology and rapid urease test. UBT was performed after gastroscopy by microdose "C urea capsules. Sensitivity, specificity and accuracy of UBT were calculated and compared with histology and rapid urease test. Cost comparison of these tests was also performed.RESULTS: H pylori was diagnosed by histology and rapid urease test in 66 (70%) and 61 (65%) patients, while 14C UBT detected infection in 63 (67%). Accuracy of UBT was 93% in comparison with histology while its positive and negative predictive values were 97% and 84%, respectively. Comparison of 14C UBT with rapid urease test gives an accuracy of 96%, with positive and negative predictive values of 95% and 97%, respectively. These results were highly reproducible with a Kappa test (P value < 0.001). Cost of histology or rapid urease test with gastroscopy was 110 USD or 95 USD respectively while the cost of UBT was 15 USD.CONCLUSION: Microdose 14C UBT was comparable to histology and rapid urease test. 14C UBT is an economical, self sufficient and suitable test to diagnose active Hpylori infection in less developed countries.

  3. Breath hydrogen test and sucrase isomaltase deficiency.

    Ford, R P; Barnes, G L

    1983-01-01

    Sucrose breath hydrogen tests were performed on 7 children with proved sucrase isomaltase deficiency. All children had raised breath hydrogen excretion. The amount of hydrogen produced and symptoms experienced increased with increasing sucrose loads. The sucrose breath hydrogen test appears to be a reliable indicator of sucrose malabsorption in sucrase isomaltase deficiency.

  4. Biokinetics and radiation dosimetry of {sup 14}C-labelled triolein, urea, glycocholic acid and xylose in man. Studies related to nuclear medicine 'breath tests' using accelerator mass spectrometry

    Gunnarsson, Mikael

    2002-08-01

    {sup 14}C-labelled substances have been used in biomedical research and clinical medicine for over 50 years. Physicians and scientists however, often hesitate to use these substances in patients and volunteers because the radiation dosimetry is unclear. In this work detailed long-term biokinetic and dosimetric estimation have been carried out for four clinically used {sup 14}C-breath tests: {sup 14}C-triolein (examination of fat malabsorption), urea (detection of Helicobacter pylori infection in the stomach), glycocholic acid and xylose (examination of bacterial overgrowth in the small intestine) by using the highly sensitive accelerator mass-spectrometry (AMS) technique. The AMS technique has been used to measure low {sup 14}C concentrations in small samples of exhaled air, urine, faeces and tissue samples and has improved the base for the estimation of the absorbed dose to various organs and tissues and the effective dose to man. The high sensitivity of the AMS system has also made it possible to perform {sup 14}C breath tests on patient groups which were earlier subject for restriction (e.g. small children). In summary, our results show that for adult patients - and in the case of {sup 14}C-urea breath test also for children down to 3 years of age - the dose contributions are comparatively low, both described as organ doses and as effective doses. For adults, the latter is: {sup 14}C-glycocholic acid - 0.4 mSv/MBq, {sup 14}C-triolein - 0.3 mSv/MBq, {sup 14}C-xylose - 0.1 mSv/MBq and {sup 14}C-urea - 0.04 mSv/MBq. Thus, from a radiation protection point of view there is no reason for restrictions in using any of the {sup 14}C-labelled radiopharmaceutical included in this work in the activities normally used (0.07-0.2 MBq for a 70 kg patient)

  5. The urine test with 14C-urea compared with other methods of diagnosing helicobacter pylori infection

    At present many diseases of the upper part of the alimentary canal are linked with infection by Helicobacter pylori (H.p.). The initiating role of that bacterium in the genesis of chronic gastritis is already recognised. Together with the progress in knowledge on H.p. the number of methods used to diagnose infection by the bacterium is also growing. So far, however, little attention has been attached to the use of measurements of the activity of the 14C excreted in the urine for the detection of H.p. infection

  6. Hydrogen Breath Tests in Gastrointestinal Diseases

    Rana, Satya Vati; Malik, Aastha

    2014-01-01

    Hydrogen breath tests are widely used to explore pathophysiology of functional gastrointestinal (GI) disorders. Small intestinal bacterial overgrowth (SIBO) and carbohydrate malabsorption are disorders detected by these tests that have been proposed to be of great importance for symptoms of GI diseases. Glucose hydrogen breath test is more acceptable for diagnosis of SIBO whereas lactose and fructose hydrogen breath tests are used for detection of lactose and fructose maldigestion respectivel...

  7. "VALIDATION OF 13C-UREA BREATH TEST WITH NON DISPERSIVE ISOTOPE SELECTIVE INFRARED SPECTROSCOPY FOR THE DIAGNOSIS OF HELICOBACTER PYLORI INFECTION: A SURVEY IN IRANIAN POPULATION"

    "Davood Beiki

    2005-04-01

    Full Text Available The urea breath test (UBT which is carried out with 13C or 14C labeled urea is one of the most important non invasive methods for detection of Helicobacter pylori infection. Application of 13C-UBT is becoming increasingly popular because of its non radioactive nature which makes it suitable for diagnostic purposes in children and women of child bearing ages. While isotope ratio mass spectrometer (IRMS is generally used to detect 13C in expired breath, this instrument is expensive and recently non dispersive isotope selective infrared (NDIR spectroscopy which is a lower cost technique has been employed as a reliable counterpart for IRMS in small clinics. The aim of this study was to assess the validity of NDIR spectroscopy technique in Iranian population in comparison with histological examination, rapid urease test and 14C-urea breath test as gold standard. Seventy six patients with dyspepsia were underwent 13CUBT for diagnosis of Helicobacter pylori infection. Good agreements were found between the 13C-UBT and gold standard methods. The 13C-UBT showed 100% sensitivity, 97.3% specificity, 97.56% positive predictive value, 100% negative predictive value and 98.65% accuracy. On the basis of these results it could be concluded that 13C-UBT performed with NDIR spectroscopy is a reliable, accurate and non invasive diagnostic tool for detection of Helicobacter pylori infection in the Iranian population.

  8. How to interpret hydrogen breath tests.

    Ghoshal, Uday C

    2011-07-01

    Hydrogen breath tests using various substrates like glucose, lactulose, lactose and fructose are being used more and more to diagnose small intestinal bacterial overgrowth (SIBO) and lactose or fructose malabsorption. Though quantitative culture of jejunal aspirate is considered as gold standard for the diagnosis of SIBO, hydrogen breath tests, in spite of their low sensitivity, are popular for their non-invasiveness. Glucose hydrogen breath test is more acceptable for the diagnosis of SIBO as conventionally accepted double-peak criterion on lactulose hydrogen breath test is very insensitive and recently described early-peak criterion is often false positive. Hydrogen breath test is useful to diagnose various types of sugar malabsorption. Technique and interpretation of different hydrogen breath tests are outlined in this review. PMID:21860825

  9. How to Interpret Hydrogen Breath Tests

    Ghoshal, Uday C

    2011-01-01

    Hydrogen breath tests using various substrates like glucose, lactulose, lactose and fructose are being used more and more to diagnose small intestinal bacterial overgrowth (SIBO) and lactose or fructose malabsorption. Though quantitative culture of jejunal aspirate is considered as gold standard for the diagnosis of SIBO, hydrogen breath tests, in spite of their low sensitivity, are popular for their non-invasiveness. Glucose hydrogen breath test is more acceptable for the diagnosis of SIBO a...

  10. Breath test to diagnose the presence of Helicobacter pylori, the causative agent of active chronic gastritis and ulcers

    In Brazil almost 80% of the population presents the bacterium Helicobacter pylori, considered to be the causative agent of active chronic gastritis and ulcers. This does not mean that all of these people will suffer gastritis or ulcers, but it is highly probable. The usual diagnostic procedure used a microbiological culture in mucus biopsy specimens collected during gastroscopy, an invasive method. The problem was to find a non-invasive, easy, fast and efficient procedure to diagnose this bacterium. The nuclear technique applied was liquid scintillation, a suitable technique to measure the low energy β emission of 14C. This was the best method available at the time to develop and establish the test. In order to develop a non-invasive test to diagnose H. pylori, research was carried out with doctors from the Department of Gastroenterology at the School of Medicine of the Federal University of Minas Gerais. This research applied a radiochemical method using 14C, a radioisotope of carbon. The patient's control breath sample was obtained after a 12 hour fast. Then a standard meal was offered to delay gastric emptying, after which the patient drank a determined amount of urea labelled with 14C in water. Breath samples were collected at 10, 15, 30 and 60 minutes in a hyaline-ethanol solution with a pH (acid) indicator. If the bacteria were present, the labelled urea would be metabolized and the 14C would be eliminated as 14CO2 by exhalation; otherwise the 14C would be eliminated through the faeces. This 14C urea breath test was applied in around 5000 participants and the results were compared with results obtained through culture

  11. Breath tests and irritable bowel syndrome

    Rana, Satya Vati; Malik, Aastha

    2014-01-01

    Breath tests are non-invasive tests and can detect H2 and CH4 gases which are produced by bacterial fermentation of unabsorbed intestinal carbohydrate and are excreted in the breath. These tests are used in the diagnosis of carbohydrate malabsorption, small intestinal bacterial overgrowth, and for measuring the orocecal transit time. Malabsorption of carbohydrates is a key trigger of irritable bowel syndrome (IBS)-type symptoms such as diarrhea and/or constipation, bloating, excess flatulence...

  12. Hydrogen breath tests in gastrointestinal diseases.

    Rana, Satya Vati; Malik, Aastha

    2014-10-01

    Hydrogen breath tests are widely used to explore pathophysiology of functional gastrointestinal (GI) disorders. Small intestinal bacterial overgrowth (SIBO) and carbohydrate malabsorption are disorders detected by these tests that have been proposed to be of great importance for symptoms of GI diseases. Glucose hydrogen breath test is more acceptable for diagnosis of SIBO whereas lactose and fructose hydrogen breath tests are used for detection of lactose and fructose maldigestion respectively. Lactulose hydrogen breath test is also used widely to measure the orocecal transit time for GI motility. These methods are noninvasive and inexpensive. Many patients with functional gut disorders are unaware of the relationship between diet and GI symptoms they present. In particular, patients with chronic symptoms may regard their condition as normal and may not be aware that their symptoms can be effectively managed following a proper diagnosis. Patients with symptoms of abdominal pain, bloating, flatulence and altered bowel movements (diarrhea and constipation), or with a medical diagnosis of irritable bowel syndrome or celiac disease, may have undiagnosed carbohydrate malabsorption or SIBO. Hydrogen breath tests are specific and sensitive diagnostic tests that can be used to either confirm or eliminate the possibility of carbohydrate malabsorption or SIBO in such patients. Breath tests, though valuable tools, are underutilized in evaluating dyspepsia and functional bloating and diarrhea as well as suspected malabsorption. However, because of their simplicity, reproducibility and safety of procedure they are now being substituted to more uncomfortable and expensive techniques that were traditionally used in gastroenterology. PMID:25298621

  13. Breath Testing for Small Intestinal Bacterial Overgrowth: Should We Bother?

    Pimentel, Mark

    2016-03-01

    The hydrogen breath test is based on following breath hydrogen levels after the administration of a carbohydrate (most commonly lactulose) to a patient with suspected small intestinal bacterial overgrowth. The test is based on the interaction between the administered carbohydrate and the intestinal bacteria. The resulting fermentation produces hydrogen. A positive breath test is based on a breath hydrogen rise prior to the expected arrival time in the highly microbial cecum. Despite renewed enthusiasm for breath testing in recent years due to associations with conditions such as irritable bowel syndrome, breath testing poses many challenges. In this argument against breath testing, several pitfalls that complicate breath testing will be described. PMID:26902227

  14. 42 CFR 84.88 - Breathing bag test.

    2010-10-01

    ... 42 Public Health 1 2010-10-01 2010-10-01 false Breathing bag test. 84.88 Section 84.88 Public... RESEARCH AND RELATED ACTIVITIES APPROVAL OF RESPIRATORY PROTECTIVE DEVICES Self-Contained Breathing Apparatus § 84.88 Breathing bag test. (a) Breathing bags will be tested in an air atmosphere saturated...

  15. Breath tests: principles, problems, and promise

    Breath tests rely on the measurement of gases produced in the intestine, absorbed, and expired in the breath. Carbohydrates, such as lactose and sucrose, can be administered in ysiologic doses; if malabsorbed, they will be metabolized to hydrogen by colonic bacteria. Since hydrogen is not produced by human metabolic reactions, a rise in breath hydrogen, as measured by gas chromatography, is evidence of carbohydrate malabsorption. Likewise, a rise in breath hydrogen marks the transit time of nonabsorbable carbohydrates such as lactulose through the small intestine into the colon. Simple end-expiratory interval collection into nonsiliconized vacutainer tubes has made these noninvasive tests quite convenient to perform, but various problems, including changes in stool pH intestinal motility, or metabolic rate, may influence results. Another group of breath tests uses substrates labeled with radioactive or stable isotopes of carbon. Labeled fat substrates such as trioctanoin, tripalmitin, and triolein do not produce the expected rise in labeled breath CO2 if there is fat malabsorption. Bile acid malabsorption and small intestinal bacterial overgrowth can be measured with labeled cholylglycine or cholyltaurine. Labeled drugs such as aminopyrine, methacetin, and phenacetin can be used as an indication of drug metabolism and liver function. Radioactive substrates have been used to trace metabolic pathways and can be measured by scintillation counters. The availability of nonradioactive stable isotopes has made these ideal for use in children and pregnant women, but the cost of substrates and the mass spectrometers to measure them has so far limited their use to research centers. It is hoped that new techniques of processing and measurement will allow further realization of the exciting potential breath analysis has in a growing list of clinical applications

  16. 42 CFR 84.91 - Breathing resistance test; exhalation.

    2010-10-01

    ... 42 Public Health 1 2010-10-01 2010-10-01 false Breathing resistance test; exhalation. 84.91...-Contained Breathing Apparatus § 84.91 Breathing resistance test; exhalation. (a) Resistance to exhalation...-circuit apparatus with a breathing machine as described in § 84.88, and the exhalation resistance...

  17. Breathing air trailer acceptance test report

    This Acceptance Test Report documents compliance with the requirements of specification WHC-S-0251, Rev.0 and ECNs 613530 and 606113. The equipment was tested according to WHC-SD-WM-ATP-104. The equipment tested is a Breathing Air Supply Trailer purchased as a design and fabrication procurement activity. The ATP was written by the Seller and was performed by the Seller with representatives of the Westinghouse Hanford Company witnessing portions of the test at the Seller's location

  18. Application of stable isotope to breath test

    Needles to say, radioisotopes have good characteristics as a tracer for examining biological functions. In fact, scyntigraphy is widely used over Japan. It is true, however, that there are some difficulties in applying radioisotopes to humans. Thus, greater attention began to be attracted to stable isotopes in the late 1960s, because these substances can be used for infants and pregnant women. They can be stored for a long period of time since they do not suffer damping as in the case of radioisotopes. In addition to serving as a tracer, stable isotopes can provide structural-chemical information including the position of isotope labels, and the mass and atomic composition of fragment ions. Such techniques as NMR spectroscopy is employed for this purpose. The method is currently used to perform examinations of congenital metabolic disorders. The carbon isotopes of 13C and 14C are used for breath test. Compounds labeled with these isotopes are administered and their ratio to the total CO2 in breath is measured to diagnose diseases. In the early 1970s, 13C has come into use for breath test. Similar breath test is applied to diagnosis of the bacterial overgrowth syndrome and ileal dysfunction syndrome. (Nogami, K.)

  19. Breath tests and irritable bowel syndrome.

    Rana, Satya Vati; Malik, Aastha

    2014-06-28

    Breath tests are non-invasive tests and can detect H₂ and CH₄ gases which are produced by bacterial fermentation of unabsorbed intestinal carbohydrate and are excreted in the breath. These tests are used in the diagnosis of carbohydrate malabsorption, small intestinal bacterial overgrowth, and for measuring the orocecal transit time. Malabsorption of carbohydrates is a key trigger of irritable bowel syndrome (IBS)-type symptoms such as diarrhea and/or constipation, bloating, excess flatulence, headaches and lack of energy. Abdominal bloating is a common nonspecific symptom which can negatively impact quality of life. It may reflect dietary imbalance, such as excess fiber intake, or may be a manifestation of IBS. However, bloating may also represent small intestinal bacterial overgrowth. Patients with persistent symptoms of abdominal bloating and distension despite dietary interventions should be referred for H₂ breath testing to determine the presence or absence of bacterial overgrowth. If bacterial overgrowth is identified, patients are typically treated with antibiotics. Evaluation of IBS generally includes testing of other disorders that cause similar symptoms. Carbohydrate malabsorption (lactose, fructose, sorbitol) can cause abdominal fullness, bloating, nausea, abdominal pain, flatulence, and diarrhea, which are similar to the symptoms of IBS. However, it is unclear if these digestive disorders contribute to or cause the symptoms of IBS. Research studies show that a proper diagnosis and effective dietary intervention significantly reduces the severity and frequency of gastrointestinal symptoms in IBS. Thus, diagnosis of malabsorption of these carbohydrates in IBS using a breath test is very important to guide the clinician in the proper treatment of IBS patients. PMID:24976698

  20. Accuracy of a rapid 10-minute carbon-14 urea breath test for the diagnosis of Helicobacter pylori-associated peptic ulcer disease

    Urease in the human gastric mucosa is a marker for infection with Helicobacter pylori (HP), an organism which is associated with peptic ulcer disease. To detect gastric urease, we examined 184 patients (144 males, 40 females; mean age: 49.8±15.6 years) with suspected peptic ulcer disease. Fasting patients were given orally 5 μCi of carbon-14 labelled urea. For each patient only one breath sample was collected in hyamine at 10 min. The amount of 14C collected at 10 min was expressed as follows: [(DPM/mmol CO2 collected)/(DPM administered)]x100xbody weight (kg). The presence of HP colonization was determined by examination of multiple endoscopic prepyloric antral biopsy specimens subjected to culture or a rapid urease test. For the purpose of this study, HP-positive patients were defined as those with characteristic bacteria as indicated by a positive result of either the culture or the rapid urease test; HP-negative patients were defined as those with negative findings on both the culture and the rapid urease test. Of the 184 cases, 99 (53.8%) were positive for HP infection, and 85 (46.2%), negative. The sensitivity and specificity of the rapid 10 min 14C-urea breath test for the diagnosis of HP-associated peptic ulcer disease were evaluated by a receiver operating characteristic (ROC) curve with a variable cut-off value from 1.5 to 4.5. When a cut-off value of 1.5 was selected, the sensitivity was 100% and the specificity, 83.5%; when a cut-off value of 4.5 was selected, the sensitivity was 54.5% and the specificity, 97.6%. (orig.)

  1. Accuracy of a rapid 10-minute carbon-14 urea breath test for the diagnosis of Helicobacter pylori-associated peptic ulcer disease

    Kao Chiahung (Taichung Veterans General Hospital (Taiwan, Province of China). Dept. of Nuclear Medicine); Wang Shyhjen (Taichung Veterans General Hospital (Taiwan, Province of China). Dept. of Nuclear Medicine); Hsu Chungyuan (Taichung Veterans General Hospital (Taiwan, Province of China). Dept. of Nuclear Medicine); Lin Wanyu (Taichung Veterans General Hospital (Taiwan, Province of China). Dept. of Nuclear Medicine); Huang Chihkua (Taichung Veterans General Hospital (Taiwan, Province of China). Dept. of Gastroenterology); Chen Granhum (Taichung Veterans General Hospital (Taiwan, Province of China). Dept. of Gastroenterology)

    1993-08-01

    Urease in the human gastric mucosa is a marker for infection with Helicobacter pylori (HP), an organism which is associated with peptic ulcer disease. To detect gastric urease, we examined 184 patients (144 males, 40 females; mean age: 49.8[+-]15.6 years) with suspected peptic ulcer disease. Fasting patients were given orally 5 [mu]Ci of carbon-14 labelled urea. For each patient only one breath sample was collected in hyamine at 10 min. The amount of [sup 14]C collected at 10 min was expressed as follows: (DPM/mmol CO[sub 2] collected)/(DPM administered)x100xbody weight (kg). The presence of HP colonization was determined by examination of multiple endoscopic prepyloric antral biopsy specimens subjected to culture or a rapid urease test. For the purpose of this study, HP-positive patients were defined as those with characteristic bacteria as indicated by a positive result of either the culture or the rapid urease test; HP-negative patients were defined as those with negative findings on both the culture and the rapid urease test. Of the 184 cases, 99 (53.8%) were positive for HP infection, and 85 (46.2%), negative. The sensitivity and specificity of the rapid 10 min [sup 14]C-urea breath test for the diagnosis of HP-associated peptic ulcer disease were evaluated by a receiver operating characteristic (ROC) curve with a variable cut-off value from 1.5 to 4.5. When a cut-off value of 1.5 was selected, the sensitivity was 100% and the specificity, 83.5%; when a cut-off value of 4.5 was selected, the sensitivity was 54.5% and the specificity, 97.6%. (orig.)

  2. 42 CFR 84.122 - Breathing resistance test; minimum requirements.

    2010-10-01

    ... 42 Public Health 1 2010-10-01 2010-10-01 false Breathing resistance test; minimum requirements. 84... Masks § 84.122 Breathing resistance test; minimum requirements. (a) Resistance to airflow will be measured in the facepiece or mouthpiece of a gas mask mounted on a breathing machine both before and...

  3. 42 CFR 84.152 - Breathing tube test; minimum requirements.

    2010-10-01

    ... 42 Public Health 1 2010-10-01 2010-10-01 false Breathing tube test; minimum requirements. 84.152... Respirators § 84.152 Breathing tube test; minimum requirements. (a)(1) Type A and Type B supplied-air respirators shall employ one or two flexible breathing tubes of the nonkinking type which extend from...

  4. 46 CFR 197.450 - Breathing gas tests.

    2010-10-01

    ... 46 Shipping 7 2010-10-01 2010-10-01 false Breathing gas tests. 197.450 Section 197.450 Shipping....450 Breathing gas tests. The diving supervisor shall insure that— (a) The output of each air... or modification. (b) Purchased supplies of breathing mixtures supplied to a diver are checked...

  5. 42 CFR 84.90 - Breathing resistance test; inhalation.

    2010-10-01

    ... 42 Public Health 1 2010-10-01 2010-10-01 false Breathing resistance test; inhalation. 84.90...-Contained Breathing Apparatus § 84.90 Breathing resistance test; inhalation. (a) Resistance to inhalation airflow will be measured in the facepiece or mouthpiece while the apparatus is operated by a...

  6. Air-breathing Rocket Engine Test

    1999-01-01

    This Quick Time movie depicts the Rocketdyne static test of an air-breathing rocket. Air-breathing engines, known as rocket based, combined-cycle engines, get their initial take-off power from specially designed rockets, called air-augmented rockets, that boost performance about 15 percent over conventional rockets. When the vehicle's velocity reaches twice the speed of sound, the rockets are turned off and the engine relies totally on oxygen in the atmosphere to burn hydrogen fuel, as opposed to a rocket that must carry its own oxygen, thus reducing weight and flight costs. Once the vehicle has accelerated to about 10 times the speed of sound, the engine converts to a conventional rocket-powered system to propel the craft into orbit or sustain it to suborbital flight speed. NASA's advanced Transportation Program at the Marshall Space Flight Center, along with several industry partners and collegiate forces, is developing this technology to make space transportation affordable for everyone from business travelers to tourists. The goal is to reduce launch costs from today's price tag of $10,000 per pound to only hundreds of dollars per pound. NASA's series of hypersonic flight demonstrators currently include three air-breathing vehicles: the X-43A, X-43B and X-43C.

  7. Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy.

    Saad, Richard J; Chey, William D

    2014-12-01

    The diagnosis of small intestinal bacterial overgrowth (SIBO) has increased considerably owing to a growing recognition of its association with common bowel symptoms including chronic diarrhea, bloating, abdominal distention, and the irritable bowel syndrome. Ideally, an accurate and objective diagnosis of SIBO should be established before initiating antibiotic treatment. Unfortunately, no perfect test exists for the diagnosis of SIBO. The current gold standard, small-bowel aspiration and quantitative culture, is limited by its high cost, invasive nature, lack of standardization, sampling error, and need for dedicated infrastructure. Although not without shortcomings, hydrogen breath testing provides the simplest noninvasive and widely available diagnostic modality for suspected SIBO. Carbohydrates such as lactulose and glucose are the most widely used substrates in hydrogen breath testing, with glucose arguably providing greater testing accuracy. Lactose, fructose, and sorbitol should not be used as substrates in the assessment of suspected SIBO. The measurement of methane in addition to hydrogen can increase the sensitivity of breath testing for SIBO. Diagnostic accuracy of hydrogen breath testing in SIBO can be maximized by careful patient selection for testing, proper test preparation, and standardization of test performance as well as test interpretation. PMID:24095975

  8. Air-Breathing Rocket Engine Test

    2000-01-01

    This photograph depicts an air-breathing rocket engine that completed an hour or 3,600 seconds of testing at the General Applied Sciences Laboratory in Ronkonkoma, New York. Referred to as ARGO by its design team, the engine is named after the mythological Greek ship that bore Jason and the Argonauts on their epic voyage of discovery. Air-breathing engines, known as rocket based, combined-cycle engines, get their initial take-off power from specially designed rockets, called air-augmented rockets, that boost performance about 15 percent over conventional rockets. When the vehicle's velocity reaches twice the speed of sound, the rockets are turned off and the engine relies totally on oxygen in the atmosphere to burn hydrogen fuel, as opposed to a rocket that must carry its own oxygen, thus reducing weight and flight costs. Once the vehicle has accelerated to about 10 times the speed of sound, the engine converts to a conventional rocket-powered system to propel the craft into orbit or sustain it to suborbital flight speed. NASA's Advanced SpaceTransportation Program at Marshall Space Flight Center, along with several industry partners and collegiate forces, is developing this technology to make space transportation affordable for everyone from business travelers to tourists. The goal is to reduce launch costs from today's price tag of $10,000 per pound to only hundreds of dollars per pound. NASA's series of hypersonic flight demonstrators currently include three air-breathing vehicles: the X-43A, X-43B and X-43C.

  9. Breath Testing and the Demand for Drunk Driving

    Henry Saffer; Frank Chaloupka

    1987-01-01

    This paper presents an empirical investigation of the effect of a preliminary breath test law on drunk driving behavior. A preliminary breath test law reduces the procedural problems associated with obtaining evidence of drunk driving and thus increases the probability that a drunk driver will be arrested. In 1985, only 23 states had a preliminary breath test law. According to the theory of deterrence, increasing the probability of arrest for drunk driving will reduce the future occurrence of...

  10. Application of isotope-selective non-dispersive infrared spectrometry for the evaluation of the 13C-urea breath test: comparison with three concordant methods

    Coelho L.G.V.

    1999-01-01

    Full Text Available The aim of this work was to compare the performance of isotope-selective non-dispersive infrared spectrometry (IRIS for the 13C-urea breath test with the combination of the 14C-urea breath test (14C-UBT, urease test and histologic examination for the diagnosis of H. pylori (HP infection. Fifty-three duodenal ulcer patients were studied. All patients were submitted to gastroscopy to detect HP by the urease test, histologic examination and 14C-UBT. To be included in the study the results of the 3 tests had to be concordant. Within one month after admission to the study the patients were submitted to IRIS with breath samples collected before and 30 min after the ingestion of 75 mg 13C-urea dissolved in 200 ml of orange juice. The samples were mailed and analyzed 11.5 (4-21 days after collection. Data were analyzed statistically by the chi-square and Mann-Whitney test and by the Spearman correlation coefficient. Twenty-six patients were HP positive and 27 negative. There was 100% agreement between the IRIS results and the HP status determined by the other three methods. Using a cutoff value of delta-over-baseline (DOB above 4.0 the IRIS showed a mean value of 19.38 (minimum = 4.2, maximum = 41.3, SD = 10.9 for HP-positive patients and a mean value of 0.88 (minimum = 0.10, maximum = 2.5, SD = 0.71 for negative patients. Using a cutoff value corresponding to 0.800% CO2/weight (kg, the 14C-UBT showed a mean value of 2.78 (minimum = 0.89, maximum = 5.22, SD = 1.18 in HP-positive patients. HP-negative patients showed a mean value of 0.37 (minimum = 0.13, maximum = 0.77, SD = 0.17. IRIS is a low-cost, easy to manage, highly sensitive and specific test for H. pylori detection. Storing and mailing the samples did not interfere with the performance of the test.

  11. 42 CFR 84.203 - Breathing resistance test; minimum requirements.

    2010-10-01

    ... 42 Public Health 1 2010-10-01 2010-10-01 false Breathing resistance test; minimum requirements. 84.203 Section 84.203 Public Health PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES... Chemical Cartridge Respirators § 84.203 Breathing resistance test; minimum requirements. (a) Resistance...

  12. 13CO2-breath tests as diagnostic tools in gastroenterology

    The diagnostic breath test in gastroenterology and hepatology uses specifically 13C-labelled substrate containing a ''target bond'' which, on enzymatic cleavage, results in the release of a functional group destined to produce labelled 13CO2 as a metabolic end product. Advantages and methodology of the 13CO2 breath tests are presented together with the calculation methods for 13C dose ratios. An example is given with the 13C-octanoic acid breath test to measure gastric emptying of solids. 2 figs., 5 refs

  13. Comparative study on cardiac autonomic modulation during deep breathing test and diaphragmatic breathing in type 2 diabetes and healthy subjects

    Subbalakshmi, Narsajjana Krishnadasa; Adhikari, Prabha; Shanmugavel Jeganathan, Punnaimuthu

    2013-01-01

    Abstract Aims/Introduction Diaphragmatic breathing is known to have a beneficial effect on the cardiopulmonary system, and enhances parasympathetic activation. We evaluated the influence of diaphragmatic breathing on time domain measures of heart rate variability in diabetics and healthy subjects. Materials and Methods A total of 122 type 2 diabetics and 94 healthy subjects (controls) were randomly allocated to a deep breathing test and diaphragmatic breathing (61 diabetics and 47 controls in...

  14. Sensors for breath testing: from nanomaterials to comprehensive disease detection.

    Konvalina, Gady; Haick, Hossam

    2014-01-21

    The analysis of volatile organic compounds in exhaled breath samples represents a new frontier in medical diagnostics because it is a noninvasive and potentially inexpensive way to detect illnesses. Clinical trials with spectrometry and spectroscopy techniques, the standard volatile-compound detection methods, have shown the potential for diagnosing illnesses including cancer, multiple sclerosis, Parkinson's disease, tuberculosis, diabetes, and more via breath tests. Unfortunately, this approach requires expensive equipment and high levels of expertise to operate the necessary instruments, and the tests must be done quickly and use preconcentration techniques, all of which impede its adoption. Sensing matrices based on nanomaterials are likely to become a clinical and laboratory diagnostic tool because they are significantly smaller, easier-to-use, and less expensive than spectrometry or spectroscopy. An ideal nanomaterial-based sensor for breath testing should be sensitive at very low concentrations of volatile organic compounds, even in the presence of environmental or physiological confounding factors. It should also respond rapidly and proportionately to small changes in concentration and provide a consistent output that is specific to a given volatile organic compound. When not in contact with the volatile organic compounds, the sensor should quickly return to its baseline state or be simple and inexpensive enough to be disposable. Several reviews have focused on the methodological, biochemical, and clinical aspects of breath analysis in attempts to bring breath testing closer to practice for comprehensive disease detection. This Account pays particular attention to the technological gaps and confounding factors that impede nanomaterial-sensor-based breath testing, in the hope of directing future research and development efforts towards the best possible approaches to overcome these obstacles. We discuss breath testing as a complex process involving numerous

  15. Hydrogen and methane breath tests for evaluation of resistant carbohydrates

    Rumessen, J J

    1992-01-01

    This review considers in detail the background, principles, techniques, limitations and advantages of the hydrogen and methane breath tests. Resistant food carbohydrates, defined as dietary carbohydrates partly or totally escaping small intestinal assimilation, are fermented in the human colon....... Due to the large interindividual variations of hydrogen excretion, unabsorbable standards should be used. The intraindividual variations of H2 production/excretion and differences in fermentability of different carbohydrate substrates only allow for semiquantitative estimates of malabsorbed amounts of...... some carbohydrates. Methane breath tests may supplement the information gained from hydrogen measurements, but further evaluations are needed. The hydrogen breath technique is rapid, simple and non-invasive as well as non-radioactive. It may be carried out in a large number of intact individuals under...

  16. A simple breath test for fat malabsorption in man

    The metabolic pathway of 14C-labeled oleic acid leads to the formation and the breath excretion of 14CO2. This behavior can be used for measuring lipid absorption. The simple, accurate screening test includes the ingestion of 14C-labeled triolein and the intermittent collection of breath 14CO2 in a trapping solution. The results are strongly correlated to the measurement of fecal fat. The use of carbon-14 in man should not be restricted, provided the labeled substrates are converted into rapidly excreted metabolites

  17. 21 CFR 862.3050 - Breath-alcohol test system.

    2010-04-01

    ... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Breath-alcohol test system. 862.3050 Section 862.3050 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED... diagnosis of alcohol intoxication. (b) Classification. Class I....

  18. LOW DOSE CAPSULE BASED 13C-UREA BREATH TEST COMPARED WITH THE CONVENTIONAL 13C-UREA BREATH TEST AND INVASIVE TESTS

    Rejane MATTAR

    2014-04-01

    Full Text Available Context One of the limitations of 13C-urea breath test for Helicobacter pylori infection diagnosis in Brazil is the substrate acquisition in capsule presentation. Objectives The purpose of this study was to evaluate a capsule-based 13C-urea, manipulated by the Pharmacy Division, for the clinical practice. Methods Fifty patients underwent the conventional and the capsule breath test. Samples were collected at the baseline and after 10, 20 and 30 minutes of 13C-urea ingestion. Urease and histology were used as gold standard in 83 patients. Results In a total of 50 patients, 17 were positive with the conventional 13C-urea (75 mg breath test at 10, 20 and 30 minutes. When these patients repeated breath test with capsule (50 mg, 17 were positive at 20 minutes and 15 at 10 and 30 minutes. The relative sensitivity of 13C-urea with capsule was 100% at 20 minutes and 88.24% at 10 and at 30 minutes. The relative specificity was 100% at all time intervals. Among 83 patients that underwent capsule breath test and endoscopy the capsule breath test presented 100% of sensitivity and specificity. Conclusions Capsule based breath test with 50 mg 13C-urea at twenty minutes was found highly sensitive and specific for the clinical setting. HEADINGS- Helicobacter pylori. Breath Test. Urea, analysis.

  19. Deadspace breathing as a screening test for early lung damage

    Breathing through added external deadspace (V/sub Dext/) was found to increase the tidal volume of normal dogs in order to achieve alveolar ventilation adequate for gas exchange. Addition of V/sub Dext/ did not alter alveolar-arterial gas gradients or cardiovascular function. Respiratory patterns during V/sub Dext/ breathing were compared with variables measured during treadmill exercise to investigate deadspace breathing as an indicator of early lung dysfunction caused by radiation pneumonitis in dogs. Dogs were evaluated clinically, radiographically and by pulmonary function tests at rest before and after inhaling 144Ce in fused aluminosilicate particles. By 4 mo after inhalation of 32 to 50 μCi/kg 144Ce, there were increases in respiratory frequency and minute volume during V/sub Dext/ breathing and in minute volume and the ventilatory equivalent for O2 while running. No other significant functional, radiographic or clinical changes were noted. The dogs were sacrificed and scattered foci of inflammation were found in their lungs. Deadspace testing detected early, subclinical lung alterations with a sensitivity and at a time identical to treadmill testing and did not require whole-body exercise or training

  20. Clinical 13CO2 breath tests: methodology and limitations

    Methods were developed to perform 13CO2 breath tests and the limitations and sources of error in these tests were explored. The random error introduced during each step of the analysis was determined and it was found that the precision was limited by the fluctuations in the isotope ratio of the patient's endogenous CO2. The detection limit was a 1.4 percent increase in the isotope ratio. This corresponds to an oxidation rate of 140 nmoles/kg-hr of singly labeled substrate to CO2. The use of stable isotope 13C provides a safe and sensitive alternative to the use of the radionuclide 14C and extends the utility of CO2 breath tests to the previously exempted populations of children and pregnant women

  1. Development of Synthetic Methods of Breath Test Drug Carbon Labeled Methacetin

    ZHAO; Si-qian; CHEN; Bao-jun; LUO; Zhi-fu

    2013-01-01

    The accurate detection of liver function has important clinical significance.Breath test,due to it’s many advantages such as noninvasive,simple as well as good accuracy when applied to liver function test,has been deeply researched and applied in clinic.There are some common breath tests to reflect hepatocyte microsome function:Aminopyrine breath

  2. Examination of dialysis patients with the aminophenazone breath test

    In 12 endstage kidney disease patients (8 without and 4 with liver diseases) the activities of cytochrome P450-dependent mixed functional oxidases system (MFO) of the liver were studied by using the 14C-aminophenazone breath test before and after dialysis. The results showed that uremia seems to have a pressing influence on MFO activity. The activity was only significantly increased after dialysis in the group of patients without liver diseases. The MFO activity was reduced in patients with liver diseases. This is a restriction of the hepatic metabolic demethylation capacity. It is unclear if the 14C-aminophenazone breath test in dialysis patients is qualified to estimate metabolic capacity of the liver. Differentiation between the influence of uremia and of the liver disease on the alteration of MFO activity cannot be made. (author)

  3. Test-retest reproducibility of hydrogen breath test for lactose maldigestion in preschool children.

    Barillas-Mury, C; Solomons, N W

    1987-01-01

    The test-retest reproducibility of the H2 breath test within the same individual has not been rigorously evaluated in preschool children. In the present study, 10 children--5 of whom were diagnosed as lactose-digesters on their first testing, and 5 of whom were diagnosed as lactose-maldigesters at first screening--were retested under identical conditions of a second opportunity. In each case, the same diagnostic classification was provided, for a reproducibility of 100%. Regression of the area under the curve of the change in breath H2 concentration during the 3 h of the test had a Pearson's correlation coefficient of 0.59 (p = 0.05). The time-course of 3-h H2 breath tests in 43 children with lactose maldigestion revealed a peaking of the concentration of H2 most commonly 120 min following the oral dose of 240 ml whole milk. Seventy-seven percent of the children who eventually proved to be lactose maldigesters were so diagnosed by the end of the second hour of the breath test. Thus, even the abbreviated breath sampling schedule used in children is sensitive, and few maldigesters would go undetected because of a late rise in breath H2 concentration. PMID:3694351

  4. 14C-glycocholate breath test and pathological digestive transit

    14C-glycine glycocholate breath test is elegant, atraumatic and detects bacterial overgrowth in the proximal portion of small intestine. In such cases an early increase of specific radioactivity of CO2 occurs in expired air. Ileal bile salts malabsorption can also induce such an increase in principle later. However, a modification of transit (acceleration or paresis) can shift the time of appearance of the physiological 14CO2 peak due to colonic deconjugation of the labelled tracer, leading to a diagnostic error. Microbial overgrowth, gastroparesis, accelerated intestinal transit or malabsorption can complicate diabetes mellitus, especially in the case of diabetic neuropathy. Several of these disorder can coexist. It is possible to detect and quantify all these abnormalities in a single examination by the simultaneous use of labelled glycocholate and sup(99m)Tc DTPA. Oral administration of this mixture allows the measurement of gastric emptying half-time and the scintigraphic visualisation of labelled meal progression. Thus, the association of 14C-glycocholate breath-test and sup(99m)Tc DTPA digestive transit insures a correct interpretation in case of associated abnormalities

  5. Exhaled breath for drugs of abuse testing - evaluation in criminal justice settings.

    Beck, Olof

    2014-01-01

    Exhaled breath is being developed as a possible specimen for drug testing based on the collection of aerosol particles originating from the lung fluid. The present study was aimed to evaluate the applicability of exhaled breath for drugs of abuse testing in criminal justice settings. Particles in exhaled breath were collected with a new device in parallel with routine urine testing in two Swedish prisons, comprising both genders. Urine screening was performed according to established routines either by dipstick or by immunochemical methods at the Forensic Chemistry Laboratory and confirmations were with mass spectrometry methods. A total of 247 parallel samples were studied. Analysis of exhaled breath samples was done with a sensitive mass spectrometric method and identifications were made according to forensic standards. In addition tested subjects and personnel were asked to fill in a questionnaire concerning their views about drug testing. In 212 cases both the urine and breath testing were negative, and in 22 cases both urine and breath were positive. Out of 6 cases where breath was negative and urine positive 4 concerned THC. Out of 7 cases where, breath was positive and urine negative 6 concerned amphetamine. Detected substances in breath comprised: amphetamine, methamphetamine, THC, methylphenidate, buprenorphine, 6-acetylmorphine, cocaine, benzoylecgonine, diazepam and tramadol. Both the prison inmates and staff members reported breath testing to be preferable due to practical considerations. The results of this study documented that drug testing using exhaled breath provided as many positives as urine testing despite an expected shorter detection window, and that the breath sampling procedure was well accepted and provided practical benefits reported both by the prison inmates and testing personnel. PMID:24438778

  6. Activity calibration in breath test for diagnosis of Helicobacter pylori

    Some technical and measurement problems of the breath test for diagnosis of Helicobacter pylori are briefly discussed. Calibrated results obtained for population of 108 cases indicate difference between HP+ (infected with Helicobacter pylori) and HP- (non infected with Helicobacter pylori) in exhaled 14C activity not less than 3.9 kBq while the lower limit for HP+ cases was set at 6.8 kBq at the detection limit: 0.9 Bq/mmol of CO2. It was estimated that in exhalation way up to 29% of the taken activity was removed in HP+ cases during first 35 minutes. Radiation hazard for the patient system is negligibly small - dose equipment not exceeds 0.29% of the natural (environmental) yearly exposure. (author)

  7. Aspiration tests in aqueous foam using a breathing simulator

    Archuleta, M.M.

    1995-12-01

    Non-toxic aqueous foams are being developed by Sandia National Laboratories (SNL) for the National Institute of Justice (NIJ) for use in crowd control, cell extractions, and group disturbances in the criminal justice prison systems. The potential for aspiration of aqueous foam during its use and the resulting adverse effects associated with complete immersion in aqueous foam is of major concern to the NIJ when examining the effectiveness and safety of using this technology as a Less-Than-Lethal weapon. This preliminary study was designed to evaluate the maximum quantity of foam that might be aspirated by an individual following total immersion in an SNL-developed aqueous foam. A.T.W. Reed Breathing simulator equipped with a 622 Silverman cam was used to simulate the aspiration of an ammonium laureth sulfate aqueous foam developed by SNL and generated at expansion ratios in the range of 500:1 to 1000:1. Although the natural instinct of an individual immersed in foam is to cover their nose and mouth with a hand or cloth, thus breaking the bubbles and decreasing the potential for aspiration, this study was performed to examine a worst case scenario where mouth breathing only was examined, and no attempt was made to block foam entry into the breathing port. Two breathing rates were examined: one that simulated a sedentary individual with a mean breathing rate of 6.27 breaths/minute, and one that simulated an agitated or heavily breathing individual with a mean breathing rate of 23.7 breaths/minute. The results of this study indicate that, if breathing in aqueous foam without movement, an air pocket forms around the nose and mouth within one minute of immersion.

  8. (13) C Breath Tests Are Feasible in Patients With Extracorporeal Membrane Oxygenation Devices.

    Bednarsch, Jan; Menk, Mario; Malinowski, Maciej; Weber-Carstens, Steffen; Pratschke, Johann; Stockmann, Martin

    2016-07-01

    Temporary extracorporeal membrane oxygenation (ECMO) has been established as an essential part of therapy in patients with pulmonary or cardiac failure. As physiological gaseous exchange is artificially altered in this patient group, it is debatable whether a (13) C-breath test can be carried out. In this proof of technical feasibility report, we assess the viability of the (13) C-breath test LiMAx (maximum liver function capacity) in patients on ECMO therapy. All breath probes for the test device were obtained directly via the membrane oxygenator. Data of four patients receiving liver function assessment with the (13) C-breath test LiMAx while having ECMO therapy were analyzed. All results were compared with validated scenarios of the testing procedures. The LiMAx test could successfully be carried out in every case without changing ECMO settings. Clinical course of the patients ranging from multiorgan failure to no sign of liver insufficiency was in accordance with the results of the LiMAx liver function test. The (13) C-breath test is technically feasible in the context of ECMO. Further evaluation of (13) C-breath test in general would be worthwhile. The LiMAx test as a (13) C-breath test accessing liver function might be of particular predictive interest if patients with ECMO therapy develop multiorgan failure. PMID:26527580

  9. Lactose malabsorption during gastroenteritis, assessed by the hydrogen breath test.

    Gardiner, A. J.; Tarlow, M J; Sutherland, I T; Sammons, H. G.

    1981-01-01

    Thirty-eight infants and young children with gastroenteritis were investigated for lactose malabsorption. Each of them was given an oral lactose load of either 0.5 g/kg or 2 g/kg after which breath hydrogen excretion was measured, and each was observed to see if he had clinical symptoms of lactose intolerance. Only one patient, given 2 g/kg lactose, had clinical intolerance. His breath hydrogen excretion however was negative. Three of 18 patients given 0.5 g/kg lactose had positive breath hyd...

  10. Phase V of the single-breath washout test

    Nichol, G. M.; Michels, D. B.; Guy, H. J. B.

    1982-01-01

    A downward-deflecting phase V is often seen following the terminal rise (phase IV) in single-breath washout tests. To investigate the nature of phase V, experiments using simultaneous washouts of N2 and tracer boluses of Ar were performed on eight normal nonsmoking subjects aged 27-41 who exhibited a phase V. Phase V is found to occur in all subjects at expiratory flow rates between 0.1 and 2.0 l/sec shortly after expiration became flow limited. Volumes of both phases IV and V increase with increasing flow rate. The difference between the exhaled volumes at which flow became limited and phase V appeared is shown to be approximately equal to the anatomic dead space. Results support a model of lung emptying in a gravitational field in which flow limitation occurs first in the lower lung regions and then progresses toward the upper regions, causing phase IV. A decrease in the amount of flow from the upper relative to the lower regions after all regions have become flow limited then causes phase V.

  11. Almagate interference in breath test results for the diagnosis of Helicobacter pylori infection

    Carles Pons

    2014-08-01

    Full Text Available Background: Infection by Helicobacter pylori is common and affects both genders at any age. The 13C-urea breath test is a widely used test for the diagnosis of this infection. However, multiple drugs used for the treatment of Helicobacter pylori infection symptoms have interactions with this breath test that generate false negative results. This observational study was to assess the potential interaction between almagate and the breath test. Methods: Thirty subjects on almagate therapy who underwent a breath test were included. If the result was negative, almagate was withdrawn for a month and the breath test was then repeated. Results: In general, 51.9 % of assessed subjects had a negative result after the first test, and 100 % of these also had a negative result after the second test. Conclusions: It was concluded that the use of almagate does not interfere in breath test results. These results provide a drug therapy option for the treatment of symptoms associated with Helicobacter pylori infection during the diagnostic process.

  12. (13)C-5-FU breath test current status and future directions: a comprehensive review.

    Ezzeldin, Hany H; Acosta, Edward P; Mattison, Lori K; Fourie, Jeanne; Modak, Anil; Diasio, Robert B

    2009-12-01

    Breath tests (BTs) represent a safe non-invasive alternative strategy that could provide valuable diagnostic information in conditions like fat malabsorption, carbohydrate (lactose and fructose) malabsorption, liver dysfunction, impaired gastric emptying, abnormal small bowel transit time, small intestinal bacterial overgrowth and Helicobacter pylori infection. To date, despite the availability of a number of breath tests, only three have gained approval by the FDA for application in a clinical setting ((13)C-urea breath test for the detection of H. pylori; NO breath test for monitoring asthma and alkane breath test for heart transplant rejection). Unfortunately, none of these tests investigate cancer patients or response to cancer chemotherapy. Several years ago it was realized that the presence of a reliable non-invasive approach could assist in the detection of patients at risk of developing severe life-threatening toxicities prior to the administration of fluoropyrimidines (e.g. 5-FU) or related cancer chemotherapy. 5-FU toxicity results mainly from deficient uracil catabolism. This review discusses the development of a BT that utilizes an orally administered pyrimidine ([2-(13)C]-uracil) which is metabolized via the same catabolic pathway as 5-FU. This ([2-(13)C]-uracil) breath test could provide a valuable addition to the patients' standard of care. PMID:21386199

  13. Significance of hydrogen breath tests in children with suspected carbohydrate malabsorption

    Däbritz, Jan; Mühlbauer, Michael; Domagk, Dirk; Voos, Nicole; Henneböhl, Geraldine; Siemer, Maria L; Foell, Dirk

    2014-01-01

    Background Hydrogen breath tests are noninvasive procedures frequently applied in the diagnostic workup of functional gastrointestinal disorders. Here, we review hydrogen breath test results and the occurrence of lactose, fructose and sorbitol malabsorption in pediatric patients; and determine the significance of the findings and the outcome of patients with carbohydrate malabsorption. Methods We included 206 children (88 male, 118 female, median age 10.7 years, range 3–18 years) with a total...

  14. Methodology and application of 13C breath test in gastroenterology practice

    13C breath test has been widely used in research of nutrition, pharmacology and gastroenterology for its properties such as safety, non-invasion and so on. The author describes the principle, methodology of 13C breath test and its application in detection to Helico-bacteria pylori infection in stomach and small bowl bacterial overgrowth, measurement of gastric emptying, pancreatic exocrine function and liver function with various substrates

  15. Can Handling E85 Motor Fuel Cause Positive Breath Alcohol Test Results?

    Ran, Ran; Mullins, Michael E.

    2013-01-01

    Hand-held breath alcohol analyzers are widely used by police in traffic stops of drivers suspected of driving while intoxicated (DWI). E85 is a motor fuel consisting of 85% ethanol and 15% gasoline or other hydrocarbons, and is available at nearly 2,600 stations in the USA. We sought to determine whether handling E85 fuel could produce measurable breath alcohol results using a hand-held analyzer and to see if this would be a plausible explanation for a positive breath alcohol test. Five healt...

  16. Acidic colonic microclimate--possible reason for false negative hydrogen breath tests.

    Vogelsang, H; Ferenci, P; Frotz, S; Meryn, S.; Gangl, A

    1988-01-01

    About 5% of normal subjects fail to produce increased hydrogen breath concentration after ingestion of the non-digestible carbohydrate lactulose (low hydrogen producers). The existence of low hydrogen producers limits the diagnostic use of hydrogen (H2) breath tests. We studied the effects of lactulose and of magnesium sulphate (MgSO4) pretreatment on stool-pH and on hydrogen exhalation after oral loading with lactulose or lactose in 17 hydrogen producers and 12 low hydrogen producers. In sev...

  17. Tricks for interpreting and making a good report on hydrogen and 13C breath tests.

    D'Angelo, G; Di Rienzo, T A; Scaldaferri, F; Del Zompo, F; Pizzoferrato, M; Lopetuso, L R; Laterza, L; Bruno, G; Petito, V; Campanale, M C; Cesario, V; Franceschi, F; Cammarota, G; Gaetani, E; Gasbarrini, A; Ojetti, V

    2013-01-01

    Breath tests (BT) represent a valid and non-invasive diagnostic tool in many gastroenterological disorders. Their wide diffusion is due to the low cost, simplicity and reproducibility and their common indications include diagnosis of carbohydrate malabsorption, Helicobacter pylori infection, small bowel bacterial overgrowth, gastric emptying time and orocaecal transit time. The review deals with key points on methodology, which would influence the correct interpretation of the test and on a correct report. While a clear guideline is available for lactose and glucose breath tests, no gold standard is available for Sorbitol, Fructose or other H2 BTs. Orocaecal transit time (OCTT) defined as time between assumption of 10 g lactulose and a peak > 10 ppm over the baseline value, is a well-defined breath test. The possible value of lactulose as a diagnostic test for the diagnosis of small bowel bacterial overgrowth is still under debate. Among (13)C breath test, the best and well characterized is represented by the urea breath test. Well-defined protocols are available also for other (13)C tests, although a reimbursement for these tests is still not available. Critical points in breath testing include the patient preparation for test, type of substrate utilized, reading machines, time between when the test is performed and when the test is processed. Another crucial point involves clinical conclusions coming from each test. For example, even if lactulose could be utilized for diagnosing small bowel bacterial overgrowth, this indication should be only secondary to orocaecal transit time, and added into notes, as clinical guidelines are still uncertain. PMID:24443074

  18. Aminopyrine breath test for evaluation of liver function. How to analyse the 14CO2 data

    Previous studies in our laboratory have shown that breath analysis of 14CO2, following administration of specifically labelled 14C-dimethylaminoantipyrine, allows assessment of Vsub(max) and Ksub(m) of in vivo demethylation in the rat. Consequently, this procedure was modified for application in man. Whereas in 23 liver normals the disappearance constant ksub(B) of 14CO2 from breath was 21+-SD4%/h, ksub(B) was significantly reduced in 14 patients with alcoholic cirrhosis (8+-4%/h). Breath analysis is suggested as a non-invasive, convenient and valid method for measuring hepatic microsomal demethylation. Breath analysis discriminates between liver normals and patients with impaired liver function as well as established quantitative liver function tests (disappearance rate of BSP, galactose elimination capacity)

  19. A 14-day elemental diet is highly effective in normalizing the lactulose breath test.

    Pimentel, Mark; Constantino, Tess; Kong, Yuthana; Bajwa, Meera; Rezaei, Abolghasem; Park, Sandy

    2004-01-01

    Treatment of small intestinal bacterial overgrowth is frustrated by the low efficacy of antibiotics. Elemental diets have been shown to reduce enteric flora. In this study, we evaluate the ability of an elemental diet to normalize the lactulose breath test (LBT) in IBS subjects with abnormal breath test findings. Consecutive subjects with IBS and abnormal LBT suggesting the presence of bacterial overgrowth underwent a 2-week exclusive elemental diet. The diet consisted of Vivonex Plus (Novartis Nutrition Corp., Minneapolis, MN) in a quantity based on individual caloric requirement. On day 15 (prior to solid food), subjects returned for a follow-up breath test and those with an abnormal LBT were continued on the diet for an additional 7 days. The ability of an elemental diet to normalize the LBT was determined for days 15 and 21. A chart review was then conducted to evaluate any clinical benefit 1 month later. Of the 93 subjects available for analysis, 74 (80%) had a normal LBT on day 15 of the elemental diet. When those who continued to day 21 were included, five additional patients normalized the breath test (85%). On chart review, subjects who successfully normalized their breath test had a 66.4 +/- 36.1% improvement in bowel symptoms, compared to 11.9 +/- 22.0% in those who failed to normalize (P < 0.001). An elemental diet is highly effective in normalizing an abnormal LBT in IBS subjects, with a concomitant improvement in clinical symptoms. PMID:14992438

  20. Change of Gastric Emptying With Chewing Gum: Evaluation Using a Continuous Real-Time 13C Breath Test (BreathID System)

    Sakamoto, Yasunari; Kato, Shingo; Sekino, Yusuke; Sakai, Eiji; Uchiyama, Takashi; Iida, Hiroshi; Hosono, Kunihiro; Endo, Hiroki; Fujita, Koji; Koide, Tomoko; Takahashi, Hirokazu; Yoneda, Masato; Tokoro, Chikako; Goto, Ayumu; Abe, Yasunobu

    2011-01-01

    Background/Aims There are few reports on the correlation between chewing gum and the gastrointestinal functions. But previous report showed use of chewing gum to be an effective method for controlling gastrointestinal symptoms. The aim of this study was to determine the correlation between chewing gum and gastric emptying using the continuous real time 13C breath test (BreathID system). Methods Ten healthy male volunteers participated in this randomized, 2-way crossover study. The subjects fa...

  1. Rapid point-of-care breath test for biomarkers of breast cancer and abnormal mammograms.

    Michael Phillips

    Full Text Available BACKGROUND: Previous studies have reported volatile organic compounds (VOCs in breath as biomarkers of breast cancer and abnormal mammograms, apparently resulting from increased oxidative stress and cytochrome p450 induction. We evaluated a six-minute point-of-care breath test for VOC biomarkers in women screened for breast cancer at centers in the USA and the Netherlands. METHODS: 244 women had a screening mammogram (93/37 normal/abnormal or a breast biopsy (cancer/no cancer 35/79. A mobile point-of-care system collected and concentrated breath and air VOCs for analysis with gas chromatography and surface acoustic wave detection. Chromatograms were segmented into a time series of alveolar gradients (breath minus room air. Segmental alveolar gradients were ranked as candidate biomarkers by C-statistic value (area under curve [AUC] of receiver operating characteristic [ROC] curve. Multivariate predictive algorithms were constructed employing significant biomarkers identified with multiple Monte Carlo simulations and cross validated with a leave-one-out (LOO procedure. RESULTS: Performance of breath biomarker algorithms was determined in three groups: breast cancer on biopsy versus normal screening mammograms (81.8% sensitivity, 70.0% specificity, accuracy 79% (73% on LOO [C-statistic value], negative predictive value 99.9%; normal versus abnormal screening mammograms (86.5% sensitivity, 66.7% specificity, accuracy 83%, 62% on LOO; and cancer versus no cancer on breast biopsy (75.8% sensitivity, 74.0% specificity, accuracy 78%, 67% on LOO. CONCLUSIONS: A pilot study of a six-minute point-of-care breath test for volatile biomarkers accurately identified women with breast cancer and with abnormal mammograms. Breath testing could potentially reduce the number of needless mammograms without loss of diagnostic sensitivity.

  2. Photoacoustic sensor for VOCs: first step towards a lung cancer breath test

    Wolff, Marcus; Groninga, Hinrich G.; Dressler, Matthias; Harde, Hermann

    2005-08-01

    Development of new optical sensor technologies has a major impact on the progression of diagnostic methods. Specifically, the optical analysis of breath is an extraordinarily promising technique. Spectroscopic sensors for the non-invasive 13C-breath tests (the Urea Breath Test for detection of Helicobacter pylori is most prominent) are meanwhile well established. However, recent research and development go beyond gastroenterological applications. Sensitive and selective detection of certain volatile organic compounds (VOCs) in a patient's breath, could enable the diagnosis of diseases that are very difficult to diagnose with contemporary techniques. For instance, an appropriate VOC biomarker for early-stage bronchial carcinoma (lung cancer) is n-butane (C4H10). We present a new optical detection scheme for VOCs that employs an especially compact and simple set-up based on photoacoustic spectroscopy (PAS). This method makes use of the transformation of absorbed modulated radiation into a sound wave. Employing a wavelength-modulated distributed feedback (DFB) diode laser and taking advantage of acoustical resonances of the sample cell, we performed very sensitive and selective measurements on butane. A detection limit for butane in air in the ppb range was achieved. In subsequent research the sensitivity will be successively improved to match the requirements of the medical application. Upon optimization, our photoacoustic sensor has the potential to enable future breath tests for early-stage lung cancer diagnostics.

  3. Panic disorder in a breath-holding challenge test: a simple tool for a better diagnosis

    Nardi Antonio E.; Nascimento Isabella; Valença Alexandre M; Lopes Fabiana L.; Mezzasalma Marco A; Zin Walter A.

    2003-01-01

    OBJECTIVE: Our aim was to observe if anxiety disorder patients - DSM-IV - respond in a similar way to the induction of panic attacks by a breath-holding challenge test. METHOD: We randomly selected 29 panic disorder (PD) patients, 27 social anxiety disorder (SAD) patients, 21 generalized anxiety disorder (GAD) patients. They were induced to breath-hold for as long as possible four times with two-minute interval between them. Anxiety scales were applied before and after the test. RESULTS: A to...

  4. Ten years experience of isotopic breath test with special reference to Helicobacter pylori detection

    The use of the carbon 14 urea breath test by comparison with culture for campylobacter of gastric endoscopic biopsies is studied in 91 patients. They were divided into 2 groups. The first group consisted of 53 patients examined by gastric endoscopy and carbon 14 urea breath test. In this population, gastric biopsies were taken at different regions of the stomach and duodenum. The breath test was performed within 3 hours after endoscopy. The second group consisted of 38 asymptomatic patients whom 23 were parent of children with campylobacter positive gastritis. For the whole population, neither antibiotic therapy nor bismuth medication was administrated within the 15 days before the realization of the test. Results were expressed in % of injected dose/mmole of CO2 after correction of endogenous production of CO2. In conclusion, carbon 14 urea breath test is a reliable noninvasive test for detection and follow-up of gastritis caused by a widespread microorganism. Also, the precision of both tests, 14 C-UBT and 13 C-UBT, are compared simultaneously in 84 adults patients. The results were expressed as % of administered dose expired in 30 minutes. A better precision is observed with the 13 C-UBT

  5. Ten years experience of isotopic breath test with special reference to Helicobacter pylori detection

    Verhas, M.; Tricht, L.Van; Verschaeren, A.; Delmotte, E.; Martin, P

    1997-12-31

    The use of the carbon 14 urea breath test by comparison with culture for campylobacter of gastric endoscopic biopsies is studied in 91 patients. They were divided into 2 groups. The first group consisted of 53 patients examined by gastric endoscopy and carbon 14 urea breath test. In this population, gastric biopsies were taken at different regions of the stomach and duodenum. The breath test was performed within 3 hours after endoscopy. The second group consisted of 38 asymptomatic patients whom 23 were parent of children with campylobacter positive gastritis. For the whole population, neither antibiotic therapy nor bismuth medication was administrated within the 15 days before the realization of the test. Results were expressed in % of injected dose/mmole of CO{sub 2} after correction of endogenous production of CO{sub 2}. In conclusion, carbon 14 urea breath test is a reliable noninvasive test for detection and follow-up of gastritis caused by a widespread microorganism. Also, the precision of both tests, {sup 14} C-UBT and {sup 13} C-UBT, are compared simultaneously in 84 adults patients. The results were expressed as % of administered dose expired in 30 minutes. A better precision is observed with the {sup 13} C-UBT

  6. 14C octanoic acid breath tests correlate with scintigraphy in the critically ill

    Full text: Gastric stasis is common in the critically ill and reduces tolerance to nasogastric feeding. Scintigraphic measurement of gastric emptying is rarely used in the critically ill for practical reasons. Breath testing would be a more convenient way of determining gastric emptying. The purpose of this study was to validate 14C octanoic acid breath tests against scintigraphy in ventilated patients. 21 unselected mechanically ventilated patients receiving enteral nutrition via a nasogastric tube (14M, mean age 58yrs) were fed a dual radiolabelled nutrient meal consisting of 100ml Ensure, 74KBq 14C octanoic acid and 20MBq 99Tc sulphur colloid. 12 normal volunteers (9M mean age 38yrs) were also studied to establish normal ranges. Dynamic scintigraphic images were collected with subjects in 20 deg LAO position over 4 hours utilising a GE Starcam 300M mobile gamma camera. Breath samples were collected using the RAH 'Rapid-14' collection methodology at baseline and every 10 -15 minutes for 4 hours. Gastric emptying parameters were calculated and correlated. Normal breath test mean t- = 117min (SD=46). Delayed gastric emptying was seen in some of the critically ill patients, mean t- - 143 mm (SD=86). Strongest correlations were between normals scintigraphic t- (t-s) and breath test t- (t-B), r=0.96 (p-B, r=0.75 (p-s and t-B, n=16, r=0.73 (p14C octanoic acid breath tests in normal subjects and the critically ill. This may be a useful alternative for measurement of gastric emptying in the critically ill. Copyright (2002) The Australian and New Zealand Society of Nuclear Medicine Inc

  7. FEV manoeuvre induced changes in breath VOC compositions: an unconventional view on lung function tests.

    Sukul, Pritam; Schubert, Jochen K; Oertel, Peter; Kamysek, Svend; Taunk, Khushman; Trefz, Phillip; Miekisch, Wolfram

    2016-01-01

    Breath volatile organic compound (VOC) analysis can open a non-invasive window onto pathological and metabolic processes in the body. Decades of clinical breath-gas analysis have revealed that changes in exhaled VOC concentrations are important rather than disease specific biomarkers. As physiological parameters, such as respiratory rate or cardiac output, have profound effects on exhaled VOCs, here we investigated VOC exhalation under respiratory manoeuvres. Breath VOCs were monitored by means of real-time mass-spectrometry during conventional FEV manoeuvres in 50 healthy humans. Simultaneously, we measured respiratory and hemodynamic parameters noninvasively. Tidal volume and minute ventilation increased by 292 and 171% during the manoeuvre. FEV manoeuvre induced substance specific changes in VOC concentrations. pET-CO2 and alveolar isoprene increased by 6 and 21% during maximum exhalation. Then they decreased by 18 and 37% at forced expiration mirroring cardiac output. Acetone concentrations rose by 4.5% despite increasing minute ventilation. Blood-borne furan and dimethyl-sulphide mimicked isoprene profile. Exogenous acetonitrile, sulphides, and most aliphatic and aromatic VOCs changed minimally. Reliable breath tests must avoid forced breathing. As isoprene exhalations mirrored FEV performances, endogenous VOCs might assure quality of lung function tests. Analysis of exhaled VOC concentrations can provide additional information on physiology of respiration and gas exchange. PMID:27311826

  8. FEV manoeuvre induced changes in breath VOC compositions: an unconventional view on lung function tests

    Sukul, Pritam; Schubert, Jochen K.; Oertel, Peter; Kamysek, Svend; Taunk, Khushman; Trefz, Phillip; Miekisch, Wolfram

    2016-06-01

    Breath volatile organic compound (VOC) analysis can open a non-invasive window onto pathological and metabolic processes in the body. Decades of clinical breath-gas analysis have revealed that changes in exhaled VOC concentrations are important rather than disease specific biomarkers. As physiological parameters, such as respiratory rate or cardiac output, have profound effects on exhaled VOCs, here we investigated VOC exhalation under respiratory manoeuvres. Breath VOCs were monitored by means of real-time mass-spectrometry during conventional FEV manoeuvres in 50 healthy humans. Simultaneously, we measured respiratory and hemodynamic parameters noninvasively. Tidal volume and minute ventilation increased by 292 and 171% during the manoeuvre. FEV manoeuvre induced substance specific changes in VOC concentrations. pET-CO2 and alveolar isoprene increased by 6 and 21% during maximum exhalation. Then they decreased by 18 and 37% at forced expiration mirroring cardiac output. Acetone concentrations rose by 4.5% despite increasing minute ventilation. Blood-borne furan and dimethyl-sulphide mimicked isoprene profile. Exogenous acetonitrile, sulphides, and most aliphatic and aromatic VOCs changed minimally. Reliable breath tests must avoid forced breathing. As isoprene exhalations mirrored FEV performances, endogenous VOCs might assure quality of lung function tests. Analysis of exhaled VOC concentrations can provide additional information on physiology of respiration and gas exchange.

  9. Application of the glycocolate 14C breath test in the stydy of rosacea

    Small bowel bacterial contamination was determined in patients affected by rosacea normal or gastric hyposecretors. The Breath Test 14C was used with glycocolate 14C Na. The study was completed by determination of gastric acidity, Key test, Schilling test and d xilosa test with positive results. Metronidazol was administered to these patients, thus normalizing the small bowel contamination and, at the same time, improving the dermatological process. (M.E.L.)

  10. Gastric emptying of a solid meal starts during meal ingestion : Combined study using C-13-octanoic acid breath test and Doppler ultrasonography - Absence of a lag phase in C-13-octanoic acid breath test

    Minderhoud, IM; Mundt, MW; Roelofs, JMM; Samsom, M

    2004-01-01

    Scintigraphy and the C-13-octanoic acid breath test are both applied to assess gastric emptying. Using the C-13-octanoic acid breath test, excretion curves show C-13 excretion immediately after ingestion of a solid egg meal, in contrast with scintigraphy where gastric emptying is observed after a la

  11. Breath tests sustainability in hospital settings: cost analysis and reimbursement in the Italian National Health System.

    Volpe, M; Scaldaferri, F; Ojetti, V; Poscia, A

    2013-01-01

    The high demand of Breath Tests (BT) in many gastroenterological conditions in time of limited resources for health care systems, generates increased interest in cost analysis from the point of view of the delivery of services to better understand how use the money to generate value. This study aims to measure the cost of C13 Urea and other most utilized breath tests in order to describe key aspects of costs and reimbursements looking at the economic sustainability for the hospital. A hospital based cost-analysis of the main breath tests commonly delivery in an ambulatory setting is performed. Mean salary for professional nurses and gastroenterologists, drugs/preparation used and disposable materials, purchase and depreciation of the instrument and the testing time was used to estimate the cost, while reimbursements are based on the 2013 Italian National Health System ambulatory pricelist. Variables that could influence the model are considered in the sensitivity analyses. The mean cost for C13--Urea, Lactulose and Lactose BT are, respectively, Euros 30,59; 45,20 and 30,29. National reimbursement often doesn't cover the cost of the analysis, especially considering the scenario with lower number of exam. On the contrary, in high performance scenario all the reimbursement could cover the cost, except for the C13 Urea BT that is high influenced by the drugs cost. However, consideration about the difference between Italian Regional Health System ambulatory pricelist are done. Our analysis shows that while national reimbursement rates cover the costs of H2 breath testing, they do not cover sufficiently C13 BT, particularly urea breath test. The real economic strength of these non invasive tests should be considered in the overall organization of inpatient and outpatient clinic, accounting for complete diagnostic pathway for each gastrointestinal disease. PMID:24443075

  12. Breath Ketone Testing: A New Biomarker for Diagnosis and Therapeutic Monitoring of Diabetic Ketosis

    Yue Qiao

    2014-01-01

    Full Text Available Background. Acetone, β-hydroxybutyric acid, and acetoacetic acid are three types of ketone body that may be found in the breath, blood, and urine. Detecting altered concentrations of ketones in the breath, blood, and urine is crucial for the diagnosis and treatment of diabetic ketosis. The aim of this study was to evaluate the advantages of different detection methods for ketones, and to establish whether detection of the concentration of ketones in the breath is an effective and practical technique. Methods. We measured the concentrations of acetone in the breath using gas chromatography-mass spectrometry and β-hydroxybutyrate in fingertip blood collected from 99 patients with diabetes assigned to groups 1 (−, 2 (±, 3 (+, 4 (++, or 5 (+++ according to urinary ketone concentrations. Results. There were strong relationships between fasting blood glucose, age, and diabetic ketosis. Exhaled acetone concentration significantly correlated with concentrations of fasting blood glucose, ketones in the blood and urine, LDL-C, creatinine, and blood urea nitrogen. Conclusions. Breath testing for ketones has a high sensitivity and specificity and appears to be a noninvasive, convenient, and repeatable method for the diagnosis and therapeutic monitoring of diabetic ketosis.

  13. Assessment of the (14C) aminopyrine breath test in liver disease

    Different methods of performing the (14C) aminopyrine breath test have been assessed. A tracer dose of 2 μCi without a loading dose and with a single breath collection at two hours was the method selected, since it gave the best discrimination between patients with hepatocellular diseases and normal subjects (5.2 +- 0.2%, mean - SEM). Reduced values occurred in patients with chronic active hepatitis (with and without cirrhosis) (1.5 +- 0.2%), alcoholic cirrhosis (1.7 +- 0.4%) and hepatitis (2.5 +- 0.3%), and late primary biliary cirrhosis suggesting defective microsomal function with respect to demethylation. Normal results were common in early primary biliary cirrhosis. Two weeks of prednisolone therapy caused some improvement in the breath test in nine of ten patients with chronic active hepatitis. It is concluded that the (14C) aminopyrine breath test is a simple test for detecting hepatocellular dysfunction, but has no obvious diagnostic advantage over the determination of serum aspartate transaminase and two hour post-prandial bile-acids. (author)

  14. Diabetes and the metabolic syndrome: possibilities of a new breath test in a dolphin model

    CristinaElizabethDavis

    2013-11-01

    Full Text Available Diabetes type-2 and the metabolic syndrome are prevalent in epidemic proportions and result in significant co-morbid disease. Limitations in understanding of dietary effects and cholesterol metabolism exist. Current methods to assess diabetes are essential, though many are invasive; for example, blood glucose and lipid monitoring require regular finger sticks and blood draws. A novel method to study these diseases may be non-invasive breath testing of exhaled compounds. Currently, acetone and lipid peroxidation products have been seen in small scale studies, though other compounds may be significant. As Atlantic bottlenose dolphins (Tursiops truncatus have been proposed as a good model for human diabetes, applications of dietary manipulations and breath testing in this population may shed important light on how to design human clinical studies. In addition, ongoing studies indicate that breath testing in dolphins is feasible, humane, and yields relevant metabolites. By studying the metabolic and cholesterol responses of dolphins to dietary modifications, researchers may gain insight into human diabetes, improve the design of costly human clinical trials, and potentially discover biomarkers for non-invasive breath monitoring.

  15. Additional Value of CH₄ Measurement in a Combined (13)C/H₂ Lactose Malabsorption Breath Test: A Retrospective Analysis.

    Houben, Els; De Preter, Vicky; Billen, Jaak; Van Ranst, Marc; Verbeke, Kristin

    2015-09-01

    The lactose hydrogen breath test is a commonly used, non-invasive method for the detection of lactose malabsorption and is based on an abnormal increase in breath hydrogen (H₂) excretion after an oral dose of lactose. We use a combined (13)C/H₂ lactose breath test that measures breath (13)CO₂ as a measure of lactose digestion in addition to H₂ and that has a better sensitivity and specificity than the standard test. The present retrospective study evaluated the results of 1051 (13)C/H₂ lactose breath tests to assess the impact on the diagnostic accuracy of measuring breath CH₄ in addition to H₂ and (13)CO₂. Based on the (13)C/H₂ breath test, 314 patients were diagnosed with lactase deficiency, 138 with lactose malabsorption or small bowel bacterial overgrowth (SIBO), and 599 with normal lactose digestion. Additional measurement of CH₄ further improved the accuracy of the test as 16% subjects with normal lactose digestion and no H₂-excretion were found to excrete CH₄. These subjects should have been classified as subjects with lactose malabsorption or SIBO. In conclusion, measuring CH₄-concentrations has an added value to the (13)C/H₂ breath test to identify methanogenic subjects with lactose malabsorption or SIBO. PMID:26371034

  16. A novel breath test to directly measure use of vaginal gel and condoms.

    van der Straten, Ariane; Cheng, Helen; Wasdo, Scott; Montgomery, Liz; Smith-McCune, Karen; Booth, Matthew; Gonzalez, Daniel; Derendorf, Hartmut; Morey, Timothy E; Dennis, Donn M

    2013-07-01

    We assessed the feasibility of a breath test to detect women's single or concurrent use of vaginal products by adding ester taggants to vaginal gel and condom lubricant. Healthy non-pregnant women were enrolled into a two-day cohort (N = 13) and a single-day cohort (N = 12) in San Francisco. Within each cohort, women were randomized (5:1) to tagged or untagged products, and inserted in a clinical setting: 4 mL of tenofovir placebo gel (ten tagged with 15 mg 2-pentyl acetate; three untagged), and an artificial phallus with a lubricated condom (11 tagged with 15 mg 2-butyl acetate; two untagged), on two separate days (two-day cohort) or concurrently (single-day cohort). Using a portable mini-gas chromatograph, the presence/absence of taggants was determined in breath specimens collected prior to, and at timed intervals following product exposure. Demographic, clinical and product use experience data were collected by structured interview. All participants completed all visits and inserted their assigned products. At 5 min post-insertion, the breath test was 100% accurate in identifying insertion of the tagged (or untagged) gel and/or condom. The half-life in breath of the two esters tested was <1 h with large variability between individuals, taggants and cohorts. Overall, among those receiving tagged product, six mild and two moderate product-related AEs were reported. All were transient and resolved spontaneously. Additional sensations included taste in mouth (N = 4) and scent (N = 5). The tagged products were well tolerated. This breath test has the potential to accurately and objectively monitor adherence to vaginal gel and condom used separately or concurrently. PMID:23321948

  17. 13C Urea Breath Testing to Diagnose Helicobacter pylori Infection in Children

    Deslandres, Colette

    1999-01-01

    The causal relationship between Helicobacter pylori colonization of the gastric mucosa and gastritis has been proven. Endoscopy and subsequent histological examination of antral biopsies have been regarded as the gold standard for diagnosing H pylori gastritis. The 13C urea breath test is a noninvasive test with a high specificity and sensitivity for H pylori colonization. Increasingly, it is becoming an important tool for use in diagnosing H pylori infection in paediatric populations. This t...

  18. Glucose tolerance by 13CO2 breath test methodology and utilization

    Full text: The glucose tolerance test is a valuable diagnostic aid. The ability to utilize carbohydrate is decreased in diabetics and increased in hypopituitarism, hyperinsulinism, and adrenocortical hypofunction. Developments in mass spectrometric technology and availability of 13C-enriched substrates for clinical research have enabled the clinician to perform 13CO2 breath tests in normal and patients with various diseases. In this paper, we planned to evaluate the applicability of the non-invasive 13CO2 breath test for glucose tolerance studies and for the diagnosis of disorders of carbohydrate metabolism in adults using natural glucose. The methodology for breath sample collection, storage and analysis was developed and experimental conditions were designed and optimized. Static absorption of breath CO2 was carried out by having the subject exhale through a Tygon tube attached with glass adapter into an empty 250 ml flat bottom flask. Flask was closed by stopper after adding 10 ml 1.5 N NaOH solution and was shaken for 5 minutes. Samples were stored in plastic lined screw-cap vials for analysis. Analysis of same breath sample (δ 13C value -25.63, n=3) and laboratory internal standard (δ 13C value -3.56, n=4) show precision 0.10 and 0.03 respectively. Glucose tolerance test was performed on normal volunteers using naturally labeled glucose (glaxose-D) in fasting and non fasting conditions using standard test meal. MS Excel software template for trioctanoic acid breath test, got from W. A. Coward, Dunn Nutrition Center, U. K. was modified for calculations of cumulative percentage dose of 13C recovered from natural glucose. Mean glucose tolerance test data from Marcel Lacroix (1973) was used to the modified template and cumulative percentage of 13C dose was calculated and compared with our experiments' results. Marcel Lacroix fasted data shows percentage dose recovered 30.53 ± 4.06, n=8, 20-32 years. PINSTECH fasted data shows percentage dose recovered 31.28

  19. Methodological aspects of breath hydrogen (H2) analysis. Evaluation of a H2 monitor and interpretation of the breath H2 test

    Rumessen, J J; Kokholm, G; Gudmand-Høyer, E

    1987-01-01

    is concluded that the technique used for interval sampling of end-expiratory breath samples for H2 concentration gives reliable results. The biological significance of H2 concentration increments can only be evaluated if the limitations of the technical procedures and the individual ability to......The reliability of end-expiratory hydrogen (H2) breath tests were assessed and the significance of some important pitfalls were studied, using a compact, rapid H2-monitor with electrochemical cells. The H2 response was shown to be linear and stable. The reproducibility of the breath collection...... technique was determined in 20 patients following ingestion of lactulose. The increment between consecutive means of duplicate samples indicative of a significant rise of H2 concentration never exceeded 10 p.p.m., the mean coefficient of variation of the duplicate samples was below 5%. Fasting H2 levels...

  20. 14C-triolein breath test in the diagnosis of steatorrhea

    The 14C-triolein breath test was evaluated as a screening test for steatorrhea in 66 consecutive patients. Steatorrhea was found in 20 patients. Following an oral dose of 14C-triolein, 14CO2-activity in the expiratory air was measured after zero, three, four, five and six hours. Maximum 14CO 2-expiration was calculated. The ability of the test to discriminate between patients with steatorrhea and patients without steatorrhea showed a specificity of 98%, and a sensitivity of 85%. Thus the 14C-triolein test seems to be sufficiently accurate as a screening test for steatorrhea

  1. Panic disorder in a breath-holding challenge test: a simple tool for a better diagnosis

    Nardi Antonio E.

    2003-01-01

    Full Text Available OBJECTIVE: Our aim was to observe if anxiety disorder patients - DSM-IV - respond in a similar way to the induction of panic attacks by a breath-holding challenge test. METHOD: We randomly selected 29 panic disorder (PD patients, 27 social anxiety disorder (SAD patients, 21 generalized anxiety disorder (GAD patients. They were induced to breath-hold for as long as possible four times with two-minute interval between them. Anxiety scales were applied before and after the test. RESULTS: A total of 44.8% (n=13 PD patients, 14.8% (n=4 SAD patients, 9.5% (n=2 GAD patients had a panic attack after the test (c²= 21.44, df= 2, p=0.001. There was no heart rate or anxiety levels difference among the groups before and after the test. CONCLUSION: In this breath-holding challenge test the panic disorder patients were more sensitive than other anxiety disorder patients.

  2. Update on diagnostic value of breath test in gastrointestinal and liver diseases.

    Siddiqui, Imran; Ahmed, Sibtain; Abid, Shahab

    2016-08-15

    In the field of gastroenterology, breath tests (BTs) are used intermittently as diagnostic tools that allow indirect, non-invasive and relatively less cumbersome evaluation of several disorders by simply quantifying the appearance in exhaled breath of a metabolite of a specific substrate administered. The aim of this review is to have an insight into the principles, methods of analysis and performance parameters of various hydrogen, methane and carbon BTs which are available for diagnosing gastrointestinal disorders such as Helicobacter pylori infection, small intestinal bacterial overgrowth, and carbohydrate malabsorption. Evaluation of gastric emptying is routinely performed by scintigraphy which is however, difficult to perform and not suitable for children and pregnant women, this review has abridged the 13C-octanoic acid test in comparison to scintigraphy and has emphasized on its working protocol and challenges. A new development such as electronic nose test is also highlighted. Moreover we have also explored the limitations and constraints restraining the wide use of these BT. We conclude that breath testing has an enormous potential to be used as a diagnostic modality. In addition it offers distinct advantages over the traditional invasive methods commonly employed. PMID:27574563

  3. A Modified Carbon Monoxide Breath Test for Measuring Erythrocyte Lifespan in Small Animals.

    Ma, Yong-Jian; Zhang, Hou-De; Ji, Yong-Qiang; Zhu, Guo-Liang; Huang, Jia-Liang; Du, Li-Tao; Cao, Ping; Zang, De-Yue; Du, Ji-Hui; Li, Rong; Wang, Lei

    2016-01-01

    This study was to develop a CO breath test for RBC lifespan estimation of small animals. The ribavirin induced hemolysis rabbit models were placed individually in a closed rebreath cage and air samples were collected for measurement of CO concentration. RBC lifespan was calculated from accumulated CO, blood volume, and hemoglobin concentration data. RBC lifespan was determined in the same animals with the standard biotin-labeling method. RBC lifespan data obtained by the CO breath test method for control (CON, 49.0 ± 5.9 d) rabbits, rabbits given 10 mg/kg·d(-1) of ribavirin (RIB10, 31.0 ± 4.0 d), and rabbits given 20 mg/kg·d(-1) of ribavirin (RIB20, 25.0 ± 2.9 d) were statistically similar (all p > 0.05) to and linearly correlated (r = 0.96, p animal models. PMID:27294128

  4. 13CO2 breath test to measure the hydrolysis of various starch formulations in healthy subjects.

    Hiele, M; Ghoos, Y.; RUTGEERTS, P; Vantrappen, G; de Buyser, K

    1990-01-01

    13CO2 starch breath test was used to study the effect of physicochemical characteristics of starch digestion. As starch is hydrolysed to glucose, which is subsequently oxidised to CO2, differences in 13CO2 excretion after ingestion of different starch products must be caused by differences in hydrolysis rate. To study the effect of the degree of chain branching, waxy starch, containing 98% amylopectin, was compared with high amylose starch, containing 30% amylopectin, and normal crystalline s...

  5. A Modified Carbon Monoxide Breath Test for Measuring Erythrocyte Lifespan in Small Animals

    Ma, Yong-Jian; Zhang, Hou-De; Ji, Yong-Qiang; Zhu, Guo-Liang; Huang, Jia-Liang; Du, Li-Tao; Cao, Ping; Zang, De-Yue; Du, Ji-Hui; Li, Rong; Wang, Lei

    2016-01-01

    This study was to develop a CO breath test for RBC lifespan estimation of small animals. The ribavirin induced hemolysis rabbit models were placed individually in a closed rebreath cage and air samples were collected for measurement of CO concentration. RBC lifespan was calculated from accumulated CO, blood volume, and hemoglobin concentration data. RBC lifespan was determined in the same animals with the standard biotin-labeling method. RBC lifespan data obtained by the CO breath test method for control (CON, 49.0 ± 5.9 d) rabbits, rabbits given 10 mg/kg·d−1 of ribavirin (RIB10, 31.0 ± 4.0 d), and rabbits given 20 mg/kg·d−1 of ribavirin (RIB20, 25.0 ± 2.9 d) were statistically similar (all p > 0.05) to and linearly correlated (r = 0.96, p < 0.01) with the RBC lifespan data obtained for the same rabbits by the standard biotin-labeling method (CON, 51.0 ± 2.7 d; RIB10, 33.0 ± 1.3 d; and RIB20, 27.0 ± 0.8 d). The CO breath test method takes less than 3 h to complete, whereas the standard method requires at least several weeks. In conclusion, the CO breath test method provides a simple and rapid means of estimating RBC lifespan and is feasible for use with small animal models. PMID:27294128

  6. Lactulose Hydrogen Breath Test Result Is Associated with Age and Gender

    Newberry, Carolyn; Tierney, Ann; Pickett-Blakely, Octavia

    2016-01-01

    Small intestinal bacterial overgrowth (SIBO) is associated with chronic gastrointestinal diseases and structural/functional abnormalities of the gastrointestinal tract. SIBO’s association with clinical characteristics is unclear. This study investigates the association between clinical factors and SIBO according to lactulose hydrogen breath test (LHBT) result. Methods. A cross-sectional study in a university-based gastroenterology practice was performed. Data was abstracted from the medical r...

  7. Small Intestinal Bacterial Overgrowth Diagnosed by Glucose Hydrogen Breath Test in Post-cholecystectomy Patients

    Sung, Hea Jung; Paik, Chang-Nyol; Chung, Woo Chul; Lee, Kang-Moon; Yang, Jin-Mo; Choi, Myung-Gyu

    2015-01-01

    Background/Aims Patients undergoing cholecystectomy may have small intestinal bacterial overgrowth (SIBO). We investigated the prevalence and characteristics of SIBO in patients with intestinal symptoms following cholecystectomy. Methods Sixty-two patients following cholecystectomy, 145 with functional gastrointestinal diseases (FGIDs), and 30 healthy controls undergoing hydrogen (H2)-methane (CH4) glucose breath test (GBT) were included in the study. Before performing GBT, all patients were ...

  8. A Modified Carbon Monoxide Breath Test for Measuring Erythrocyte Lifespan in Small Animals

    Yong-Jian Ma

    2016-01-01

    Full Text Available This study was to develop a CO breath test for RBC lifespan estimation of small animals. The ribavirin induced hemolysis rabbit models were placed individually in a closed rebreath cage and air samples were collected for measurement of CO concentration. RBC lifespan was calculated from accumulated CO, blood volume, and hemoglobin concentration data. RBC lifespan was determined in the same animals with the standard biotin-labeling method. RBC lifespan data obtained by the CO breath test method for control (CON, 49.0±5.9 d rabbits, rabbits given 10 mg/kg·d−1 of ribavirin (RIB10, 31.0±4.0 d, and rabbits given 20 mg/kg·d−1 of ribavirin (RIB20, 25.0±2.9 d were statistically similar (all p>0.05 to and linearly correlated (r=0.96, p<0.01 with the RBC lifespan data obtained for the same rabbits by the standard biotin-labeling method (CON, 51.0±2.7 d; RIB10, 33.0±1.3 d; and RIB20, 27.0±0.8 d. The CO breath test method takes less than 3 h to complete, whereas the standard method requires at least several weeks. In conclusion, the CO breath test method provides a simple and rapid means of estimating RBC lifespan and is feasible for use with small animal models.

  9. Application of electrochemical breath test for detection of Helicobacter pylori in screening of Moscow students.

    Kukushkina, I A; Korotkova, O A; Loginov, I A; Vasilieva, E A; Yashina, N V; Anokhina, I V; Kozlov, A V; Tumanova, G M; Tedoradze, R V; Dalin, M V

    2012-01-01

    The incidence of Helicobacter pylori infection is analyzed by the results of screening of first- and fourth-year students of Moscow Institute of Foreign Affairs using HelicoSense Scientific breath test system. Age-related dynamics of the infection in patients examined for the first time has been traced. The data on infection rates in patients after eradication therapy are presented. PMID:22803077

  10. An acetone breath analyzer using cavity ringdown spectroscopy: an initial test with human subjects under various situations

    Wang, Chuji; Surampudi, Anand B.

    2008-10-01

    We have developed a portable breath acetone analyzer using cavity ringdown spectroscopy (CRDS). The instrument was initially tested by measuring the absorbance of breath gases at a single wavelength (266 nm) from 32 human subjects under various conditions. A background subtraction method, implemented to obtain absorbance differences, from which an upper limit of breath acetone concentration was obtained, is described. The upper limits of breath acetone concentration in the four Type 1 diabetes (T1D) subjects, tested after a 14 h overnight fast, range from 0.80 to 3.97 parts per million by volume (ppmv), higher than the mean acetone concentration (0.49 ppmv) in non-diabetic healthy breath reported in the literature. The preliminary results show that the instrument can tell distinctive differences between the breath from individuals who are healthy and those with T1D. On-line monitoring of breath gases in healthy people post-exercise, post-meals and post-alcohol-consumption was also conducted. This exploratory study demonstrates the first CRDS-based acetone breath analyzer and its potential application for point-of-care, non-invasive, diabetic monitoring.

  11. An acetone breath analyzer using cavity ringdown spectroscopy: an initial test with human subjects under various situations

    We have developed a portable breath acetone analyzer using cavity ringdown spectroscopy (CRDS). The instrument was initially tested by measuring the absorbance of breath gases at a single wavelength (266 nm) from 32 human subjects under various conditions. A background subtraction method, implemented to obtain absorbance differences, from which an upper limit of breath acetone concentration was obtained, is described. The upper limits of breath acetone concentration in the four Type 1 diabetes (T1D) subjects, tested after a 14 h overnight fast, range from 0.80 to 3.97 parts per million by volume (ppmv), higher than the mean acetone concentration (0.49 ppmv) in non-diabetic healthy breath reported in the literature. The preliminary results show that the instrument can tell distinctive differences between the breath from individuals who are healthy and those with T1D. On-line monitoring of breath gases in healthy people post-exercise, post-meals and post-alcohol-consumption was also conducted. This exploratory study demonstrates the first CRDS-based acetone breath analyzer and its potential application for point-of-care, non-invasive, diabetic monitoring

  12. Diagnostic Value of the 13C Methacetin Breath Test in Various Stages of Chronic Liver Disease

    Hamizah Razlan

    2011-01-01

    Full Text Available The accuracy of the 13C-methacetin breath test (13C-MBT in differentiating between various stages of liver disease is not clear. A cross-sectional study of Asian patients was conducted to examine the predictive value of the 13C-MBT in various stages of chronic liver diseases. Diagnostic accuracy of the breath test was determined by sensitivity, specificity, positive predictive value, negative predictive value, and area under the curve analysis. Seventy-seven patients (47 men/30 women, mean age 50±16 years were recruited. Forty-seven patients had liver cirrhosis (Child Pugh A = 11, Child Pugh B = 15, and Child Pugh C = 21, 21 had fibrosis, and 9 had chronic inflammation. The sensitivity and positive predictive value for liver fibrosis, cirrhosis (all stages, Child-Pugh A, Child-Pugh B, and Child-Pugh C were 65% and 56%, 89% and 89%, 67% and 42%, 40% and 40%, and 50% and 77%, respectively. Area under curve values for fibrosis was 0.62 (0.39–0.86, whilst that for cirrhosis (all stages was 0.95 (0.91–0.99. The 13C-methacetin breath test has a poor predictive value for liver fibrosis but accurately determines advanced cirrhosis.

  13. The cut-off criterion for a positive hydrogen breath test in children: a reappraisal.

    Solomons, N W; Barillas, C

    1986-01-01

    Seventy-three preschool children with adequate nutritional status underwent interval-sampling, 3-hour breath-hydrogen carbohydrate absorption tests after consuming either 240 ml of intact milk (containing 12 g of lactose) or the same volume of milk with 90-95% of its lactose prehydrolyzed in vitro (containing less than 1 g lactose, with the remaining sugar as glucose and galactose). Results were examined in a reappraisal of the cut-off criterion for the rise of breath H2 concentration signifying biologically incomplete absorption. If the greater than or equal to 10-ppm criterion advocated by some investigators is used, 83% of our subjects would have been classified as incomplete lactose digesters and 30% would have their tests with the monosaccharide-rich milk classified as positive. With the greater than or equal to 20 ppm criterion used in our laboratory and others, the prevalence of lactose maldigestion in the sample becomes 60% and only 4% of subjects have apparent monosaccharide absorption, 96% having a rise below the cut-off level with prehydrolyzed milk. At least in Guatemalan preschoolers, the 20-ppm criterion for a positive breath H2 test provides a superior specificity-sensitivity balance and more reasonable diagnostic conclusions. PMID:3794911

  14. The interest of the 13C urea breath test for the diagnostic and monitoring of chronic duodenal ulcer

    Duodenal ulcer is very frequently associated with Helicobacter pylori (Hp) present in the gastric mucous membrane. Breath tests with 13C-labelled urea have been carried out for the detection of Hp; these tests could be more sensitive than gastric biopsies, because of the heterogenous distribution of the bacteria in the mucous membrane. This breath test may be used repetitively and allows for a non-intrusive monitoring of the Hp eradication after treatment. 12 refs

  15. On the importance of developing a new generation of breath tests for Helicobacter pylori detection.

    Kushch, Ievgeniia; Korenev, Nikolai; Kamarchuk, Lyudmila; Pospelov, Alexander; Kravchenko, Andrey; Bajenov, Leonid; Kabulov, Mels; Amann, Anton; Kamarchuk, Gennadii

    2015-12-01

    State-of-the-art methods for non-invasive detection of the Helicobacter pylori (H. pylori) infection have been considered. A reported global tendency towards a non-decreasing prevalence of H. pylori worldwide could be co-influenced by the functional limitations of urea breath tests (UBTs), currently preferred for the non-invasive recognition of H. pylori in a clinical setting. Namely, the UBTs can demonstrate false-positive or false-negative results. Within this context, limitations of conventional clinically exploited H. pylori tests have been discussed to justify the existing need for the development of a new generation of breath tests for the detection of H. pylori and the differentiation of pathogenic and non-pathogenic strains of the bacterium. This paper presents the results of a pilot clinical study aimed at evaluating the development and diagnostic potential of a new method based on the detection of the non-urease products of H. pylori vital activity in exhaled gas. The characteristics of breath of adolescents with H. pylori-positive and H. pylori-negative functional dyspepsia, together with a consideration of the cytotoxin-associated gene A (CagA) status of H. pylori-positive subjects, have been determined for the first time using innovative point-contact nanosensor devices based on salts of the organic conductor tetracyanoquinodimethane (TCNQ). The clinical and diagnostic relevance of the response curves of the point-contact sensors was assessed. It was found that the recovery time of the point-contact sensors has a diagnostic value for differentiation of the H. pylori-associated peptic ulcer disease. The diagnostically significant elongation of the recovery time was even more pronounced in patients infected with CagA-positive H. pylori strains compared to the CagA-negative patients. Taking into account the operation of the point-contact sensors in the real-time mode, the obtained results are essential prerequisites for the development of a fast and

  16. Posttreatment 13C-Urea Breath Test Is Predictive of Antimicrobial Resistance to H. pylori After Failed Therapy

    Kao, Ai-Wen; Cheng, Hsiu-Chi; Sheu, Bor-Shyang; Lin, Ching-Yih; Sheu, Ming-Jen; Yang, Hsiao-Bai; Wu, Jiunn-Jong

    2005-01-01

    OBJECTIVE We tested whether a 13C-urea breath test can predict antimicrobial resistance of Helicobacter pylori (H. pylori). METHODS Seventy patients who had failed triple eradication therapy and 108 untreated H. pylori-infected patients were given a 13C-urea breath test, endoscopy for culture of H. pylori, and assessment of clarithromycin resistance. The patients who had failed triple therapy then received 1 week of quadruple therapy to eradicate residual H. pylori. RESULTS The posttreatment value of the 13C-urea breath test expressed as excessive δ13CO2 per ml (ECR) was higher in patients with residual H. pylori with clarithromycin resistance than in those without (23.8 vs 10.6; P or≤15, the 13C-urea breath test was 88.6% sensitive and 88.9% specific in predicting clarithromycin resistance of residual H. pylori. The H. pylori eradication rate of the rescue regimen was higher for patients with a posttreatment ECR of the 13C-urea breath test ≤ 15 than for those with a value >15 (93.8% vs 73.3%; P .05). CONCLUSION The posttreatment value of the 13C-urea breath test is predictive of clarithromycin resistance in residual H. pylori after failed triple therapy and predicts efficacy of the rescue regimen. The value of the noninvasive test is promising for primary care physicians who need to select a rescue regimen without invasive H. pylori culture. PMID:15836546

  17. Four-sample lactose hydrogen breath test for diagnosis of lactose malabsorption in irritable bowel syndrome patients with diarrhea

    Yang, Jian-Feng; Fox, Mark; Chu, Hua; Zheng, Xia; Long, Yan-Qin; Pohl, Daniel; Fried, Michael; Dai, Ning

    2015-01-01

    AIM: To validate 4-sample lactose hydrogen breath testing (4SLHBT) compared to standard 13-sample LHBT in the clinical setting. METHODS: Irritable bowel syndrome patients with diarrhea (IBS-D) and healthy volunteers (HVs) were enrolled and received a 10 g, 20 g, or 40 g dose lactose hydrogen breath test (LHBT) in a randomized, double-blinded, controlled trial. The lactase gene promoter region was sequenced. Breath samples and symptoms were acquired at baseline and every 15 min for 3 h (13 ...

  18. Diagnosing lactose malabsorption in children: difficulties in interpreting hydrogen breath test results.

    Ruzsanyi, Veronika; Heinz-Erian, Peter; Entenmann, Andreas; Karall, Daniela; Müller, Thomas; Schimkowitsch, Alexander; Amann, Anton; Scholl-Bürgi, Sabine

    2016-03-01

    Lactose malabsorption (LM) is caused by insufficient enzymatic degradation of the disaccharide by intestinal lactase. Although hydrogen (H2) breath tests (HBTs) are routinely applied to diagnose LM, false-negative results are not uncommon. Thirty-two pediatric patients (19 females, 13 males) were included in this prospective study. After oral lactose administration (1 g kg(-1) bodyweight to a maximum of 25 g), breath H2 was measured by electrochemical detection. HBT was considered positive if H2 concentration exceeded an increase of  ⩾20 ppm from baseline. In addition to H2, exhaled methane (CH4), blood glucose concentrations and clinical symptoms (flatulence, abdominal pain, diarrhea) were monitored. A positive HBT indicating LM was found in 12/32 (37.5%) patients. Only five (41.7%, 5/12) of these had clinical symptoms during HBT indicating lactose intolerance (LI). Decreased blood glucose concentration increments (⩽20 mg dL(-1) (⩽1.1 mmol L(-1))) were found in 3/5 of these patients. CH4 concentrations  ⩾10 ppm at any time during the test were observed in 5/32 (15.6%) patients and in 9/32 (28.1%) between 1 ppm and 9 ppm above baseline after lactose ingestion. In patients with positive HBT 10/12 (83.3%) showed elevated CH4 (>1 ppm) above baseline in breath gas, whereas in patients with negative HBT this figure was only 4/17 (23.5%). In addition to determining H2 in exhaled air, documentation of clinical symptoms, measurement of blood glucose and breath CH4 concentrations may be helpful in deciding whether in a given case an HBT correctly identifies patients with clinically relevant LM. PMID:26934035

  19. Modified 13C-urea breath test and the detection of helicobacter pylori

    The 13C-urea breath test (13C-UBT) is one of the most important non-invasive methods for detecting Helicobacter pylori infection. This examination is innocuous, simple, highly accurate. While the major drawback of 13C-UBT is the higher cost compared with other methods which hold back its widely using. The author review focuses on the most recent advances in the machines used to measure the 13C isotope and on the most important improvements about the UBT, such as the use of lower dose 13C-urea tablet or capsule, the modification of test meal, a shortened collection time of exhalation sample and so on

  20. Assessment of liver function in dogs using the 13C-galactose breath test.

    Silva, S; Wyse, C A; Goodfellow, M R; Yam, P S; Preston, T; Papasouliotis, K; Hall, E J

    2010-08-01

    The aim of this study was to evaluate the application of the 13C-galactose breath test (13C-GBT) in assessing canine liver function by applying it to a group of healthy dogs, and to a group with clinicopathological evidence of liver dysfunction. Breath samples were collected 30 min before ingestion of 13C-galactose, and then at regular intervals thereafter for 6 h. The proportion of 13CO2/12CO2 in the breath samples was measured by isotope-ratio mass spectrometry. There was no significant difference in recovery of 13CO2 in the diseased group, compared to the healthy controls, but there was considerable inter-subject variation in both groups, possibly due to differences in the rate of gastric emptying, which could preclude detection of alterations in hepatic metabolism of galactose. The results of this study do not support the application of the 13C-GBT for assessment of canine liver function. PMID:19546016

  1. Nondispersive isotope-selective infrared spectroscopy: A new analytical method for 13C-urea breath tests

    Currently, stable isotope techniques in breath tests using 13C-labeled substrates are limited to a few centers equipped with expensive and complex isotope spectrometry (IRMS). Although breath samples can be mailed to these centers, widespread application of 13C-breath tests would be more feasible with a cheaper and more practicable analysis system at hand. The authors therefore tested the newly developed nondispersive isotope-selective infrared spectrometer (NDIRS) with reference to IRMS in a clinical setting, comparing the results of both techniques in 538 consecutive 13C-urea breath tests performed for the detection of helicobacter pylori infection. With NDIRS five false-positive and three false-negative results were observed; that is, the sensitivity of NDIRS was 98.3%, and the specificity was 98.6%. When running this large number of breath tests in 3 days, the NDIRS proved to be a reliable, stable, and easy-to-operate analytical tool, which is well qualified for gastroenterologic application in the diagnostic routine. Both the price and the easy handling of NDIRS will facilitate the widespread use of the noninvasive stable isotope technique for 13C breath test. 22 refs., 3 figs., 1 tab

  2. Reduced accuracy of 14C-D-xylose breath test for detecting bacterial overgrowth in gastrointestinal motility disorders

    The accuracy of the 14C-D-xylose breath test in the diagnosis of small-bowel bacterial overgrowth was prospectively evaluated in 10 patients with motility disorders: 6 myopathic, 3 neuropathic, and 1 mechanical obstruction. 6 of 10 patients had small-bowel bacterial overgrowth on culture of small-bowel aspirate. Increased breath 14CO2 levels were documented in 3 of 6 patients with positive cultures and in 2 of 4 with negative cultures. 2 patients with positive results by both methods and 1 of 2 with positive breath 14CO2 but negative cultures had previously undergone gastric surgery. 3 patients with myopathic dysmotility had positive cultures but negative breath tests. Cultures of duodenal aspirates and the D-xylose test had sensitivities of 80% and 40%, respectively, for the finding of hypoalbuminemia. Compared with cultures, the sensitivity and specificity of the breath test were 60% and 40%, respectively. Impaired delivery of 14C-D-xylose for bacterial metabolism may result from postprandial antral hypomotility or low amplitude small-bowel motility, contributing to the false-negative breath tests. Thus, cultures is the optimal method to detect small-bowel bacterial overgrowth in patients with motility disorders. 25 refs., 1 fig., 4 tabs

  3. Evaluation of small intestine bacterial overgrowth in patients with functional dyspepsia through H2 breath test

    Michelle Bafutto Gomes Costa

    2012-12-01

    Full Text Available CONTEXT: Functional dyspepsia is a condition in which symptoms are not related to organic underlying disease; its pathogenesis is not well known. The small intestinal bacterial overgrowth (SIBO is characterized by the increase in the number and/or type of colonic bacteria in the upper gastrointestinal tract. The hypothesis of SIBO being associated to functional dyspepsia must be considered, since the impaired motility of the gastrointestinal tract is one of the main etiologic factors involved on both pathologies. OBJECTIVE: To determine if there is SIBO in patients with functional dyspepsia. METHODS: Case-control study, evaluating 34 patients: 23 functional dyspeptic and 11 non-dyspeptic (control group. Questionnaire applied based on Rome III criteria. The patients underwent H2-lactulose breath test, considered positive when: H2 peak exceeding 20 ppm, in relation to fasting, or two peaks exceeding 10 ppm sustained until 60 minutes. RESULTS: Of the 23 dyspeptic patients, 13 (56.5% obtained positive results for SIBO trough the H2-lactulose breath test. On control group, SIBO was not observed. The association between the dyspeptic group and the control group regarding SIBO was statistically significant, with P = 0.0052. In the group of dyspeptic patients, 12 (52.2% were using proton pump inhibitor; of these 9 (75% were positive for SIBO. In the control group, none of the 11 patients used proton pump inhibitors and SIBO was not observed. The association of the dyspeptic group using proton pump inhibitor that were positive for SIBO and the control group was statistically significant, with P = 0.0011. CONCLUSION: It was found that, patients with functional dyspepsia presented SIBO, when they underwent to H2-lactulose breath test, compared to the non-dyspeptic. In addition, it was observed a higher prevalence of SIBO in dyspeptic patients that were using proton pump inhibitors, compared to control group.

  4. A preliminary investigation of 13C background in 13C-urea breath test

    During the 13C-urea breath test which is used for diagnosis of the helicobacter pylori infection (HP), the 13C background values are measured in 495 normal donors in Beijing, Shandong, Jiangsu and Guizhou. The fluctuation is less than 0.2% for these areas and is about 0.1% within the same area. Through replacing of the individual 13C background values by the averaged values from local areas, the coincident rate for diagnosis of HP is higher than 98%

  5. Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation.

    Pizzoferrato, M; Del Zompo, F; Mangiola, F; Lopetuso, L R; Petito, V; Cammarota, G; Gasbarrini, A; Scaldaferri, F

    2013-01-01

    Breath tests are non-invasive, non-radioactive, safe, simple and effective tests able to determine significant metabolic alterations due to specific diseases or lack of specific enzymes. Carbon isotope (13)C, the stable-non radioactive isotope of carbon, is the most used substrate in breath testing, in which (13)C/(12)C ratio is measured and expressed as a delta value, a differences between readings and a fixed standard. (13)C/(12)C ratio is measured with isotope ratio mass spectrometry or non-dispersive isotope-selective infrared spectrometer and generally there is a good agreement between these techniques in the isotope ratio estimation. (13)C/(12)C ratio can be expressed as static measurement (like delta over baseline in urea breath test) or as dynamic measurement as percent dose recovery, but more dosages are necessary. (13)C Breath-tests are involved in many fields of interest within gastroenterology, such as detection of Helicobacter pylori infection, study of gastric emptying, assessment of liver and exocrine pancreatic functions, determination of oro-caecal transit time, evaluation of absorption and to a lesser extend detection of bacterial overgrowth. The use of every single test in a clinical setting is vary depending on accuracy and substrate costs. This review is meant to present (13)C the meaning of (13)C/(12)C ratio and static and dynamic measure and, finally, the instruments dedicated to its use in gastroenterology. A brief presentation of (13)C breath tests in gastroenterology is also provided. PMID:24443068

  6. An optimized 13C-urea breath test for the diagnosis of H pylori infection

    2007-01-01

    AIM: To validate an optimized 13C-urea breath test (13C-UBT) protocol for the diagnosis of-H pylori infection that is cost-efficient and maintains excellent diagnostic accuracy.METHODS: 70 healthy volunteers were tested with two simplified 13C-UBT protocols, with test meal (Protocol 2)and without test meal (Protocol 1). Breath samples were collected at 10, 20 and 30 min after ingestion of 50 mg 13C-urea dissolved in 10 mL of water, taken as a single swallow, followed by 200 mL of water (pH 6.0) and a circular motion around the waistline to homogenize the urea solution. Performance of both protocols was analyzed at various cut-off values. Results were validated against the European protocol.RESULTS: According to the reference protocol, 65.7% individuals were positive for H pylori infection and 34.3% were negative. There were no significant differences in the ability of both protocols to correctly identify positive and negative H pylori individuals. However, only Protocol 1 with no test meal achieved accuracy, sensitivity,specificity, positive and negative predictive values of 100%. The highest values achieved by Protocol 2 were 98.57%, 97.83%, 100%, 100% and 100%, respectively.CONCLUSION: A 10 min, 50 mg 13C-UBT with no test meal using a cut-off value of 2-2.5 is a highly accurate test for the diagnosis of H pylori infection at a reduced cost.

  7. Predicting outcome of paracetamol poisoning by using 14C-aminopyrine breath test

    The 14C-aminopyrine (14C-amidopyrine) breath test, carried out within 24 to 36 hours of an overdosage of paracetamol, was used to predict the extent of liver damage in 30 seriously poisoned patients. Mean 14C02 excretion was 4.4% in 20 healthy control subjects; 5.5% in six patients who escaped injury; and 2.9%, 1.5%, and 0.2% in those with mild to moderate (12 patients), severe (eight patients), and fatal (four patients) liver damage respectively. This test proved to be a more reliable predictor of the extent of liver damage than plasma paracetamol concentration or half life or the results of conventional liver function tests and may enable treatment of hepatic failure to be started at an early stage. (author)

  8. Carbon-14 urea breath test for the diagnosis of Campylobacter pylori associated gastritis

    Urease in the human gastric mucosa is a marker for infection with Campylobacter pylori (CP), an organism suspected of causing chronic gastritis and peptic ulceration. To detect gastric urease, we examined 32 patients who were being evaluated for possible peptic ulcer disease. Fasting patients were given 10 microCi (370 kBq) of 14C-labeled urea. Breath samples were collected in hyamine at intervals between 1 and 30 min. The amount of 14C collected at these times was expressed as: body weight X (% of administered dose of 14C in sample)/(mmol of CO2 collected). The presence of C. pylori colonization was also determined by examination of multiple endoscopic gastric biopsy specimens. On average, patients who were proven to have C. pylori infection exhaled 20 times more labeled CO2 than patients who were not infected. The difference between infected patients and C. pylori negative control patients was highly significant at all time points between 2 and 30 min after ingestion of the radionuclide (p less than 0.0001). The noninvasive urea breath is less expensive than endoscopic biopsy of the stomach and more accurate than serology as a means of detecting Campylobacter pylori infection. Because the test detects actual viable CP organisms, it can be used to confirm eradication of the bacterium after antibacterial therapy

  9. False-positive breath-alcohol test after a ketogenic diet.

    Jones, A W; Rössner, S

    2007-03-01

    A 59-year-old man undergoing weight loss with very low calorie diets (VLCD) attempted to drive a car, which was fitted with an alcohol ignition interlock device, but the vehicle failed to start. Because the man was a teetotaller, he was surprised and upset by this result. VLCD treatment leads to ketonemia with high concentrations of acetone, acetoacetate and beta-hydroxybutyrate in the blood. The interlock device determines alcohol (ethanol) in breath by electrochemical oxidation, but acetone does not undergo oxidation with this detector. However, under certain circumstances acetone is reduced in the body to isopropanol by hepatic alcohol dehydrogenase (ADH). The ignition interlock device responds to other alcohols (e.g. methanol, n-propanol and isopropanol), which therefore explains the false-positive result. This 'side effect' of ketogenic diets needs further discussion by authorities when people engaged in safety-sensitive work (e.g. bus drivers and airline pilots) submit to random breath-alcohol tests. PMID:16894360

  10. Solubility testing of actinides on breathing-zone and area air samples

    Metzger, Robert Lawrence

    The solubility of inhaled radionuclides in the human lung is an important characteristic of the compounds needed to perform internal dosimetry assessments for exposed workers. A solubility testing method for uranium and several common actinides has been developed with sufficient sensitivity to allow profiles to be determined from routine breathing zone and area air samples in the workplace. Air samples are covered with a clean filter to form a filter-sample-filter sandwich which is immersed in an extracellular lung serum simulant solution. The sample is moved to a fresh beaker of the lung fluid simulant each day for one week, and then weekly until the end of the 28 day test period. The soak solutions are wet ashed with nitric acid and hydrogen peroxide to destroy the organic components of the lung simulant solution prior to extraction of the nuclides of interest directly into an extractive scintillator for subsequent counting on a Photon-Electron Rejecting Alpha Liquid Scintillation (PERALSsp°ler ) spectrometer. Solvent extraction methods utilizing the extractive scintillators have been developed for the isotopes of uranium, plutonium, and curium. The procedures normally produce an isotopic recovery greater than 95% and have been used to develop solubility profiles from air samples with 40 pCi or less of Usb3Osb8. This makes it possible to characterize solubility profiles in every section of operating facilities where airborne nuclides are found using common breathing zone air samples. The new method was evaluated by analyzing uranium compounds from two uranium mills whose product had been previously analyzed by in vitro solubility testing in the laboratory and in vivo solubility testing in rodents. The new technique compared well with the in vivo rodent solubility profiles. The method was then used to evaluate the solubility profiles in all process sections of an operating in situ uranium plant using breathing zone and area air samples collected during routine

  11. Evaluation of a simple non-invasive 13C breath test to evaluate diet effects on gastric emptying in pigs

    Jørgensen, Henry; Strathe, Anders Bjerring; Theil, Peter Kappel;

    2010-01-01

    A study was carried out to validate gastric emptying using non-invasive 13C breath test against total evacuation of the stomach content through a gastric cannulae. Three different diets were used; a high soluble fibre diet based on sugar beet pulp, a high insoluble fibre diet based on wheat bran...... red isotope spectrometry (IRIS) analyzer. Feeding the sugar beet diet high in soluble fibre and high water-binding capacity reduced the physical activity. Gastric emptying estimated using non-invasive breath test with 13C labelled isotope was comparable to that observed with total collection...... of the gastric content. Thus, the breath test is applicable for evaluating dietary effects on gastric emptying and potentially improves the behaviour and well being of gestating sows and lends confidence to applicability in clinical human trials....

  12. 49 CFR 40.277 - Are alcohol tests other than saliva or breath permitted under these regulations?

    2010-10-01

    ... 49 Transportation 1 2010-10-01 2010-10-01 false Are alcohol tests other than saliva or breath permitted under these regulations? 40.277 Section 40.277 Transportation Office of the Secretary of Transportation PROCEDURES FOR TRANSPORTATION WORKPLACE DRUG AND ALCOHOL TESTING PROGRAMS Problems in...

  13. Experimental study on L-[1-13C] phenylalanine breath test for quantitative assessment of liver function with animal

    Objective: Using a small animal breath test model we designed and L-[1-13C] phenylalanine breath test (13C-PheBT) of rats, the authors investigated its feasibility and validity and determined effective parameter of the test. Methods: Twenty male Sprague-Dawley (SD) weighting 280-290 g rats randomized into two groups acute hepatitis rats (n=10) and control rats (n=10). Hepatitis was induced by carbon tetrachloride (CCl4) olive oil administration through intragastric gavage. PheBT was assisted by small mechanical ventilator improved and air samples were collected discontinuously, 20 mg/kg body weight L-[1-13C] phenylalanine (13C-Phe) was administered intravenously. Twenty-nine breath samples were taken before and different intervals within sixty minutes after administration. 13Cenrichment was measured by isotope ratio mass spectrometer. Results: All time phase curves of 13C enrichment in rat breath reached a peak almost at 2 min after the intravenous administration of 13C-Phe. The PheBT parameters, 13C excretion rate constant (PheBT-K), of CCl4 hepatitis rats were significantly lower than that of normal control rats [(2.45 ± 0.25) x 10-2 min-1 vs (2.98 ± 0.19) x 10-2 min-1, t = 5.40, P13C fast phase disposition constant did not statistically differ between the two groups (t=0.58, P>0.05). PheBT-K had significant negative cor-relation with serum ALT, AKP, TBA and total bilirum TBIL (the correlation coefficient r is -0.74, -0.73, -0.82 and -0.67 respectively, P0.05). Conclusions: It was indicated that the small animal breath test model we designed was a virtual tool to use in experimental study on breath test and PheBT-K was a sensitive index. (authors)

  14. Relationship between postoperative erythromycin breath test and early morbidity in liver transplant recipients

    Schmidt, Lars E; Rasmussen, Allan; Kirkegaard, Preben;

    2003-01-01

    BACKGROUND: Interindividual variability in dosage requirements of the calcineurin inhibitor immunosuppressive agents cyclosporine and tacrolimus after liver transplantation may result from differences in the CYP3A activity of the liver graft. Early postoperative erythromycin breath test (ERMBT) is...... an in vivo measure of graft CYP3A activity. This study evaluates the usefulness of an early postoperative ERMBT in predicting early morbidity in liver transplant recipients. METHODS: In 26 liver transplant recipients, ERMBT was performed within 2 hr after transplantation. Main end points were the...... associated with low postoperative ERMBT values (0.21%+/-0.15% 14C/hr vs. 1.09%+/-0.72% 14C/hr, P=0.002). CONCLUSION: An early postoperative ERMBT may be useful in predicting the development of cyclosporine and tacrolimus nephrotoxicity, severe graft dysfunction, or even graft loss in liver transplant...

  15. Breath test measurements in combination with indirect calorimetry for estimation of 13C-leucine oxidation in mink (Mustela vison)

    Tauson, Anne-Helene; Ali, Abdalla; Kanska, Katarzyna;

    2000-01-01

    Gas exchange measurements by means of indirect calorimetry can be used to calculate quantitative substrate oxidation. The results represents average net oxidation values (substrate disappearance rate), but they cannot describe the dynamics of the oxidation processes. Breath test measurements...... to feeding and fasting. Twelve 1-year-old male mink (Mustela vison) were measured in each five consecutive periods by means of indirect calorimetry and simultaneous breath test. In Periods 1, 3 and 5, each lasting 3 days, the animals were fed ad libitum and Periods 2 and 4 were fasting periods, each of 48 h...... before measurements started and expired air was then sucked out of the respiration chamber and collected into breath bags at frequent intervals until 5.5 h after the start of measurements. The ratio of 13C/12C was measured by means of an IRIS infrared analyser and results are reported in terms of delta...

  16. Mathematical analysis of [13CO2]-expiration curves from human breath tests using [1-13C]-amino acids as oral substrate

    Schreurs, V.V.A.M.; Krawielitzki, K.

    2003-01-01

    A [13CO2]-breath test examines the expiration of [13CO2] as function of time after oral intake of a [13C]-labelled test substrate (single dose). In clinical settings, breath test studies are often used as a simple and non-invasive tool to diagnose the activity of metabolic functions. From a nutritio

  17. Additional Value of CH4 Measurement in a Combined 13C/H2 Lactose Malabsorption Breath Test: A Retrospective Analysis

    Els Houben; Vicky De Preter; Jaak Billen; Marc Van Ranst; Kristin Verbeke

    2015-01-01

    The lactose hydrogen breath test is a commonly used, non-invasive method for the detection of lactose malabsorption and is based on an abnormal increase in breath hydrogen (H2) excretion after an oral dose of lactose. We use a combined 13C/H2 lactose breath test that measures breath 13CO2 as a measure of lactose digestion in addition to H2 and that has a better sensitivity and specificity than the standard test. The present retrospective study evaluated the results of 1051 13C/H2 lactose brea...

  18. 13C basal abundance of expired CO2 -definition of pre-requisites for kinetic breath tests.

    Dubuc, M C; Sébastien, H; Brazier, J L

    2000-01-01

    A sufficiently stable rate of 13CO2 exhalation is necessary when the diagnostic 13CO2 breath tests are performed in healthy subjects and patients. The aim of the research was to define prerequisite conditions for kinetic breath tests in order to ensure a stable 13CO2 background. A 3-part protocol was developed. Part I: a study of the one-day variation of 13CO2 abundance in expired CO2 confirmed that shifts of the basal 13C abundance in breath are inherent in nature. Part II: a study of the variations of 13C enrichment after the ingestion of different meals and beverages showed that ingestion of food items containing C4 plant sugars, such as maize, induces a significant increase in isotopic abundance. Part III: a new test breakfast containing rice grain cereal, milk and orange juice was tested. This test meal induces no significant change on the basal 13CO2 abundance in healthy subjects. This new finding allows to avoid the fasting period normally required prior to a breath test which is sometimes difficult for children and pregnant women. PMID:11077930

  19. A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection.

    J. E. Domínguez-Muñoz; Leodolter, A; Sauerbruch, T; Malfertheiner, P

    1997-01-01

    BACKGROUND: The 13C-urea breath test (13C-UBT) is a simple, non-invasive and reliable test for the diagnosis of Helicobacter pylori infection. The duration of the test, the timing of breath sampling, and the accuracy of the method vary according to the test meal used. AIM: To identify the optimal test meal or drink for rapid and accurate performance of the 13C-UBT for the detection of H pylori infection. PATIENTS: Eighty patients with dyspeptic symptoms were included. Of these, 48 patients ha...

  20. 13C-breath tests for sucrose digestion in congenital sucrase isomaltase-deficient and sacrosidase-supplemented patients

    Congenital sucrase-isomaltase deficiency (CSID) is characterized by absence or deficiency of the mucosal sucrase-isomaltase enzyme. Specific diagnosis requires upper gastrointestinal biopsy with evidence of low to absent sucrase enzyme activity and normal histology. The hydrogen breath test (BT) is ...

  1. Impact of hydrogen breath testing on diagnosis, management, and clinical outcome in children with chronic functional GI symptoms

    Chronic functional gastrointestinal (GI) symptoms (e.g. abdominal pain) in children may have numerous etiologies including carbohydrate malabsorption and small bowel bacterial overgrowth (SBBO). Hydrogen breath testing (HBT) frequently is used as a modality to evaluate for these two diagnoses. Howev...

  2. Investigation of the method and clinical usefulness of the 14CO2-glycocholate-breath-test

    14C-glycocholate breath-tests were performed in 22 clinical patients without gastrointestinal disorders, in 11 cases with M. Crohn of the ileum and in 8 patients, in whom an intestinal overgrowth with bacteria was suspected. Additional to the usual discontinuous measurement of the specific activity of 14CO2 the exhaled amount of CO2 and 14CO2 and 14C-serum activity were determined. No advantage was found in the determination of the latter; for 1) discontinuous measurement of the specific activity of 14CO2 was sufficient for detecting disturbed enterohepatic bile-salt circulation; and 2) measurement of 14C-serum-activity or 14C-activity in cholic acids or protein were of no help in differentiating between bacterial overgrowth and diseases of the ileum. There remained doubts regarding the clinical usefulness of the test. Low specifity and many positive tests in patients without corresponding symptoms require that therapeutical procedures in such patients are initiated with some reserve. (orig.)

  3. First-time urea breath tests performed at home by 36,629 patients

    Dahlerup, Søren; Andersen, Rikke Charlotte; Nielsen, Birgitte Sperling Wilms;

    2011-01-01

    BACKGROUND: The aim of the current study was (1) to describe the use of a (13) C-urea breath test (UBT) that was performed by patients at their homes as a part of a test-and-treat strategy in primary care and (2) to investigate the prevalence of Helicobacter pylori in patients taking a first......, positive H. pylori declined over the time course of the study (women: 19.6% in 2003 to 17.6% in 2009, p < .01; men: 20.7% in 2003 to 16.9% in 2009, p < .001). Patients who were older than 45 years had significantly higher positive H. pylori results than younger patients. CONCLUSIONS: A test......-and-treat system was possible to implement that allowed patients to perform UBTs at their homes. The results of the first-time UBTs demonstrated that approximately one of five patients who presented with dyspepsia in the clinical setting of Danish primary care was infected with H. pylori....

  4. Solubility testing of actinides on breathing-zone and area air samples

    A solubility testing method for several common actinides has been developed with sufficient sensitivity to allow profiles to be determined from routine breathing zone and area air samples in the workplace. Air samples are covered with a clean filter to form a filter-sample-filter sandwich which is immersed in an extracellular lung serum simulant solution. The sample is moved to a fresh beaker of the lung fluid simulant each day for one week, and then weekly until the end of the 28 day test period. The soak solutions are wet ashed with nitric acid and hydrogen peroxide to destroy the organic components of the lung simulant solution prior to extraction of the nuclides of interest directly into an extractive scintillator for subsequent counting on a Photon-Electron Rejecting Alpha Liquid Scintillation (PERALS reg-sign) spectrometer. Solvent extraction methods utilizing the extractive scintillators have been developed for the isotopes of uranium, plutonium, and curium. The procedures normally produce an isotopic recovery greater than 95% and have been used to develop solubility profiles from air samples with 40 pCi or less of U3O8. Profiles developed for U3O8 samples show good agreement with in vitro and in vivo tests performed by other investigators on samples from the same uranium mills

  5. Solubility testing of actinides on breathing-zone and area air samples

    Metzger, R.L.; Jessop, B.H.; McDowell, B.L. [Radiation Safety Engineering, Inc., Chandler, AZ (United States)

    1996-02-01

    A solubility testing method for several common actinides has been developed with sufficient sensitivity to allow profiles to be determined from routine breathing zone and area air samples in the workplace. Air samples are covered with a clean filter to form a filter-sample-filter sandwich which is immersed in an extracellular lung serum simulant solution. The sample is moved to a fresh beaker of the lung fluid simulant each day for one week, and then weekly until the end of the 28 day test period. The soak solutions are wet ashed with nitric acid and hydrogen peroxide to destroy the organic components of the lung simulant solution prior to extraction of the nuclides of interest directly into an extractive scintillator for subsequent counting on a Photon-Electron Rejecting Alpha Liquid Scintillation (PERALS{reg_sign}) spectrometer. Solvent extraction methods utilizing the extractive scintillators have been developed for the isotopes of uranium, plutonium, and curium. The procedures normally produce an isotopic recovery greater than 95% and have been used to develop solubility profiles from air samples with 40 pCi or less of U{sub 3}O{sub 8}. Profiles developed for U{sub 3}O{sub 8} samples show good agreement with in vitro and in vivo tests performed by other investigators on samples from the same uranium mills.

  6. Breathing Difficulties

    ... Discuss with your respiratory therapist the benefits of breathing techniques to increase ventilation and decrease your work of breathing Discuss with your physician appropriate use of respiratory ...

  7. 13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis.

    Mandeep S Jassal

    Full Text Available BACKGROUND: Pathogen-specific metabolic pathways may be detected by breath tests based on introduction of stable isotopically-labeled substrates and detection of labeled products in exhaled breath using portable infrared spectrometers. METHODOLOGY/PRINCIPAL FINDINGS: We tested whether mycobacterial urease activity could be utilized in such a breath test format as the basis of a novel biomarker and diagnostic for pulmonary TB. Sensitized New-Zealand White Rabbits underwent bronchoscopic infection with either Mycobacterium bovis or Mycobacterium tuberculosis. Rabbits were treated with 25 mg/kg of isoniazid (INH approximately 2 months after infection when significant cavitary lung pathology was present. [(13C] urea was instilled directly into the lungs of intubated rabbits at selected time points, exhaled air samples analyzed, and the kinetics of delta(13CO(2 formation were determined. Samples obtained prior to inoculation served as control samples for background (13CO(2 conversion in the rabbit model. (13CO(2, from metabolic conversion of [(13C]-urea by mycobacterial urease activity, was readily detectable in the exhaled breath of infected rabbits within 15 minutes of administration. Analyses showed a rapid increase in the rate of (13CO(2 formation both early in disease and prior to treatment with INH. Following INH treatment, all evaluable rabbits showed a decrease in the rate of (13CO(2 formation. CONCLUSIONS/SIGNIFICANCE: Urea breath testing may provide a useful diagnostic and biomarker assay for tuberculosis and for treatment response. Future work will test specificity for M. tuberculosis using lung-targeted dry powder inhalation formulations, combined with co-administering oral urease inhibitors together with a saturating oral dose of unlabeled urea, which would prevent the delta(13CO(2 signal from urease-positive gastrointestinal organisms.

  8. Additional Value of CH4 Measurement in a Combined 13C/H2 Lactose Malabsorption Breath Test: A Retrospective Analysis

    Houben, Els; De Preter, Vicky; Billen, Jaak; Van Ranst, Marc; Verbeke, Kristin

    2015-01-01

    The lactose hydrogen breath test is a commonly used, non-invasive method for the detection of lactose malabsorption and is based on an abnormal increase in breath hydrogen (H2) excretion after an oral dose of lactose. We use a combined 13C/H2 lactose breath test that measures breath 13CO2 as a measure of lactose digestion in addition to H2 and that has a better sensitivity and specificity than the standard test. The present retrospective study evaluated the results of 1051 13C/H2 lactose breath tests to assess the impact on the diagnostic accuracy of measuring breath CH4 in addition to H2 and 13CO2. Based on the 13C/H2 breath test, 314 patients were diagnosed with lactase deficiency, 138 with lactose malabsorption or small bowel bacterial overgrowth (SIBO), and 599 with normal lactose digestion. Additional measurement of CH4 further improved the accuracy of the test as 16% subjects with normal lactose digestion and no H2-excretion were found to excrete CH4. These subjects should have been classified as subjects with lactose malabsorption or SIBO. In conclusion, measuring CH4-concentrations has an added value to the 13C/H2 breath test to identify methanogenic subjects with lactose malabsorption or SIBO. PMID:26371034

  9. Additional Value of CH4 Measurement in a Combined 13C/H2 Lactose Malabsorption Breath Test: A Retrospective Analysis

    Els Houben

    2015-09-01

    Full Text Available The lactose hydrogen breath test is a commonly used, non-invasive method for the detection of lactose malabsorption and is based on an abnormal increase in breath hydrogen (H2 excretion after an oral dose of lactose. We use a combined 13C/H2 lactose breath test that measures breath 13CO2 as a measure of lactose digestion in addition to H2 and that has a better sensitivity and specificity than the standard test. The present retrospective study evaluated the results of 1051 13C/H2 lactose breath tests to assess the impact on the diagnostic accuracy of measuring breath CH4 in addition to H2 and 13CO2. Based on the 13C/H2 breath test, 314 patients were diagnosed with lactase deficiency, 138 with lactose malabsorption or small bowel bacterial overgrowth (SIBO, and 599 with normal lactose digestion. Additional measurement of CH4 further improved the accuracy of the test as 16% subjects with normal lactose digestion and no H2-excretion were found to excrete CH4. These subjects should have been classified as subjects with lactose malabsorption or SIBO. In conclusion, measuring CH4-concentrations has an added value to the 13C/H2 breath test to identify methanogenic subjects with lactose malabsorption or SIBO.

  10. Breath Tests in Respiratory and Critical Care Medicine: From Research to Practice in Current Perspectives

    Attapon Cheepsattayakorn

    2013-01-01

    Full Text Available Today, exhaled nitric oxide has been studied the most, and most researches have now focusd on asthma. More than a thousand different volatile organic compounds have been observed in low concentrations in normal human breath. Alkanes and methylalkanes, the majority of breath volatile organic compounds, have been increasingly used by physicians as a novel method to diagnose many diseases without discomforts of invasive procedures. None of the individual exhaled volatile organic compound alone is specific for disease. Exhaled breath analysis techniques may be available to diagnose and monitor the diseases in home setting when their sensitivity and specificity are improved in the future.

  11. Validation of ten-minute single sample carbon-14 urea breath test for diagnosis of Helicobacter pylori infection

    Prabakaran, K.; Fernandes, V.; McDonald, J. [Illawarra Regional Hospital, Wollongong, NSW (Australia). Depts of Nuclear Medicine and Gastroenterology

    1996-09-01

    Helicobacter pylori infection is traditionally diagnosed by endoscopy followed by gastric biopsy and histologic demonstration of organisms, rapid urease test and culture. The non-invasive carbon-14-urea breath test has been widely accepted now for the diagnosis of this bacterium. This study was aimed to establish and validate normal and abnormal values for an Australian population, for a single sample carbon-14-urea breath test at ten minutes. A dose of 185 kBq was used in order to achieve reasonable counting statistics. The derived values were validated with the results of the rapid urease test. This method has a high sensitivity, specificity and greater patient acceptance, and could be used in many clinical settings as the first modality for the diagnosis of H. pylori infection and for documenting response or cure after antibiotic therapy for eradication. 11 refs., 1 tab., 4 figs.

  12. Validation of ten-minute single sample carbon-14 urea breath test for diagnosis of Helicobacter pylori infection

    Helicobacter pylori infection is traditionally diagnosed by endoscopy followed by gastric biopsy and histologic demonstration of organisms, rapid urease test and culture. The non-invasive carbon-14-urea breath test has been widely accepted now for the diagnosis of this bacterium. This study was aimed to establish and validate normal and abnormal values for an Australian population, for a single sample carbon-14-urea breath test at ten minutes. A dose of 185 kBq was used in order to achieve reasonable counting statistics. The derived values were validated with the results of the rapid urease test. This method has a high sensitivity, specificity and greater patient acceptance, and could be used in many clinical settings as the first modality for the diagnosis of H. pylori infection and for documenting response or cure after antibiotic therapy for eradication. 11 refs., 1 tab., 4 figs

  13. An evaluation of the multiple-breath nitrogen washout as a pulmonary function test in horses.

    Gallivan, G J; Viel, L; McDonell, W. N.

    1990-01-01

    Multiple-breath nitrogen washouts (MBNW) were performed with 29 light horses. Seven normal horses were used to examine the reproducibility, and 22, ranging from normal to severely diseased, were used to examine the changes in chronic obstructive pulmonary disease (COPD) and the effect of a bronchodilator, salbutamol, on the distribution of ventilation. The MBNW were analyzed using the functional residual capacity (FRC), end-tidal N2 concentration of the final breath of the MBNW (FETN2,fb), en...

  14. Helicobacter pylori Infection in Infants and Toddlers in South America: Concordance between [13C]Urea Breath Test and Monoclonal H. pylori Stool Antigen Test

    Queiroz, Dulciene Maria Magalhães; Saito, Mayuko; Rocha, Gifone Aguiar; Rocha, Andreia Maria Camargos; de Melo, Fabrício Freire; Checkley, William; Braga, Lúcia Libanez Bessa C.; Silva, Igor Simões; Gilman, Robert H.; Crabtree, Jean E.

    2013-01-01

    Accurate noninvasive tests for diagnosing Helicobacter pylori infection in very young children are strongly required. We investigated the agreement between the [13C]urea breath test ([13C]UBT) and a monoclonal ELISA (HpSA) for detection of H. pylori antigen in stool. From October 2007 to July 2011, we enrolled 414 infants (123 from Brazil and 291 from Peru) of ages 6 to 30 months. Breath and stool samples were obtained at intervals of at least 3 months from Brazilian (n = 415) and Peruvian (n...

  15. Lactulose Hydrogen Breath Test Result Is Associated with Age and Gender

    Newberry, Carolyn; Tierney, Ann; Pickett-Blakely, Octavia

    2016-01-01

    Small intestinal bacterial overgrowth (SIBO) is associated with chronic gastrointestinal diseases and structural/functional abnormalities of the gastrointestinal tract. SIBO's association with clinical characteristics is unclear. This study investigates the association between clinical factors and SIBO according to lactulose hydrogen breath test (LHBT) result. Methods. A cross-sectional study in a university-based gastroenterology practice was performed. Data was abstracted from the medical records of subjects undergoing LHBT from 6/1/2009 to 6/1/2013. Logistic regression analysis was performed to determine the association between predictor variables: age, sex, body mass index (BMI), and positive LHBT, the outcome of interest. Results. LHBT was performed in 791 subjects. Fifty-four percent had a positive LHBT. There was no statistically significant difference between the LHBT results according to age or BMI. In females, the likelihood of a positive LHBT increased with age (OR 1.02; 95% CI: 1.01–1.03). In males, the likelihood of a positive LHBT result decreased with age (OR 0.98; 95% CI: 0.97–1.00). Conclusion. There was an association between age, with respect to sex, and a positive LHBT. With increased age in females, the odds of a positive LHBT increased, while, in men, the odds of a positive LHBT decreased with age. PMID:27073800

  16. Lactulose Hydrogen Breath Test Result Is Associated with Age and Gender.

    Newberry, Carolyn; Tierney, Ann; Pickett-Blakely, Octavia

    2016-01-01

    Small intestinal bacterial overgrowth (SIBO) is associated with chronic gastrointestinal diseases and structural/functional abnormalities of the gastrointestinal tract. SIBO's association with clinical characteristics is unclear. This study investigates the association between clinical factors and SIBO according to lactulose hydrogen breath test (LHBT) result. Methods. A cross-sectional study in a university-based gastroenterology practice was performed. Data was abstracted from the medical records of subjects undergoing LHBT from 6/1/2009 to 6/1/2013. Logistic regression analysis was performed to determine the association between predictor variables: age, sex, body mass index (BMI), and positive LHBT, the outcome of interest. Results. LHBT was performed in 791 subjects. Fifty-four percent had a positive LHBT. There was no statistically significant difference between the LHBT results according to age or BMI. In females, the likelihood of a positive LHBT increased with age (OR 1.02; 95% CI: 1.01-1.03). In males, the likelihood of a positive LHBT result decreased with age (OR 0.98; 95% CI: 0.97-1.00). Conclusion. There was an association between age, with respect to sex, and a positive LHBT. With increased age in females, the odds of a positive LHBT increased, while, in men, the odds of a positive LHBT decreased with age. PMID:27073800

  17. 49 CFR 40.245 - What is the procedure for an alcohol screening test using a saliva ASD or a breath tube ASD?

    2010-10-01

    ... test using a saliva ASD or a breath tube ASD? 40.245 Section 40.245 Transportation Office of the... a breath tube ASD? (a) As the STT or BAT, you must take the following steps when using the saliva ASD: (1) Check the expiration date on the device or on the package containing the device and show...

  18. [BREATH TEST WITH LOCALLY PRODUCED 13С-UREA (TBILISI, GEORGIA) IN DIAGNOSTICS OF HELICOBACTER PYLORI INFECTION].

    Girdaladze, A; Mosidze, B; Elisabedashvili, G; Kordzaia, D

    2016-04-01

    Comparative assessment of results of detection of Helicobacter pylori (Hp) infection by breath tests with standard and locally produced 13С urea was done in 213 patients with gastric and duodenal pathology, including those who already were undergone the surgery. Invasive endoscopic biopsy test including rapid urease test (RUT), smear cytology and histology were also performed (tissue samples were obtained after endoscopy or surgery). RUT was carried out with the help of URE-HP test kit. Serological test for Hp antibodies was performed by IFA using kit ELISA. 13С urea breath test (UBT) was conducted for the determination of 13/12CO2 in breath samples by using of infrared spectroscope. In I group (125 patients) UBT was performed with standard 13С urea, in II group (88 patients) with locally produced 13С urea. Based on 5 different methods of Hp infection testing Hp positivity in 172 (80,8%) and Hp negativity in 41 (19,2%) patients were revealed. 13С-UBT showed the highest diagnostic value (accuracy-97,5%, sensibility-97,0%, specificity-100%) in Hp infection diagnosis. The (accuracy, sensibility and specificity of breath test with locally issued 13С urea (98,7%, 98,5% and 100% respectively) are the same as those for BT with standard 13С urea (96,7%, 96,2% and 100% respectively). These parameters are also highly credible in control of treatment efficiency (96,7%, 90,0% and 100% respectively). The correlation of index DOB‰ of breath test with results of RUT was revealed In Hp positive patients. This can serve as a marker of Hp infection rate. Preliminarily, in pre-clinical experimental study, harmless of locally issued 13С-urea from point of view of acute/sub-acute toxicity and allergy development was confirmed. The advantages (noninvasiveness, simplicity, rapidity, safety) and high diagnostic value of UBT (with both standard as well as locally produced 13С-urea) provide the opportunity to offer 13С-UBT as screening method of Hp infection diagnosis. It also

  19. Cultural values and random breath tests as moderators of the social influence on drunk driving in 15 countries.

    CESTAC, Julien; KRAÏEM, Sami; ASSAILLY, Jean Pascal

    2016-01-01

    Introduction: The social influence on drunk driving has been previously observed in several countries. It is noteworthy, however, that the prevalence of alcohol in road fatalities is not the same in all countries. The present study aimed to explore whether cultural values and the number of roadside breath tests moderate the link between the perceived drunk driving of one's peers and self-reported behavior. Methods: Based on the European survey SARTRE 4, the responses of 10,023 car drivers fro...

  20. Determination of Rifaximin Treatment Period According to Lactulose Breath Test Values in Nonconstipated Irritable Bowel Syndrome Subjects

    Bae, Suhyun; Lee, Kwang Jae; Kim, Young-Sang; Kim, Kyu-Nam

    2015-01-01

    Small intestinal bacterial overgrowth (SIBO) can partly explain irritable bowel syndrome (IBS), and rifaximin has been observed to improve abdominal symptoms in nonconstipated IBS patients. However, there are few reports on the association of the rifaximin treatment periods with the results of a lactulose breath test (LBT). Therefore, we performed a retrospective review of patient charts to investigate the relation between the rifaximin treatment periods with LBT results in nonconstipated IBS...

  1. Noninvasive ¹³C-octanoic acid breath test shows delayed gastric emptying in patients with amyotrophic lateral sclerosis

    Toepfer, Marcel; Folwaczny, Christian; Lochmüller, H.; Schroeder, M; Riepl, R. L.; Pongratz, D; Müller-Felber, W.

    1999-01-01

    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive loss of motor neurons. However, ALS has been recognized to also involve non-motor systems. Subclinical involvement of the autonomic system in ALS has been described. The recently developed C-13-octanoic acid breath test allows the noninvasive measurement of gastric emptying. With this new technique we investigated 18 patients with ALS and 14 healthy volunteers. None of the patients had diabe...

  2. Dual therapy for third-line Helicobacter pylori eradication and urea breath test prediction

    Toshihiro Nishizawa; Hidekazu Suzuki; Takama Maekawa; Naohiko Harada; Tatsuya Toyokawa; Toshio Kuwai; Masanori Ohara

    2012-01-01

    We evaluated the efficacy and tolerability of a dual therapy with rabeprazole and amoxicillin (AMX) as an empiric third-line rescue therapy.In patients with failure of first-line treatment with a proton pump inhibitor (PPI)-AMX-clarithromycin regimen and second-line treatment with the PPI-AMX-metronidazole regimen,a third-line eradication regimen with mbeprazole (10 mg q.i.d.) and AMX (500 mg q.i.d.) was prescribed for 2 wk.Eradication was confirmed by the results of the 13C-urea breath test (UBT) at 12 wk after the therapy.A total of 46 patients were included; however,two were lost to followup.The eradication rates as determined by per-protocol and intention-to-treat analyses were 65.9% and 63.0%,respectively.The pretreatment UBT results in the subjects showing eradication failure; those patients showing successful eradication comprised 32.9 ± 28.8 permil and 14.8 ± 12.8 permil,respectively.The pretreatment UBT results in the subjects with eradication failure were significantly higher than those in the patients with successful eradication (P =0.019).A low pretreatment UBT result (≤ 28.5 permil) predicted the success of the eradication therapy with a positive predictive value of 81.3% and a sensitivity of 89.7%.Adverse effects were reported in 18.2% of the patients,mainly diarrhea and stomatitis.Dual therapy with rabeprazole and AMX appears to serve as a potential empirical third-line strategy for patients with low values on pretreatment UBT.

  3. Aperitif effects on gastric emptying: a crossover study using continuous real-time 13C breath test (BreathID System).

    Inamori, M; Iida, H; Endo, H; Hosono, K; Akiyama, T; Yoneda, K; Fujita, K; Iwasaki, T; Takahashi, H; Yoneda, M; Goto, A; Abe, Y; Kobayashi, N; Kubota, K; Nakajima, A

    2009-04-01

    The aim of this study was to determine whether there is a correlation between aperitif and gastric emptying. Ten healthy male volunteers participated in this randomized, two-way crossover study. Under two conditions (after drinking an aperitif versus not), the (13)C breath test was performed for 4 h with a liquid meal (200 kcal/200 ml) containing 100 mg (13)C acetate. We used 50 ml of umeshu as the aperitif. This is a traditional Japanese plum liqueur, and contains 7 ml alcohol (14%). In the aperitif group, T(1/2), T(lag), and T(peak) were significantly delayed [T(1/2) (132: 113-174) versus (112: 92-134) (P = 0.0069); T(lag) (80: 63-94) versus (55: 47-85) (P = 0.0069); and T(peak) (81: 62-96) versus (54: 34-84) (P = 0.0069), (median: range, aperitif versus control, min)]. Gastric emptying was significantly delayed in the aperitif group as compared with the control group. This study revealed that even a small amount of alcohol such as an aperitif may contribute to delayed gastric emptying. PMID:18688714

  4. Usefulness of N-dimethyl-13 C-aminopyrine breath test in the diagnosis of liver disease

    N-dimethyl-13C-aminopyrine breath test was performed in patients with liver disease and healthy controls to compare cumulative 13CO2% dose per 3 hrs expired during breathing. Expired cumulative values were significantly lower in patients with liver cirrhosis than in healthy controls. They were also significantly lower in cirrhosis patients with a history of hepatic insufficiency than in patients without it. However, there was no significant difference between patients with esophageal varices and patients without it. A significant difference was observed between patients with chronic active hepatitis than in healthy controls, but not observed between patients with chronic inactive hepatitis and healthy controls. They did not correlate with sGOT or sGPT, but correlated with prothrombin levels or serum albumin levels. (Namekawa, K.)

  5. Advantages of breath testing for the early diagnosis of lung cancer

    Smith, D.; Španěl, Patrik; Sule-Suso, J.

    2010-01-01

    Roč. 10, č. 3 (2010), s. 255-257. ISSN 1473-7159 Institutional research plan: CEZ:AV0Z40400503 Keywords : mass spectrometry * breath analysis * lung cancer Subject RIV: CF - Physical ; Theoretical Chemistry Impact factor: 4.652, year: 2010

  6. Evaluation of (CO2)-C-13 breath tests for the detection of fructose malabsorption

    Hoekstra, JH; VandenAker, JHL; Kneepkens, CMF; Stellaard, F; Geypens, B; Ghoos, YF

    1996-01-01

    Breath hydrogen (H-2) studies have made clear that small intestinal absorption of fructose is limited, especially in toddlers. Malabsorption of fructose may be a cause of recurrent abdominal pain and chronic nonspecific diarrhea (toddler's diarrhea). Fructose absorption is facilitated by equimolar d

  7. Bacterial contamination of the small bowel evaluated by breath tests, 75Se-labelled homocholic-tauro acid, and scanning electron microscopy

    Eighty-one patients with diarrhoea due to suspected bacterial contamination of the small intestine were investigated with the bile breath test (BABT) and 75Se-labelled homocholic-tauro acid (SeHCAT). The impact of bile acid malabsorption due to dysfunction of the terminal ileum on BABT was evaluated. The group of patients with abnormal BABT, notably the 6 h accumulated value, showed a high frequency of reduced SeHCAT values, indicating that a reliable test for bile acid malabsorption is indispensable for interpreting the BABT in the investigation of small-intestinal bacterial overgrowth. The results of the 14C-D-xylose breath test were compared with the outcome of the combined SeHCAT-BABT in 44 patients. In contrast to previous findings, no correlation between the two breath tests was found. On the contary, a significant negative correlation was encountered for patients in whom either breath test was abnormal. Scanning electron microscopy for demonstration of adherent microorganisms was including in the investigation. No correlations were found with the outcomes of the different breath tests. The effect of antibiotic treatment was evaluated with regard to symptoms and breath tests. The results of the investigation indicate that different tests are needed for the diagnosis of bacterial overgrowth of the small intestine, because of the different metabolic characteristics of the contaminating bacteria. 36 refs., 6 figs., 2 tabs

  8. Bad Breath

    ... that get stuck between your teeth. Lots of people have bad breath at some point. Don’t worry! There are steps you can take to keep your mouth fresh and healthy. Tips for preventing bad breath: Brush your teeth ( ...

  9. Breath odor

    ... distinct breath odors. Bad breath related to poor oral hygiene is most common and caused by release of ... supplements? Do you smoke? What home care and oral hygiene measures have you tried? How effective are they? ...

  10. Breathing Problems

    ... you're not getting enough air. Sometimes mild breathing problems are from a stuffy nose or hard ... conditions such as asthma, emphysema or pneumonia cause breathing difficulties. So can problems with your trachea or ...

  11. Predisposing factors for positive D-Xylose breath test for evaluation of small intestinal bacterial overgrowth: A retrospective study of 932 patients

    Schatz, Richard A; Zhang, Qing; Lodhia, Nilesh; Shuster, Jonathan; Phillip P Toskes; Moshiree, Baharak

    2015-01-01

    AIM: To investigate, in the largest cohort to date, patient characteristics and associated risk factors for developing small intestinal bacterial overgrowth (SIBO) using the D-Xylose breath test (XBT).

  12. The 14C-monomethylamino-antipyrine breath test as in vivo parameter for characterizing the induction of the drug catabolizing enzyme system in the guinea pig

    The aim of these investigations was to help clarify the following questions: 1) Does MAAP, following 14C labelling of the exocyclic aminomethyl group, offer a suitable substrate for a breath test in guinea pigs. 2) Which procedures for evaluating the 14C exhalation curves of the breath test are especially valid. 3) Can an induction of the drug catabolizing enzyme system following pre-treatment with various inducing substances be detected by the 14C-MAAP breath test. 4) Do inducer-specific differences arise in response to the 14C-MAAP breath test by which the inducers can be characterized. 5) Is monomethylamino-antipyrine similar to amidopyrine in that it is a suitable independent in vivo parameter for the drug metasbolizing enzyme system in the liver of guinea pigs. (orig./MG)

  13. Cost effectiveness analysis of population-based serology screening and 13C-Urea breath test for Helicobacter pylori to prevent gastric cancer: A markov model

    Xie, Feng; Luo, Nan; Lee, Hin-Peng

    2008-01-01

    AIM: To compare the costs and effectiveness of no screening and no eradication therapy, the population-based Helicobacter pylori (H pylori) serology screening with eradication therapy and 13C-Urea breath test (UBT) with eradication therapy.

  14. Effect of loperamide and naloxone on mouth-to-caecum transit time evaluated by lactulose hydrogen breath test.

    Basilisco, G; Bozzani, A; Camboni, G; M. Recchia; Quatrini, M; Conte, D.; Penagini, R; PA Bianchi

    1985-01-01

    The effect of loperamide and naloxone on mouth-to-caecum transit time was evaluated by the lactulose hydrogen breath test in four men and four women. Each subject underwent tests during the administration of placebo, loperamide (12-16 mg po), naloxone (40 micrograms/kg/h by a three-hour intravenous infusion), and loperamide plus naloxone, carried out at intervals of one or two weeks. The transit time was significantly longer after loperamide, and this effect was antagonised by the concomitant...

  15. Tidal volume single breath washout of two tracer gases--a practical and promising lung function test.

    Florian Singer

    Full Text Available BACKGROUND: Small airway disease frequently occurs in chronic lung diseases and may cause ventilation inhomogeneity (VI, which can be assessed by washout tests of inert tracer gas. Using two tracer gases with unequal molar mass (MM and diffusivity increases specificity for VI in different lung zones. Currently washout tests are underutilised due to the time and effort required for measurements. The aim of this study was to develop and validate a simple technique for a new tidal single breath washout test (SBW of sulfur hexafluoride (SF(6 and helium (He using an ultrasonic flowmeter (USFM. METHODS: The tracer gas mixture contained 5% SF(6 and 26.3% He, had similar total MM as air, and was applied for a single tidal breath in 13 healthy adults. The USFM measured MM, which was then plotted against expired volume. USFM and mass spectrometer signals were compared in six subjects performing three SBW. Repeatability and reproducibility of SBW, i.e., area under the MM curve (AUC, were determined in seven subjects performing three SBW 24 hours apart. RESULTS: USFM reliably measured MM during all SBW tests (n = 60. MM from USFM reflected SF(6 and He washout patterns measured by mass spectrometer. USFM signals were highly associated with mass spectrometer signals, e.g., for MM, linear regression r-squared was 0.98. Intra-subject coefficient of variation of AUC was 6.8%, and coefficient of repeatability was 11.8%. CONCLUSION: The USFM accurately measured relative changes in SF(6 and He washout. SBW tests were repeatable and reproducible in healthy adults. We have developed a fast, reliable, and straightforward USFM based SBW method, which provides valid information on SF(6 and He washout patterns during tidal breathing.

  16. Imaging and retention measurements of selenium 75 homocholic acid conjugated with taurine, and the carbon 14 glycochol breath test to document ileal dysfunction due to late radiation damage

    In order to assess ileal dysfunction in patients with complaints after pelvic radiation therapy, retention measurements and scintigraphic imaging with selenium 75 homocholic acid conjugated with taurine (75Se-HCAT), combined with the carbon 14 clycochol breath test, were evaluated in 39 patients. In 22 patients without ileal resection the results of the 75Se-HCAT test and the breath test differentiated between a normal functioning ileum (both tests negative) and ileal dysfunction as a cause of complaints (one or both tests positive). Among the patients with ileal dysfunction, the combination of both tests permitted those with bacterial overgrowth (breath test positive, 75Se-HCAT negative) to be separated from patients with evidence of bile acid malabsorption (75Se-HCAT positive, breath test positive or negative). In 17 patients with small-bowel resection, the 75Se-HCAT test helped to estimate the severity of bile acid malabsorption with implications for therapy. In this group the breath test was false-negative in 7 cases with abnormal 75Se-HCAT. Additional systematically performed scintigraphic imaging improved the accuracy of the 75Se-HCAT test, revealing cases with prolonged colonic accumulation of the radiopharmaceutical, causing spurious retention values. In conclusion, assessment of ileal dysfunction by nuclear medicine techniques in post-irradiation conditions provides information about the aetiology and therefore the possibility of adjustment in the clinical management. (orig.)

  17. Comparison of breath testing with fructose and high fructose corn syrups in health and IBS

    Skoog, S. M.; Bharucha, A. E.; Zinsmeister, A R

    2008-01-01

    Although incomplete fructose absorption has been implicated to cause gastrointestinal symptoms, foods containing high fructose corn syrup (HFCS) contain glucose. Glucose increases fructose absorption in healthy subjects. Our hypothesis was that fructose intolerance is less prevalent after HFCS consumption compared to fructose alone in healthy subjects and irritable bowel syndrome (IBS). Breath hydrogen levels and gastrointestinal symptoms were assessed after 40 g of fructose (12% solution) pr...

  18. Metallo-Dielectric Multilayer Structure for Lactose Malabsorption Diagnosis through H2 Breath Test

    Cioffi, N.; de Ceglia, D.; De Sario, M; D'Orazio, A; Petruzzelli, V.(Dipartimento di Ingegneria Elettrica e dell'Informazione – Politecnico di Bari, Bari, Italy); F. Prudenzano; Scalora, M.; Trevisi, S.; Vincenti, M. A.

    2007-01-01

    A metallo-dielectric multilayer structure is proposed as a novel approach to the analysis of lactose malabsorption. When lactose intolerance occurs, the bacterial overgrowth in the intestine causes an increased spontaneous emission of H2 in the human breath. By monitoring the changes in the optical properties of a multilayer palladium-polymeric structure, one is able to detect the patient's disease and the level of lactose malabsorption with high sensitivity and rapid response.

  19. Relationship between the single-breath N test and age, sex, and smoking habit in three North American cities.

    Buist, A S; Ghezzo, H; Anthonisen, N R; Cherniack, R M; Ducic, S; Macklem, P T; Manfreda, J; Martin, R R; McCarthy, D; Ross, B B

    1979-08-01

    This report describes a collaborative study conducted in Montreal, Canada, Portland, Ore., and Winnipeg, Canada, to establish the relationship between the single-breath N2 test and age, sex, and smoking and to determine the prevalence of functional abnormalities in these populations. In nonsmokers, age-related regressions for closing volume, closing capacity, and the slope of phase III obtained from the single-breath N2 test, plus the ratio of the I-s forced expiratory volume to the forced vital capacity had very similar slopes, suggesting that differences in geographic location, climate, air pollution, and occupation had no effect on lung function detectable by these tests. Among the 6 city/six groups there was no systematic difference in the prevalence of functional abnormalities between the cities, but closing capacity expressed as a percentage of total lung capacity was abnormal most often in men and the slope of the alveolar plateau was abnormal most often in women. The prevalence of respiratory symptoms within different smoking categories was similar in the 3 cities. Although the number of cigarettes smoked had a significant effect on every test except the ratio of the I-s forced expiratory volume to forced vital capacity in men, the effect of age was considerably greater than the effect of smoking, and the dose-response relationship was weak. We conclude that additional factors may interact with smoking to place a smoker at risk of developing chronic airflow limitation. PMID:475152

  20. Correlation between symptoms developed after the oral ingestion of 50 g lactose and results of hydrogen breath testing for lactose intolerance

    Beyerlein, L; Pohl, D.; Delco, F; Stutz, B; Fried, M; Tutuian, R

    2008-01-01

    BACKGROUND: Lactase deficiency is a common condition responsible for various abdominal symptoms. Lactose hydrogen breath test is currently the gold standard in diagnosing lactose intolerance. AIM: To assess sensitivity and specificity of symptoms developed after oral lactose challenge. METHODS: Intensity of nausea, abdominal pain, borborygmi, bloating and diarrhoea was recorded every 15 min up to 3 h after ingestion of 50 g lactose in patients with positive (i.e. breath H2-concentration > or ...

  1. COPD: When You Learn More, You'll Breathe Better

    ... are treatments that do help people breathe easier." Spirometry: A Simple Breathing Test Everyone at risk for ... tested for COPD with a simple breathing test. Spirometry is one of the best and most common ...

  2. Evaluation of [13C]Urea Breath Test and Helicobacter pylori Stool Antigen Test for Diagnosis of H. pylori Infection in Children from a Developing Country

    Cardinali, Luciana de Carvalho Costa; Rocha, Gifone Aguiar; Rocha, Andreia Maria Camargos; de Moura, Sílvia Beleza; de Figueiredo Soares, Taciana; Esteves, Ana Maria Braz; Nogueira, Ana Margarida Miguel Ferreira; Cabral, Mônica Maria Demas Álvares; de Carvalho, Anfrisina Sales Teles; Bitencourt, Paulo; Ferreira, Alexandre; Queiroz, Dulciene Maria Magalhães

    2003-01-01

    The [13C]urea breath test (13C-UBT) and Helicobacter pylori stool antigen test (HpSA) for the diagnosis of H. pylori infection in children were validated. The sensitivity, specificity, and positive and negative predictive values were 93.8, 99.1, 97.8, and 98.0%, respectively, for the 13C-UBT and 96.9, 100, 100, and 98.0%, respectively, for HpSA. Both tests are appropriate for diagnosing H. pylori infection in children. PMID:12843086

  3. Evaluation of [13C]Urea Breath Test and Helicobacter pylori Stool Antigen Test for Diagnosis of H. pylori Infection in Children from a Developing Country

    Cardinali, Luciana de Carvalho Costa; Rocha, Gifone Aguiar; Rocha, Andreia Maria Camargos; de Moura, Sílvia Beleza; de Figueiredo Soares, Taciana; Esteves, Ana Maria Braz; Nogueira, Ana Margarida Miguel Ferreira; Cabral, Mônica Maria Demas Álvares; de Carvalho, Anfrisina Sales Teles; Bitencourt, Paulo; Ferreira, Alexandre; Queiroz, Dulciene Maria Magalhães

    2003-01-01

    The [13C]urea breath test (13C-UBT) and Helicobacter pylori stool antigen test (HpSA) for the diagnosis of H. pylori infection in children were validated. The sensitivity, specificity, and positive and negative predictive values were 93.8, 99.1, 97.8, and 98.0%, respectively, for the 13C-UBT and 96.9, 100, 100, and 98.0%, respectively, for HpSA. Both tests are appropriate for diagnosing H. pylori infection in children.

  4. Comparison of the 13C-urea breath test and the endoscopic phenol red mucosal pH test in the quantification of Helicobacter pylori infection loading

    Cho, Young-Seok; Chae, Hiun-Suk; Jang, Se Na; Kim, Jin-Soo; Son, Hye Suk; Kim, Hyung-Keun; Kim, Byung-Wook; Han, Sok-Won; Choi, Kyu-Yong; Lee, Hae Kyung; Chang, Eun Deok

    2008-01-01

    Background/Aims The 13C-urea breath test (UBT) is a semiquantitative test for measuring Helicobacter pylori infection loading. H. pylori produces ammonia, which elevates the pH of the gastric mucosa and is detectable via endoscopy using a phenol red indicator. We evaluated whether this test could be used to diagnose H. pylori infection and whether phenol red staining was correlated with 13C-UBT results. Methods One hundred and twenty-three patients participated. The UBT was performed after in...

  5. Lactose malabsorption testing in daily clinical practice: a critical retrospective analysis and comparison of the hydrogen/methane breath test and genetic test (c/t-13910 polymorphism) results.

    Enko, Dietmar; Rezanka, Erwin; Stolba, Robert; Halwachs-Baumann, Gabriele

    2014-01-01

    The aim of this study was to establish a retrospective evaluation and comparison of the hydrogen/methane (H2/CH4) breath test and genetic test (C/T-13910 polymorphism) results in lactose malabsorption testing. In total 263 consecutive patients with suspected lactose malabsorption were included in this study. They underwent the H2/CH4 breath test following the ingestion of 50 g lactose and were tested for the C/T-13910 polymorphism. In total 51 patients (19.4%) had a C/C-13910 genotype, indicating primary lactose malabsorption. Only 19 patients (7.2%) also had a positive H2/CH4 breath test. All in all 136 patients (51.69%) had a C/T-13910 and 76 patients (28.91%) a T/T-13910 genotype, indicating lactase persistence. Four patients (1.5%) with the C/T-13910 genotype and one patient (0.4%) with the T/T-13910 genotype had a positive H2/CH4 breath test result, indicating secondary lactose malabsorption. Cohen's Kappa measuring agreement between the two methods was 0.44. Twenty patients (7.6%) with a positive H2/CH4 peak within 60 minutes after lactose ingestion were classified as patients with lactose-dependent small intestinal bacterial overgrowth (SIBO). In conclusion, only moderate agreement between the breath test and the genetic test was shown. Secondary lactose malabsorption as well as preanalytical limitations of the combined H2/CH4 breath test procedure can cause discrepant results. This trial is registered with K-42-13. PMID:24829570

  6. Turnover of carbon in the 13C-urea breath test for the detection of Helicobacter pylori infection

    To obtain a standard protocol for the application of 13C-urea breath test (13C-UBT) analyzed by Isotope Ratio Mass Spectrometer (IRMS) to detect helicobacter pylori infection in the population is necessary to know the behavior of the turnover of 13C during the test in different individuals. The aims of this study was to find out a pattern for the turnover of the 13C in the 13C-UBT, analyzed by IRMS, in patients infected with H. pylori, in a Brazilian population, to define a protocol test application. We found that the isotopic ratio 13C/12C in expired CO2 from patients infected with H. pylori and subjected to 13C-UBT does not follow a single pattern of behavior. However this behavior can be similar in subjects having the same maximum values following an inverse proportional relationship between the maximum value and the time of appearance in the curve. (author)

  7. Assessment of the peripheral ventilatory response to CO2 in heart failure patients: reliability of the single-breath test

    The assessment of chemoreflex sensitivity in heart failure patients is gaining increasing interest since recent studies demonstrated that augmented chemosensitivity is an independent predictor of mortality and represents an important pathogenic factor in the development of Cheyne–Stokes respiration. The single-breath CO2 test is a well-established method to quantify peripheral hypercapnic chemoreflex sensitivity. As the original criteria for the computation of the chemoreflex sensitivity in healthy subjects need to be modified in heart failure patients to take into account impaired cardiac function, the effects of such modifications on measurement reliability deserve investigation. Hence, we devised this study to assess the reliability of the single-breath CO2 test in heart failure patients. In 27 clinically stable, mild-to-moderate heart failure patients (age (mean±SD): 64±10 years, left ventricular ejection fraction: 34±7%, NYHA class: 2.7±0.4), the test was administered on two consecutive days in the same conditions. Reliability was assessed by the standard error of measurement (SEM) and by the intraclass correlation coefficient (ICC). The mean value of the chemoreflex sensitivity on the two days was: 0.25 ± 0.12 and 0.24 ± 0.12 l min−1 mmHg−1 (p = 0.45), respectively. The SEM was 0.05 l min−1 mmHg−1, indicating large intra-subject variability. Consequently, in order to be 95% confident that a real change has occurred between two measurements taken on the same individual (test–retest), the observed difference must be higher than ±0.15 l min−1 mmHg−1, which is about 60% of the mean value across our population. The ICC was 0.71, indicating thatintra-subject variability, although high, is a limited (29%) portion of inter-subject variability. Intra-subject variability should be carefully taken into account when using the single-breath CO2 test in assessing changes in individual patients. The observed ICC indicates that this test may provide

  8. A simplified 13C-Urea breath test (13C-UBT) in the diagnosis of Helicobacter pylori (HP) infection

    Rahman, T.; Bartholomeusz, F.D. L.; Bellon, M.S.; Chatterton, B.E. [Royal Adelaide Hospital, Adelaide. SA (Australia). Department of Nuclear Medicine

    1998-06-01

    Full text: The Urea Breath Test (UBT) is an accurate, noninvasive means of assessing the presence of Helicobacter pylori in the stomach. Two tests are currently available, using 13C- and 14C-labelled urea, respectively. 13C is a nonradioactive isotope, unlike 14C, but the 13C-UBT is technically more challenging. The aim of this study was to determine the accuracy of a simplified 13C-UBT with no test meal, using the 14C-UBT as the previously validated standard. 76 studies were performed on 72 patients; 4 patients performed the test twice. 28 patients were female, 44 male. The mean age was 51.1 years (range 23-86 years). 42 patients presented for post-eradication follow up, and 30 for initial diagnosis. All subjects underwent a 14C-UBT with a 15 minute sample. The 13C-UBT was then performed without a test meal and the breath samples obtained at baseline and 20 minutes. Of the 14C-UBT studies, 27 were positive, ranging from 1372 to 10,987 DPM (Normal <1000 DPM), and 49 were negative, range 177-946 DPM. 26 of the 13C-UBT studies were positive, with a Delta value ranging from 4.29-47.89 (Normal: Delta <3.5), and 50 were negative, range -0.20-2.80. There were 1 false-positive and 2 false-negative 13-UBT studies. This yielded a sensitivity of 92.6% and specificity of 98.0% for the simplified 13C-UBT. From these results we conclude that the simplified 13C-UBT is an accurate means of detecting the presence of Helicobacter pylori within the stomach

  9. A simplified 13C-Urea breath test (13C-UBT) in the diagnosis of Helicobacter pylori (HP) infection

    Full text: The Urea Breath Test (UBT) is an accurate, noninvasive means of assessing the presence of Helicobacter pylori in the stomach. Two tests are currently available, using 13C- and 14C-labelled urea, respectively. 13C is a nonradioactive isotope, unlike 14C, but the 13C-UBT is technically more challenging. The aim of this study was to determine the accuracy of a simplified 13C-UBT with no test meal, using the 14C-UBT as the previously validated standard. 76 studies were performed on 72 patients; 4 patients performed the test twice. 28 patients were female, 44 male. The mean age was 51.1 years (range 23-86 years). 42 patients presented for post-eradication follow up, and 30 for initial diagnosis. All subjects underwent a 14C-UBT with a 15 minute sample. The 13C-UBT was then performed without a test meal and the breath samples obtained at baseline and 20 minutes. Of the 14C-UBT studies, 27 were positive, ranging from 1372 to 10,987 DPM (Normal <1000 DPM), and 49 were negative, range 177-946 DPM. 26 of the 13C-UBT studies were positive, with a Delta value ranging from 4.29-47.89 (Normal: Delta <3.5), and 50 were negative, range -0.20-2.80. There were 1 false-positive and 2 false-negative 13-UBT studies. This yielded a sensitivity of 92.6% and specificity of 98.0% for the simplified 13C-UBT. From these results we conclude that the simplified 13C-UBT is an accurate means of detecting the presence of Helicobacter pylori within the stomach

  10. Fabry-Perot microcavity sensor for H2-breath-test analysis

    Vincenti, Maria Antonietta; De Sario, Marco; Petruzzelli, V.; D'Orazio, Antonella; Prudenzano, Francesco; de Ceglia, Domenico; Scalora, Michael

    2007-10-01

    Leak detection of hydrogen for medical purposes, based on the monitoring of the optical response of a simple Fabry-Perot microcavity, is proposed to investigate either the occurrence of lactose intolerance, or lactose malabsorption condition. Both pathologic conditions result in bacterial overgrowth in the intestine, which causes increased spontaneous emission of H2 in the human breath. Two sensitivity figures of merit are introduced to inspect changes in the sensor response, and to relate the microcavity response to a pathologic condition, which is strictly related to a different level of exhaled hydrogen. Different sensor configurations using a metal-dielectric microcavity are reported and discussed in order to make the most of the well-known ability of palladium to spontaneously absorb hydrogen.

  11. Quantification of Helicobacter pylori infection in gastritis and ulcer disease using a simple and rapid carbon-14-urea breath test

    Gastric urease was studied isotopically in 230 patients with biopsy-proven normal mucosa or chronic gastritis, including 59 patients with ulcer disease. Carbon-14-urea was given in 25 ml of water without substrate carrier or nutrient-dense meal, and breath samples were collected over a 60-min period. The amount of 14CO2 excreted at 10 min was independent of the rate of gastric emptying and was not quantitatively influenced by the buccal urease activity. The 10-min 14CO2 values discriminated well between Helicobacter pylori positive and negative patients (94% sensitivity, 89% specificity) and correlated with the number of organisms assessed by histology. The test was a good predictor of chronic gastritis (95% sensitivity and 96% specificity), and a quantitative relationship was observed between 14CO2 values and the severity and activity of the gastritis. In H. pylori positive patients, breath 14CO2 was found to be similar in patients with and without ulcer disease, suggesting that the number of bacteria is not a determining factor for the onset of ulceration

  12. Quantification of Helicobacter pylori infection in gastritis and ulcer disease using a simple and rapid carbon-14-urea breath test

    Debongnie, J.C.; Pauwels, S.; Raat, A.; de Meeus, Y.; Haot, J.; Mainguet, P. (Department of Nuclear Medicine, University of Louvain Medical School, Brussels (Belgium))

    1991-06-01

    Gastric urease was studied isotopically in 230 patients with biopsy-proven normal mucosa or chronic gastritis, including 59 patients with ulcer disease. Carbon-14-urea was given in 25 ml of water without substrate carrier or nutrient-dense meal, and breath samples were collected over a 60-min period. The amount of 14CO2 excreted at 10 min was independent of the rate of gastric emptying and was not quantitatively influenced by the buccal urease activity. The 10-min 14CO2 values discriminated well between Helicobacter pylori positive and negative patients (94% sensitivity, 89% specificity) and correlated with the number of organisms assessed by histology. The test was a good predictor of chronic gastritis (95% sensitivity and 96% specificity), and a quantitative relationship was observed between 14CO2 values and the severity and activity of the gastritis. In H. pylori positive patients, breath 14CO2 was found to be similar in patients with and without ulcer disease, suggesting that the number of bacteria is not a determining factor for the onset of ulceration.

  13. 14C-lactose breath tests during pelvic radiotherapy: the effect of the amount of small bowel irradiated

    Thirty patients who were undergoing pelvic radiotherapy had 14C-lactose breath tests performed in the first and fifth weeks of treatment. In Group I (21 patients), a significant portion of the small intestine was irradiated, and in Group II (9 patients), only a small portion of the small intestine was irradiated. In Group I, the average reductions in the excretion of ingested 14C between the first- and fifth-week tests were 41.5% at 1/2 hour postingestion (p0.05). The data suggest that lactose malabsorption is a factor in the etiology of the nausea, vomiting, and diarrhea experienced by patients who are undergoing pelvic radiotherapy, and that the amount of bowel included in the treatment volume significantly influences the degree of malabsorption

  14. Measurement of the rate of fat absorption by the 14C-triolein breath test

    To characterize the extent to which continuous measurement of the rate of 14CO2 excretion following the oral administration of 14C-labeled triolein (14C-T) would estimate the rate of absorption of triolein by the gut, ten adult male rats were fed 0.5 ml of 14C-T and the rate of production of expired labeled CO2 was measured continuously. Pairs of animals were sacrificed at 30 min intervals between 90 and 210 min and absorption rates were calculated by quantitating substrate remaining in the gut. Comparison of these rates with the cumulative excretion rates of labeled CO2 revealed a linear relationship with a correlation coefficient of 0.91. In a second experiment, adult rats received an intravenous injection of Triton WR-1339, a potent inhibitor of lipoprotein lipase, prior to receiving 14C-T. The rate of intestinal 14C-triglyceride output was determined from the increase in 14C in the blood over a 6 hr period. Comparison of the rates of intestinal secretion using Triton WR-1339 with that determined from the cumulative rates of excretion of 14CO2 revealed a correlation coefficient of 0.98. The authors conclude that rates of triglyceride absorption can be estimated in vivo by the continuous measurement of labeled CO2 excreted in breath

  15. The 1-g 14C-d-xylose breath test in gallstone patients with and without duodenal diverticula

    To assess whether gallstone patients with duodenal diverticula have bacterial overgrowth in the proximal small bowel, the results of the 1-g 14C-d-xylose breath test were compared in 24 patients with duodenal diverticula, and in 24 without diverticula. All patients had been treated with endoscopic papillotomy (EPT) for stones in the common bile duct before the study, and cholecystectomy had previously been performed in 20 patients. No significant differences between the groups were found concerning age, sex and body weight. Cummulative 14CO2 expired in 3 h in percentage of administered dose of 14C-d-xylose was 8.55% (7.58-9.57%) and 7.38% (6.32-8.96%) in patients with and without diverticula, respectively (p=0.06), indicating a higher bacterial activity in the small bowel in patients with duodenal diverticula than in those without diverticula. The results appeared to be influenced by cholecystectomy

  16. Breath sounds

    Causes of abnormal breath sounds may include: Acute bronchitis Asthma Bronchiectasis Chronic bronchitis Congestive heart failure Emphysema Interstitial lung disease Foreign body obstruction of the airway Pneumonia Pulmonary edema Tracheobronchitis

  17. Breath sounds

    The lung sounds are best heard with a stethoscope. This is called auscultation. Normal lung sounds occur ... the bottom of the rib cage. Using a stethoscope, the doctor may hear normal breathing sounds, decreased ...

  18. Bad Breath

    ... garlic, onions, cheese, orange juice, and soda poor dental hygiene (say: HI-jeen), meaning not brushing and flossing regularly smoking and other tobacco use Poor oral hygiene leads to bad breath because when food particles ...

  19. Breathing difficulty

    ... getting enough air Considerations There is no standard definition for difficulty breathing. Some people feel breathless with ... M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health ...

  20. Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: Comparison with Child-Pugh score and serum bile acid levels

    D. Festi; P. Portincasa; E. Roda; A. Colecchia; S. Capodicasa; L. Sandri; L. Colaiocco-Ferrante; T. Staniscia; E. Vitacolonna; A. Vestito; P. Simoni; G. Mazzella

    2005-01-01

    AIM: To evaluate and compare the clinical usefulness of 13C-phenylalanine and 13C-methacetin breath tests in quantitating functional hepatic mass in patients with chronic liver disease and to further compare these results with those of conventional tests, Child-Pugh score and serum bile acid levels.METHODS: One hundred and forty patients (50 HCV-related chronic hepatitis, 90 liver cirrhosis patients) and 40 matched healthy controls were studied. Both breath test and routine liver test, serum levels of cholic and chenodeoxycholic acid conjugates were evaluated.RESULTS: Methacetin breath test, expressed as 60 min cumulative percent of oxidation, discriminated the hepatic functional capacity not only between controls and liver disease patients, but also between different categories of chronic liver disease patients. Methacetin breath test was correlated with liver function tests and serum bile acids.Furthermore, methacetin breath test, as well as serum bile acids, were highly predictive of Child-Pugh scores. The diagnostic power of phenylalanine breath test was always less than that of methacetin breath test.CONCLUSION: Methacetin breath test represents a safe and accurate diagnostic tool in the evaluation of hepatic functional mass in chronic liver disease patients.

  1. Cardiogenic oscillation phase relationships during single-breath tests performed in microgravity

    Lauzon, A. M.; Elliott, A. R.; Paiva, M.; West, J. B.; Prisk, G. K.

    1998-01-01

    We studied the phase relationships of the cardiogenic oscillations in the phase III portion of single-breath washouts (SBW) in normal gravity (1 G) and in sustained microgravity (microG). The SBW consisted of a vital capacity inspiration of 5% He-1.25% sulfurhexafluoride-balance O2, preceded at residual volume by a 150-ml Ar bolus. Pairs of gas signals, all of which still showed cardiogenic oscillations, were cross-correlated, and their phase difference was expressed as an angle. Phase relationships between inspired gases (e.g., He) and resident gas (n2) showed no change from 1 G (211 +/- 9 degrees) to microG (163 +/- 7 degrees). Ar bolus and He were unaltered between 1 G (173 +/- 15 degrees) and microG (211 +/- 25 degrees), showing that airway closure in microG remains in regions of high specific ventilation and suggesting that airway closure results from lung regions reaching low regional volume near residual volume. In contrast, CO2 reversed phase with He between 1 G (332 +/- 6 degrees) and microG (263 +/- 27 degrees), strongly suggesting that, in microG, areas of high ventilation are associated with high ventilation-perfusion ratio (VA/Q). This widening of the range of VA/Q in microG may explain previous measurements (G.K. Prisk, A.R. Elliott, H.J.B. Guy, J.M. Kosonen, and J.B. West J. Appl. Physiol. 79: 1290-1298, 1995) of an overall unaltered range of VA/Q in microG, despite more homogeneous distributions of both ventilation and perfusion.

  2. Application of 13C-urea breath test in patients diagnosed as H. pylori-negative by gastroscopy

    13C-urea breath test(13C-UBT)was used to evaluate infection rate of H. pylori(HP) and effect of HP eradication in patients diagnosed as HP-negative by histology and rapid urease test. Patiens without gastrointestinal disorders were set as control group. Within 640 patients diagnosed as HP-negative by histology and rapid urease test, there were 389 patients showed HP-positive by 13C-UBT. The positive rate of HP was 60.8%. 389 patients diagnosed as HP- positive by 13C-UBT were treated with PPI-based triple therapy, PPI-based double therapy and single PPI therapy, respectively. After treatment, the negative rate of 13C-UBT was 83.8%, 18.4% and 3.3%, respectively. The results showed significant difference between three kinds of therapy (P13C-UBT could improve the diagnostic rate of HP to patients who diagnosed as HP-negative by histology and rapid urease test. (authors)

  3. Can the C-14 urea breath test reflect the extent and degree of ongoing helicobacter pylori infection

    The C-14 urea breath test (C-14 UBT) is the most specific noninvasive method to detect Helicobacter (H) pylori infection. We investigated if the C-14 UBT can reflect the presence and degree of H. pylori detected by gastroduodenoscopic biopsies (GBx). One hundred fifty patients (M:F=83:67,age 48.6±11.2 yrs) underwent C-14 UBT, rapid urease test (CLO test) and GBx on the same day. For the C-14 UBT, a single breath sample was collected at 10 minutes after ingestion of C-14 urea (137 KBq) capsule and counting was done in a liquid scintillation counter for 1 minute, and the results were classified as positive (≥200 dpm), intermediate ( 50 ∼ 199 dpm) or negative ( < 50 dpm). The results of CLO tests were classified as positive or negative according to color change. The results of GBx on giemsa stain were graded 0 (normal) to 4(diffuse) according to the distribution of H. pylori by the Wyatt method. We compared C-14 UBT results with GBx grade as a gold standard. In the assessment of the presence of H. pylori infection, the C-14 UBT global performance yielded sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of 92.5%, 88.4%, 97.1%, 88.4% and 91.3%, respectively. However, the CLO test had sensitivity, specificity, PPV, NPV and accuracy of 83.2%, 81.4%, 91.8%, 81.4% and 82.7%, respectively. The quantitative values of the C-14 UBT were 45 ± 27 dpm in grade 0, 707 ±584 dpm in grade 1, 1558±584 dpm in grade 2, 1851±604 dpm in grade 3, and 2719 ± 892 dpm in grade 4. A significant correlation (r=0.848, p<0.01) was found between C-14 UBT and the grade of distribution of H. pylori infection on GBx with giemsa stain. We conclude that the C-14 UBT is a highly accurate, simple and noninvasive method for the diagnosis of ongoing H. pylori infection and reflects the degree of bacterial distribution

  4. Comparison of the 1-gram [14C]xylose, 10-gram lactulose-H2, and 80-gram glucose-H2 breath tests in patients with small intestine bacterial overgrowth

    The sensitivity of three breath tests (1-g [14C]xylose, 10-g lactulose-H2, and 80-g glucose-H2) was studied in 20 subjects with culture-documented small intestine bacterial overgrowth. Elevated breath 14CO2 levels were seen within 30 min of [14C]xylose administration in 19 of 20 subjects with bacterial overgrowth and 0 of 10 controls. In contrast, H2 breath tests demonstrated uninterpretable tests (absence of H2-generating bacteria) in 2 of 20 subjects with bacterial overgrowth and 1 of 10 controls and nondiagnostic increases in H2 production in 3 of 18 glucose-H2 and 7 of 18 lactulose-H2 breath tests in subjects with bacterial overgrowth. These findings demonstrate continued excellent reliability of the 1-g [14C]xylose breath test as a diagnostic test for bacterial overgrowth, indicate inadequate sensitivity of H2 breath tests in detecting bacterial overgrowth, and suggest the need for evaluation of a 13CO2 breath test having the same characteristics as the [14C]xylose test (avidly absorbed substrate having minimal contact with the colonic flora) for nonradioactive breath detection of bacterial overgrowth in children and reproductive-age women

  5. 13C-tryptophan breath test detects increased catabolic turnover of tryptophan along the kynurenine pathway in patients with major depressive disorder

    Toshiya Teraishi; Hiroaki Hori; Daimei Sasayama; Junko Matsuo; Shintaro Ogawa; Miho Ota; Kotaro Hattori; Masahiro Kajiwara; Teruhiko Higuchi; Hiroshi Kunugi

    2015-01-01

    Altered tryptophan–kynurenine (KYN) metabolism has been implicated in major depressive disorder (MDD). The l-[1-13C]tryptophan breath test (13C-TBT) is a noninvasive, stable-isotope tracer method in which exhaled 13CO2 is attributable to tryptophan catabolism via the KYN pathway. We included 18 patients with MDD (DSM-IV) and 24 age- and sex-matched controls. 13C-tryptophan (150 mg) was orally administered and the 13CO2/12CO2 ratio in the breath was monitored for 180 min. The cumulative recove...

  6. Occult H. pylori infection partially explains ‘false-positive’ results of 13C-urea breath test

    Ramírez-Lázaro, María J; Lario, Sergio; Sánchez-Delgado, Jordi; Montserrat, Antònia; Quílez, Elisa M; Casalots, Alex; Suarez, David; Campo, Rafel; Brullet, Enric; Junquera, Félix; Sanfeliu, Isabel; Segura, Ferran

    2015-01-01

    Background In a previous study, UBiT-100 mg, (Otsuka, Spain), a commercial 13C-urea breath test omitting citric acid pre-treatment, had a high rate of false-positive results; however, it is possible that UBiT detected low-density ‘occult’ infection missed by other routine reference tests. We aimed to validate previous results in a new cohort and to rule out the possibility that false-positive UBiT were due to an ‘occult’ infection missed by reference tests. Methods Dyspeptic patients (n = 272) were prospectively enrolled and UBiT was performed, according to the manufacturer’s recommendations. Helicobacter pylori infection was determined by combining culture, histology and rapid urease test results. We calculated UBiT sensitivity, specificity, positive and negative predictive values (with 95% CI). In addition, we evaluated ‘occult’ H. pylori infection using two previously-validated polymerase chain reaction (PCR) methods for urease A (UreA) and 16 S sequences in gastric biopsies. We included 44 patients with a false-positive UBiT, and two control groups of 25 patients each, that were positive and negative for all H. pylori tests. Results UBiT showed a false-positive rate of 17%, with a specificity of 83%. All the positive controls and 12 of 44 patients (27%) with false-positive UBiT were positive for all two PCR tests; by contrast, none of our negative controls had two positive PCR tests. Conclusions UBiT suffers from a high rate of false-positive results and sub-optimal specificity, and the protocol skipping citric acid pre-treatment should be revised; however, low-density ‘occult’ H. pylori infection that was undetectable by conventional tests accounted for around 25% of the ‘false-positive’ results. PMID:26535122

  7. Carbon sequestration and estimated carbon credit values as measured using 13C labeling and analysis by an optical breath test analyser

    Full text: Recent developments in optical systems for breath testing have provided a robust, low-cost option for undertaking 13C analysis. Although these systems were initially developed for breath testing for Helicobacter pylori, they have an enormous potential as a soil science research tool. The relatively low cost of the equipment at US$ 15000-25000 is within the research budgets of most institutes or universities. The simplicity of the mechanisms and optical nature mean that the equipment requires relatively low maintenance and minimal training. Thus methods were developed to prepare soil and plant materials for analysis using the breath test analyser. Results that compare the conventional mass spectrometry methods with the breath test analyser will be presented. In combination with simple 13C-plant-labeling techniques it is possible to devise methods for estimating carbon sequestration under different agronomic management practices within a short time frame. This allows an assessment of the carbon credit value of a particular agronomic practice, which can in turn be used by policy makers for decision-making purposes. For a global understanding of the effect of agricultural practices on the carbon cycle data is required from a range of cropping systems and agro-ecological zones. The method and the approach described will allow collection of hard data within a reasonable time frame. (author)

  8. Carbon sequestration and estimated carbon credit values as measured using 13C labelling and analysis by means of an optical breath test analyser.

    Hood, R C; Khan, M; Haque, A; Khadir, M; Bonetto, J P; Syamsul, R; Mayr, L; Heiling, M

    2004-05-01

    Recent developments in optical systems (isotope-selective non-dispersive infrared spectrometry) for breath testing have provided a robust, low-cost option for undertaking (13)C analysis. Although these systems were initially developed for breath testing for Helicobacter pylori, they have an enormous potential as a soil science research tool. The relatively low cost of the equipment, US$15,000-25,000, is within the research budgets of most institutes or universities. The simplicity of the mechanisms and optical nature mean that the equipment requires relatively low maintenance and minimal training. Thus methods were developed to prepare soil and plant materials for analysis using the breath test analyser. Results that compare conventional mass spectrometric methods with the breath test analyser will be presented. In combination with simple (13)C-plant-labeling techniques it is possible to devise methods for estimating carbon sequestration under different agronomic management practices within a short time frame. This enables assessment of the carbon credit value of a particular agronomic practice, which can in turn be used by policy makers for decision-making purposes. For global understanding of the effect of agricultural practices on the carbon cycle, data are required from a range of cropping systems and agro-ecological zones. The method and the approach described will enable collection of hard data within a reasonable time. PMID:14963630

  9. Breathing Problems? Learn to Recognize the Symptoms of COPD

    ... Printable Version (PDF—498 kb) Coping with Grief Breathing Problems? Breathing Problems? Learn to Recognize the Symptoms of COPD ... health care provider and ask for a simple breathing test called spirometry. Together, you can come up ...

  10. How to breathe when you are short of breath

    Pursed lip breathing; COPD - pursed lip breathing; Emphysema - pursed lip breathing; Chronic bronchitis - pursed lip breathing; Pulmonary fibrosis - pursed lip breathing; Interstitial lung disease - pursed lip breathing; Hypoxia - pursed lip breathing; ...

  11. Turnover of carbon in the {sup 13}C-urea breath test for the detection of Helicobacter pylori infection

    Costa, Vladimir E.; Andreazzi, Mariana; Cury, Caio S.; Bassetto Junior, Carlos A.Z.; Rodrigues, Maria A.M.; Ducatti, Carlos, E-mail: vladimir@ibb.unesp.br, E-mail: ducatti@ibb.unesp.br, E-mail: mariana.andreazazi@gmail.com, E-mail: caiocury@hotmail.com, E-mail: juniorbassett@hotmail.com, E-mail: mariar@fmb.unesp.br [Universidade Estadual Paulista Julio de Mesquita Filho (UNESP), Botucatu, SP (Brazil)

    2013-07-01

    To obtain a standard protocol for the application of {sup 13}C-urea breath test ({sup 13}C-UBT) analyzed by Isotope Ratio Mass Spectrometer (IRMS) to detect helicobacter pylori infection in the population is necessary to know the behavior of the turnover of {sup 13}C during the test in different individuals. The aims of this study was to find out a pattern for the turnover of the {sup 13}C in the {sup 13}C-UBT, analyzed by IRMS, in patients infected with H. pylori, in a Brazilian population, to define a protocol test application. We found that the isotopic ratio {sup 13}C/{sup 12}C in expired CO{sub 2} from patients infected with H. pylori and subjected to {sup 13}C-UBT does not follow a single pattern of behavior. However this behavior can be similar in subjects having the same maximum values following an inverse proportional relationship between the maximum value and the time of appearance in the curve. (author)

  12. Evaporative emissions in three-day diurnal breathing loss tests on passenger cars for the Japanese market

    Yamada, Hiroyuki; Inomata, Satoshi; Tanimoto, Hiroshi

    2015-04-01

    Breakthrough emissions that dominate diurnal evaporative emissions from gasoline vehicles were observed in continuous 3-day diurnal breathing loss (DBL) tests. These measurements were conducted on nine vehicles for the Japanese market. Two of these vehicles, made by US and European manufacturers, also meet regulations in their countries of origin. Four vehicles exhibited marked emissions caused by breakthrough emissions during the experimental period, all made by Japanese manufacturers. Using our experimental results, we estimate the total diurnal evaporative emissions from gasoline vehicles in Japan to be 32,792 t y-1. The compositions of the breakthrough and permeation emissions were analyzed in real time using proton transfer reaction plus switchable reagent ion mass spectrometry to estimate the ozone formation potential for the evaporative emissions. The real-time measurements showed that the adsorption of hydrocarbons in a sealed housing evaporative determination unit can result in underestimation, when concentrations are only monitored before and after a DBL test. The composition analysis gave an estimated maximum incremental reactivity (MIR) 20% higher for the breakthrough emissions than for the gasoline that was tested, while the MIR for the permeation emissions was almost the same as the MIR for the fuel. Evaporative emissions from gasoline vehicles in Japan were found to contribute 4.2% to emissions from stationary sources using a mass-based estimate, or 6.1% of emissions from stationary sources using a MIR-based estimate.

  13. Helicobacter pylori Infection in Infants and Toddlers in South America: Concordance between [13C]Urea Breath Test and Monoclonal H. pylori Stool Antigen Test

    Saito, Mayuko; Rocha, Gifone Aguiar; Rocha, Andreia Maria Camargos; Melo, Fabrício Freire; Checkley, William; Braga, Lúcia Libanez Bessa C.; Silva, Igor Simões; Gilman, Robert H.

    2013-01-01

    Accurate noninvasive tests for diagnosing Helicobacter pylori infection in very young children are strongly required. We investigated the agreement between the [13C]urea breath test ([13C]UBT) and a monoclonal ELISA (HpSA) for detection of H. pylori antigen in stool. From October 2007 to July 2011, we enrolled 414 infants (123 from Brazil and 291 from Peru) of ages 6 to 30 months. Breath and stool samples were obtained at intervals of at least 3 months from Brazilian (n = 415) and Peruvian (n = 908) infants. [13C]UBT and stool test results concurred with each other in 1,255 (94.86%) cases (kappa coefficient = 0.90; 95% confidence interval [CI] = 0.87 to 0.92). In the H. pylori-positive group, delta-over-baseline (DOB) and optical density (OD) values were positively correlated (r = 0.62; P < 0.001). The positivity of the tests was higher (P < 0.001; odds ratio [OR] = 6.01; 95% CI = 4.50 to 8.04) in Peru (546/878; 62.2%) than in Brazil (81/377; 21.5%) and increased with increasing age in Brazil (P = 0.02), whereas in Peru it decreased with increasing age (P < 0.001). The disagreement between the test results was associated with birth in Brazil and female gender but not with age and diarrhea. Our results suggest that both [13C]UBT and the stool monoclonal test are reliable for diagnosing H. pylori infection in very young children, which will facilitate robust epidemiological studies in infants and toddlers. PMID:24006009

  14. Hydrogen breath test for the diagnosis of lactose intolerance, is the routine sugar load the best one?

    Fiorenza Argnani, Mauro Di Camillo, Vanessa Marinaro, Tiziana Foglietta, Veronica Avallone, Carlo Cannella, Piero Vernia

    2008-10-01

    Full Text Available AIM: To evaluate the prevalence of lactose intolerance (LI following a load of 12.5 g in patients diagnosed as high-grade malabsorbers using the hydrogen breath test (HBT-25.METHODS: Ninety patients showing high-grade malabsorption at HBT-25 were submitted to a second HBT with a lactose load of 12.5 g. Peak hydrogen production, area under the curve of hydrogen excretion and occurrence of symptoms were recorded.RESULTS: Only 16 patients (17.77% with positive HBT-25 proved positive at HBT-12.5. Hydrogen production was lower as compared to HBT-25 (peak value 21.55 parts per million (ppm ± 29.54 SD vs 99.43 ppm ± 40.01 SD; P < 0.001. Symptoms were present in only 13 patients. The absence of symptoms during the high-dose test has a high negative predictive value (0.84 for a negative low-dose test. The presence of symptoms during the first test was not useful for predicting a positive low-dose test (positive predictive value 0.06-0.31.CONCLUSION: Most patients with a positive HBT-25 normally absorb a lower dose of lactose and a strict lactose restriction on the basis of a “standard” HBT is, in most instances, unnecessary. Thus, the 25 g lactose tolerance test should probably be substituted by the 12.5 g test in the diagnosis of LI, and in providing dietary guidelines to patients with suspected lactose malabsorption/intolerance.

  15. Hydrogen breath test for the diagnosis of lactose intolerance, is the routine sugar load the best one?

    Fiorenza Argnani; Mauro Di Camillo; Vanessa Marinaro; Tiziana Foglietta; Veronica Avallone; Carlo Cannella; Piero Vernia

    2008-01-01

    AIM: To evaluate the prevalence of lactose intolerance (LI) following a load of 12.5 g in patients diagnosed as high-grade malabsorbers using the hydrogen breath test (HBT)-25. METHODS: Ninety patients showing high-grade malabsorption at HBT-25 were submitted to a second HBT with a lactose load of 12.5 g. Peak hydrogen production, area under the curve of hydrogen excretion and occurrence of symptoms were recorded. RESULTS: Only 16 patients (17.77%) with positive HBT-25 proved positive at HBT-12.5. Hydrogen production was lower as compared to HBT-25 (peak value 21.55 parts per million (ppm)±29.54 SD vs 99.43 ppm±40.01 SD; P<0.001). Symptoms were present in only 13 patients. The absence of symptoms during the high-dose test has a high negative predictive value (0.84) for a negative low-dose test. The presence of symptoms during the first test was not useful for predicting a positive low-dose test (positive predictive value 0.06-0.31). CONCLUSION: Most patients with a positive HBT-25 normally absorb a lower dose of lactose and a strict lactose restriction on the basis of a "standard" HBT is, in most instances, unnecessary. Thus, the 25 g lactose tolerance test should probably be substituted by the 12.5 g test in the diagnosis of LI, and in providing dietary guidelines to patients with suspected lactose malabsorption/intolerance.

  16. An inventory of aeronautical ground research facilities. Volume 2: Air breathing engine test facilities

    Pirrello, C. J.; Hardin, R. D.; Heckart, M. V.; Brown, K. R.

    1971-01-01

    The inventory covers free jet and direct connect altitude cells, sea level static thrust stands, sea level test cells with ram air, and propulsion wind tunnels. Free jet altitude cells and propulsion wind tunnels are used for evaluation of complete inlet-engine-exhaust nozzle propulsion systems under simulated flight conditions. These facilities are similar in principal of operation and differ primarily in test section concept. The propulsion wind tunnel provides a closed test section and restrains the flow around the test specimen while the free jet is allowed to expand freely. A chamber of large diameter about the free jet is provided in which desired operating pressure levels may be maintained. Sea level test cells with ram air provide controlled, conditioned air directly to the engine face for performance evaluation at low altitude flight conditions. Direct connect altitude cells provide a means of performance evaluation at simulated conditions of Mach number and altitude with air supplied to the flight altitude conditions. Sea level static thrust stands simply provide an instrumented engine mounting for measuring thrust at zero airspeed. While all of these facilities are used for integrated engine testing, a few provide engine component test capability.

  17. Biokinetics and radiation dosimetry for patients undergoing a glycerol tri[1-14C]oleate fat malabsorption breath test

    The glycerol tri[1-14C]olein test for fat malabsorption was carried out in two male volunteers and measurements of the loss of 14C in expired air, urine and faeces and the retention of 14C in biopsy samples of abdominal fat were made using accelerator mass spectrometry. Exhalation accounted for 73% and 55% of the administered activity and could be described by three-component exponential functions with halftimes of about 1 h, 2 days and 150 days, respectively. Urinary excretion accounted for 24% of the administered activity, almost all during the first 24 h after administration; about 2% was excreted in the faeces in 48 h. The halftime of retention of 14C in fat ranged from 137 to 620 days. Absorbed dose calculations indicate that for a normal adult the largest dose, 1.5-7.0 mGy/MBq is received by the adipose tissue, and that the effective dose is 0.3-0.5 mSv/MBq. It is concluded that no restrictions need to be placed on radiation safety grounds on the administration of 0.05-0.1 MBq 14C-triolein for the triolein breath test

  18. 14C-lactose breath tests during pelvic radiotherapy: the effect of the amount of small bowel irradiated

    Thirty patients who were undergoing pelvic radiotherapy had 14C-lactose breath tests performed in the first and fifth weeks of treatment. In Group I (21 patients), a significant portion of the small intestine was irradiated, and in Group II (9 patients), only a small portion of the small intestine was irradiated. In Group I, the average reductions in the excretion of ingested 14C between the first- and fifth-week tests were 41.5% at 1/2 hour postingestion (p less than 0.05), and 21.8% at 1 hour postingestion (p less than 0.05). In Group II, the percentage reductions were 11.8% and 3.7% at 1/2 and 1 hour, respectively (p greater than 0.05). The data suggest that lactose malabsorption is a factor in the etiology of the nausea, vomiting, and diarrhea experienced by patients who are undergoing pelvic radiotherapy, and that the amount of bowel included in the treatment volume significantly influences the degree of malabsorption

  19. Design, fabrication and testing of an air-breathing micro direct methanol fuel cell with compound anode flow field

    An air-breathing micro direct methanol fuel cell (μDMFC) with a compound anode flow field structure (composed of the parallel flow field and the perforated flow field) is designed, fabricated and tested. To better analyze the effect of the compound anode flow field on the mass transfer of methanol, the compound flow field with different open ratios (ratio of exposure area to total area) and thicknesses of current collectors is modeled and simulated. Micro process technologies are employed to fabricate the end plates and current collectors. The performances of the μDMFC with a compound anode flow field are measured under various operating parameters. Both the modeled and the experimental results show that, comparing the conventional parallel flow field, the compound one can enhance the mass transfer resistance of methanol from the flow field to the anode diffusion layer. The results also indicate that the μDMFC with an anode open ratio of 40% and a thickness of 300 µm has the optimal performance under the 7 M methanol which is three to four times higher than conventional flow fields. Finally, a 2 h stability test of the μDMFC is performed with a methanol concentration of 7 M and a flow velocity of 0.1 ml min−1. The results indicate that the μDMFC can work steadily with high methanol concentration.

  20. Breathing and Relaxation

    ... related breathing difficulties. Learn some ways to control breathing and some techniques to help you reach a greater level of relaxation during your day: Diaphragmatic Breathing Minimizing Shortness of Breath Instant Relaxation Drill Meditation ...

  1. Traveling with breathing problems

    If you have breathing problems and you: Are short of breath most of the time Get short of breath when you walk 150 ... or less Have been in the hospital for breathing problems recently Use oxygen at home, even if ...

  2. Comparison of a monoclonal antigen stool test (Hp StAR) with the 13C-urea breath test in monitoring Helicobacter pylori eradication therapy

    Francesco Perri; Michele Quitadamo; Rosalba Ricciardi; Ada Piepoli; Rosa Cotugno; Annamaria Gentile; Alberto Pilotto; Angelo Andriulli

    2005-01-01

    AIM: To evaluate the agreement between a mAb-based stool test (HP StAR) and the urea breath test (UBT) in monitoring (H pylori) infection after eradication therapy.METHODS: Patients with discordant results on UBT and Hp StAR underwent endoscopy with biopsies for rapid urease test, culture, and histology to confirm H pylori status.RESULTS: Among 250 patients (50±14 years), 240 (96.0%) had concordant UBT and Hp StAR tests with a significant correlation between DOB and A values (R = 0.87; P<0.0001).The remaining 10 (4.0%) patients had discordant tests (positive Hp StAR and negative UBT) with the Hp StAR inaccurate in five cases (false positive) and UBT inaccurate in the other five cases (false negative). The "maximal expected" sensitivity, specificity, +PV, -PV, +LR, and -LR were 91%, 100%, 100%, 97.4%, ∞, and 8.2 respectively,for the UBT, and 100%, 97.4%, 91%, 100%, 38.8, and 0,respectively, for the Hp StAR. Overall accuracy for both tests was 98%.CONCLUSION: Both the UBT and the Hp StAR are equally accurate in monitoring H pylori infection. Nowadays,the choice of the "best" non-invasive H pylori test in the post-treatment setting should be done not only in terms of diagnostic accuracy but also in view of cost and local facilities.

  3. Intestinal transport and fermentation of resistant starch evaluated by the hydrogen breath test

    Olesen, M; Rumessen, J J; Gudmand-Høyer, E

    1994-01-01

    To study fermentability of different samples of resistant starch (RS), compared to one another and to lactulose, and to study the effect on gastric emptying of addition of RS to test meal. Finally to study if adaptation to RS results in a measurable change in fermentation pattern, (H2/CH4 product...... production). Sources of RS: Raw potato starch (RPS), 58% RS; corn flakes (CF), 5% RS; hylon VII high amylomaize starch, extrusion cooked and cooled (HAS) 30% RS; highly retrograded hylon VII high amylomaize starch (HRA) 89% RS.......To study fermentability of different samples of resistant starch (RS), compared to one another and to lactulose, and to study the effect on gastric emptying of addition of RS to test meal. Finally to study if adaptation to RS results in a measurable change in fermentation pattern, (H2/CH4...

  4. 13C-methacetin breath test reproducibility study reveals persistent CYP1A2 stimulation on repeat examinations

    Anna Kasicka-Jonderko; Anna Nita; Krzysztof Jonderko; Magdalena Kami(n)ska; Barbara B(l)o(n)ska-Fajfrowska

    2011-01-01

    AIM: To find the most reproducible quantitative parameter of a standard 13C-methacetin breath test (13C-MBT).METHODS: Twenty healthy volunteers (10 female, 10 male) underwent the 13C-MBT after intake of 75 mg 13C-methacetin p.o. on three occasions. Short- and medium-term reproducibility was assessed with paired examinations taken at an interval of 2 and 18 d (medians), respectively.RESULTS: The reproducibility of the 1-h cumulative 13C recovery (AUC0-60), characterized by a coefficient of variation of 10%, appeared to be considerably better than the reproducibility of the maximum momentary 13C recovery or the time of reaching it. Remarkably, as opposed to the short gap between consecutive examinations, the capacity of the liver to handle 13C-methacetin increased slightly but statistically significantly when a repeat dose was administered after two to three weeks. Regarding the AUC0-60, the magnitude of this fixed bias amounted to 7.5%. Neither the time gap between the repeat examinations nor the gender of the subjects affected the 13C-MBT reproducibility. CONCLUSION: 13C-MBT is most reproducibly quantified by the cumulative 13C recovery, but the exactitude thereof may be modestly affected by persistent stimulation of CYP1A2 on repeat examinations.

  5. Where c-14 urea breath tests lie in nuclear medicine. The detection of H pylori

    Since the early 20th century, ulcers have been believed to be caused by stress and dietary factors. Treatment had focussed on hospitalisation, bed rest, and prescription of special bland foods. Later on, gastric acid was blamed for ulcer disease. Antacids and medication that block acid production became the standard of therapy. Despite this treatment, there seemed to be a high recurrence of ulcers. In 1982 a pair of Australian physicians Robin Warren and Barry Marshall were first to identify a link between Helicobacter pylori (H. pylori) and ulcers, concluding that bacterium, not stress or diet, causes ulcers. However, the medical community was slow to accept their findings. It was not until 1994 that a Health Consensus Development Conference concluded that there was a strong association between H. pylori and ulcer diseases also recommending ulcer patients with H. pylori infection be treated with antibiotics. The paper discusses several tests, which have become available to medical staff in the detection of H. pylori. Sensitivity, specificity, relatively inexpensive ease of use and patient compliance are factors of a good diagnostic test. Copyright (2000) ANZ Nuclear Medicine

  6. Water cooling system for an air-breathing hypersonic test vehicle

    Petley, Dennis H.; Dziedzic, William M.

    1993-01-01

    This study provides concepts for hypersonic experimental scramjet test vehicles which have low cost and low risk. Cryogenic hydrogen is used as the fuel and coolant. Secondary water cooling systems were designed. Three concepts are shown: an all hydrogen cooling system, a secondary open loop water cooled system, and a secondary closed loop water cooled system. The open loop concept uses high pressure helium (15,000 psi) to drive water through the cooling system while maintaining the pressure in the water tank. The water flows through the turbine side of the turbopump to pump hydrogen fuel. The water is then allowed to vent. In the closed loop concept high pressure, room temperature, compressed liquid water is circulated. In flight water pressure is limited to 6000 psi by venting some of the water. Water is circulated through cooling channels via an ejector which uses high pressure gas to drive a water jet. The cooling systems are presented along with finite difference steady-state and transient analysis results. The results from this study indicate that water used as a secondary coolant can be designed to increase experimental test time, produce minimum venting of fluid and reduce overall development cost.

  7. Discussion on test and application of Reilly breathing technique for self-contained breathing apparatus%自给正压式空气呼吸器R式呼吸法测试与应用探析

    胡晔

    2014-01-01

    Reilly emergency breathing technique,as one of basic skills of fireground survival for firefighters,can efficiently prolong the consumption time of self-contained breathing apparatus in case of disorientation,trauma or entrapment,and raise the success rate of rapid intervention. The values were tested,compared and analyzed be-tween the consumption time of 5 . 5 MPa air in cylinder with normal breathing model and Reilly emergency breathing technique in the state of running at 6 Km/h in treadmill and prone position in the field,and the proposal was put forward that the Reilly emergency breathing technique should be trained in the fire brigade and the rapid interven-tion system should be completed and implemented in order to improve the skills of breathing protection and the op-portunity of fireground survival.%对遇险消防员迅速实施二次救援是目前减少消防员火场伤亡的重要措施。当遭遇迷失、受伤、被困等意外而依靠自身的力量无法脱险、或空气呼吸器低压报警装置起鸣时,消防员如果能延长空气呼吸器的使用时间,就能够为外部救援力量的二次救援提供宝贵的时间,为成功获救创造条件。测试采用自由呼吸和R式呼吸法两种呼吸方式下、在跑步机上以6km/h的速度快步行走和俯卧状伏于地面两种运动状态下5.5MPa空气的使用时间。结果证明,采用R式呼吸法较之自由呼吸时空气的使用时间更长,采用R式呼吸法俯卧状伏于地面能更有效地延长空气的使用时间。为了提高火场遇险消防员的生存机率,应将R式呼吸法作为消防员基本生存技能纳入灭火救援业务训练大纲,规范消防员火场避险行动程序,并系统化地开展实战化专项训练。

  8. Prognostic value of 13C-phenylalanine breath test on predicting survival in patients with chronic liver failure

    I Gallardo-Wong; S Morán; G Rodríguez-Leal; B Casta(n)eda-Romero; R Mera; J Poo; M Uribe; M Dehesa

    2007-01-01

    AIM: To evaluate the prognostic value of percentage of 13C-phenylalanine oxidation (13C-PheOx) obtained by 13C-phenylalanine breath test (13C-PheBT) on the survival of patients with chronic liver failure.METHODS: The hepatic function was determined by standard liver blood tests and the percentage of 13C-PheOx in 118 chronic liver failure patients. The follow-up period was of 64 mo. Survival analysis was performed by the Kaplan-Meier method and variables that were significant (P < 0.10) in univariate analysis and subsequently introduced in a multivariate analysis according to the hazard model proposed by Cox.RESULTS: Forty-one patients died due to progressive liver failure during the follow-up period. The probability of survival at 12, 24, 36, 48 and 64 mo was 0.88, 0.78,0.66, 0.57 and 0.19, respectively. Multivariate analysis demonstrated that Child-Pugh classes, age, creatinine and the percentage of 13C-PheOx (HR 0.338, 95% CI:0.150-0.762, P = 0.009) were independent predictors of survival. When Child-Pugh classes were replaced by all the parameters of the score, only albumin, bilirubin,creatinine, age and the percentage of 13C-PheOx (HR 0.449, 95% CI: 0.206-0.979, P = 0.034) were found to be independent predictors of survival.CONCLUSION: Percentage of 13C-PheOx obtained by 13C-PheBT is a strong predictor of survival in patients with chronic liver disease.

  9. Experience with the 14C-aminopyrine breath test in hepatic cirrhosis and under the influence of diclofenac-sodium (Voltaren/sup R/)

    The 14C-aminopyrine breath test is a simple procedure for the non-invasive determination of the microsomal function of the liver. After oral administration of 74 kBq 14C-aminopyrine the 14CO2 activity of the expired breath air is determined in hourly intervals. There is a close correlation between its decrease and the elimination of aminopyrine from the plasma. Both the elimination constant of 14CO2 and the maximal specific 14CO2 activity are useful quantitative parameters of the test. They allow conclusions as to the hepatic demethylation capacity. Both parameters were significantly lower in 15 patients with liver cirrhosis than in 12 control patients. The non-steroidal anti-inflammatory drug diclofenac-sodium did not significantly influence the demethylation of 14C-aminopyrine in 5 patients with rheumatic diseases and in 2 healthy probands. Further experience with the breath test is necessary, especially with respect to its suitability for prospective investigation. (author)

  10. Increased accuracy of the carbon-14 D-xylose breath test in detecting small-intestinal bacterial overgrowth by correction with the gastric emptying rate

    The aim of this study was to determine whether the accuracy of 14C-D-xylose breath test for detecting bacterial overgrowth can be increased by correction with the gastric emptying rate of 14C-D-xylose. Ten culture-positive patients and ten culture-negative controls were included in the study. Small-intestinal aspirates for bacteriological culture were obtained endoscopically. A liquid-phase gastric emptying study was performed simultaneously to assess the amount of 14C-D-xylose that entered the small intestine. The results of the percentage of expired 14CO2 at 30 min were corrected with the amount of 14C-D-xylose that entered the small intestine. There were six patients in the culture-positive group with a 14CO2 concentration above the normal limit. Three out of four patients with initially negative results using the uncorrected method proved to be positive after correction. All these three patients had prolonged gastric emptying of 14C-D-xylose. When compared with cultures of small-intestine aspirates, the sensitivity and specificity of the uncorrected 14C-D-xylose breath test were 60% and 90%, respectively. In contrast, the sensitivity and specificity of the corrected 14C-D-xylose breath test improved to 90% and 100%, respectively. (orig./MG)